Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADIPOQ,Adiponectin,38013,-0.260118545574371,0.00598944099957986,-0.271857849933547,-0.248379241215194,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGRP,Agouti-related protein,40516,0.278718836358516,0.00462997734020372,0.269644080771717,0.287793591945316,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN1,CCN family member 1,40280,0.38100986779326,0.0068389380234638,0.367605549267271,0.394414186319249,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES1,Liver carboxylesterase 1,40352,0.302673595970582,0.0069059680748791,0.289137898543819,0.316209293397345,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F7,Coagulation factor VII,40376,0.114110714294912,0.00272733229099619,0.108765143004559,0.119456285585264,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FURIN,Furin,40411,0.133974099907276,0.00305125128594529,0.127993647386823,0.139954552427729,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCG,Pro-glucagon,39980,0.484557820296963,0.0113168285470002,0.462376836344842,0.506738804249083,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHR,Growth hormone receptor,37671,0.106800088918435,0.00261587478040897,0.101672974348833,0.111927203488036,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.303411193105101,0.00676334337838812,0.29015504008346,0.316667346126742,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF9,Protein turtle homolog A,37990,0.293080957153983,0.007227901053077,0.278914271089952,0.307247643218014,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INHBC,Inhibin beta C chain,40332,0.155919561176876,0.00389805020730527,0.148279382770558,0.163559739583195,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0819258949701096,0.00201844199521609,0.0779697486594861,0.0858820412807332,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LDLR,Low-density lipoprotein receptor,40356,0.432396962601006,0.00367469233167689,0.42519456563092,0.439599359571093,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPL,Lipoprotein lipase,40359,-0.194257039316499,0.00412421810447371,-0.202340506801267,-0.18617357183173,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFGE8,Lactadherin,40332,0.224944046183449,0.0036368118083784,0.217815895039028,0.232072197327871,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPY,Pro-neuropeptide Y,40489,0.354846834799766,0.00575150488793003,0.343573885219423,0.366119784380109,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.118662849818476,0.00286546929460062,0.113046530001059,0.124279169635893,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRAP1,Proline-rich acidic protein 1,37998,0.161082901009712,0.00383206002664626,0.153572063357485,0.168593738661939,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,40424,0.18341757716213,0.00417941311340235,0.175225927459861,0.191609226864399,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.13094916983333,0.0029917585909481,0.125085322995072,0.136813016671588,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.153548957394004,0.00385292314081685,0.145997228038003,0.161100686750005,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL27,C-C motif chemokine 27,40359,0.209661263228238,0.00546119049222103,0.198957329863484,0.220365196592991,2.01934983990875e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTH,Parathyroid hormone,37572,0.275803994924803,0.00719326047380739,0.261705204396141,0.289902785453466,5.79410715027154e-305
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL23,C-C motif chemokine 23,40422,0.142580647035719,0.00376854056929897,0.135194307519893,0.149966986551545,4.55347203428154e-300
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPM,Carboxypeptidase M,40415,0.118319161229951,0.0031516597372182,0.112141908145003,0.124496414314899,1.16037084838251e-295
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG2,Desmoglein-2,40332,-0.0928707310768121,0.00248027770821145,-0.0977320753849065,-0.0880093867687177,3.95683279004314e-294
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRP1,Neuropilin-1,40424,-0.097012469132057,0.0025922133622565,-0.10209320732208,-0.0919317309420343,6.51577690987041e-294
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD4,T-cell surface glycoprotein CD4,40309,0.10441971406319,0.00280830957819873,0.0989154272899209,0.10992400083646,3.23396576502444e-290
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR37,Prosaposin receptor GPR37,40042,0.228430322592808,0.00618069537229684,0.216316159663107,0.24054448552251,1.0540547866306e-286
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS15,Enteropeptidase,40305,0.309203891589409,0.00847870473778208,0.292585630303356,0.325822152875462,1.09966961535315e-279
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC39A5,Zinc transporter ZIP5,40341,0.17896683392198,0.00493572574488321,0.169292811462009,0.188640856381951,1.15683875630894e-276
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.268638059104333,0.00740968825500092,0.254115070124531,0.283161048084135,2.37505949153047e-276
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.292295544901514,0.00809191937258227,0.276435382931253,0.308155706871775,1.2195669797747e-274
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROC,Vitamin K-dependent protein C,40372,0.0840097465654886,0.00232880608715248,0.0794452866346697,0.0885742064963074,5.42310279860438e-274
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLTP,Phospholipid transfer protein,40461,-0.112605845264668,0.0031611304286471,-0.118801660904816,-0.10641002962452,1.57647346417692e-267
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APCS,Serum amyloid P-component,37882,0.117687460425304,0.00330052818163815,0.111218425189293,0.124156495661315,3.79600285113148e-266
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,40228,0.0955975331931722,0.00270975840969676,0.0902864067101665,0.100908659676178,1.73358743657733e-262
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.337455831799976,0.00968801152995894,0.318467329201257,0.356444334398696,3.2238075965701e-256
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.254539143566228,0.00731061379217891,0.240210340533557,0.268867946598899,5.16505884093287e-256
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300LG,CMRF35-like molecule 9,40332,-0.119626205676389,0.00349335741364997,-0.126473186207143,-0.112779225145635,5.11530570541905e-248
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.109646982143601,0.00321634759960102,0.103342940848383,0.115951023438819,5.60206210413927e-246
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.210732315000836,0.00625393227488819,0.198474607742056,0.222990022259617,1.84133390662278e-240
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTR,Transthyretin,37871,0.0794902079894597,0.00235951004099263,0.0748655683091142,0.0841148476698053,6.40105347894583e-239
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.320116601328643,0.00956073951314267,0.301377551882883,0.338855650774403,1.45766028803527e-237
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.168830886128642,0.00505016547199177,0.158932561803538,0.178729210453746,1.02212547358287e-236
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.458006304573359,0.0137224928651715,0.431110218557623,0.484902390589095,4.98188832640774e-236
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUSB,Beta-glucuronidase,40419,0.180537851903009,0.00542459605070719,0.169905643643622,0.191170060162395,7.03184930720218e-235
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL6,C-X-C motif chemokine 6,40516,0.239856903091084,0.00721261938761907,0.225720169091351,0.253993637090818,1.42890833559907e-234
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.258028311967256,0.0078053734084683,0.242729780086658,0.273326843847854,1.10312548180992e-231
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFI,Complement factor I,38013,0.0612019078113585,0.00186000894884143,0.0575562902716293,0.0648475253510877,1.63564161785398e-228
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F9,Coagulation factor IX,40372,0.0545773307246858,0.00166932755018234,0.0513054487263284,0.0578492127230432,5.62714312934973e-227
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRIP2,Cysteine-rich protein 2,40228,0.109612019334714,0.00335592097726675,0.103034414219271,0.116189624450156,1.73916126418181e-226
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINF1,Pigment epithelium-derived factor,37790,0.0777933320765154,0.00239959517874712,0.0730901255261711,0.0824965386268598,5.34612146781397e-222
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.156589689382632,0.00485184805690374,0.147080067191101,0.166099311574164,1.86154070541348e-221
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0912953272337154,0.00282629684150064,-0.0968348690430567,-0.0857557854243742,2.13644443340981e-220
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFH,Complement factor H,37301,0.0690870953312194,0.00213783646334114,0.0648969358630708,0.0732772547993681,2.38346755131399e-220
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPIND1,Heparin cofactor 2,37981,0.0818026600710146,0.00253506190017023,0.0768339387466809,0.0867713813953482,3.81761404632326e-220
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON3,Serum paraoxonase/lactonase 3,40422,-0.0813348721033596,0.00255048598280954,-0.0863338246296663,-0.0763359195770529,2.11645337463359e-216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.176662270488978,0.00557110744561481,-0.187581641082383,-0.165742899895573,5.46328584908763e-214
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0909780647653346,0.00287156933702262,0.0853497888647703,0.096606340665899,1.0357903678064e-213
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN3,Contactin-3,40332,0.103164503583721,0.00325626852201954,0.096782217280563,0.10954678988688,1.16502108207482e-213
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGR3,Anterior gradient protein 3,39963,0.175246599835092,0.00553905421978404,0.164390053564315,0.186103146105868,6.01551372707518e-213
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTA1,Glutathione S-transferase A1,40333,0.243381357258193,0.0076989252997337,0.228291463670715,0.258471250845671,9.21631084431066e-213
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFPI,Tissue factor pathway inhibitor,40309,0.0912545438552731,0.0028986216707772,0.0855732453805498,0.0969358423299964,4.52899616584634e-211
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.161157801672533,0.00513268292865087,0.151097743132378,0.171217860212689,5.38560282047905e-210
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAMR1,Inactive serine protease PAMR1,40332,0.0817150835577723,0.00260270843216485,0.0766137750307292,0.0868163920848155,5.64836801290378e-210
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA5,Plasma serine protease inhibitor,37835,0.0959274725304716,0.00305578377165751,0.0899381363380229,0.10191680872292,8.73735750147602e-209
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",39961,0.158695612229937,0.00509382138418928,0.148711722316926,0.168679502142948,9.75661999451387e-207
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFP,Properdin,38013,0.0632879314458799,0.0020318367832013,0.0593055313508054,0.0672703315409545,8.72049760563893e-206
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP5,Retinol-binding protein 5,40305,0.159791523676784,0.00515205327831887,0.14969349925128,0.169889548102289,4.29299450806594e-205
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.182686639547369,0.0059244094184358,-0.194298482007503,-0.171074797087234,6.78999325816589e-203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.167662311104488,0.00546285970509296,0.156955106082505,0.17836951612647,7.04666999089837e-201
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.334199464346381,0.0109448289380598,-0.355651329064979,-0.312747599627784,4.24740360171042e-199
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACY1,Aminoacylase-1,40359,0.168947288485889,0.00554923702884094,0.158070783909361,0.179823793062417,6.32360499225851e-198
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTA3,Glutathione S-transferase A3,39980,0.214671638819092,0.00705790157179802,0.200838151738367,0.228505125899816,1.99656076732166e-197
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPB1,Beta-ureidopropionase,37990,0.258165840239558,0.00849990194051128,0.241506032436156,0.274825648042961,4.40046780071384e-196
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAT,Tissue-type plasminogen activator,40490,0.137439647388978,0.00457698933506192,0.128468748292257,0.1464105464857,8.69886640421712e-193
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,40359,0.08377312016805,0.00279011984114511,0.0783044852794056,0.0892417550566944,1.05838526632351e-192
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF21,Fibroblast growth factor 21,40453,0.328102443328827,0.0109353848832181,0.306669088957719,0.349535797699934,1.80274180520452e-192
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.128404245246051,0.00429374391839858,0.11998850716599,0.136819983326112,3.7012681065506e-191
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0966129205882253,0.003232160887779,-0.102947955928272,-0.0902778852481785,4.15304409020472e-191
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMBP,Protein AMBP,40470,0.0558681686174453,0.00187020305316849,0.0522025706332351,0.0595337666016556,7.32447692232278e-191
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.205445239270963,0.00690766729683802,0.191906211369161,0.218984267172766,3.556909293928e-189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.202549524221565,0.00685136321666742,0.189120852316897,0.215978196126233,5.48089487077222e-187
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,39980,0.300067282142761,0.0101529574825812,0.280167485476902,0.31996707880862,8.16645546296404e-187
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,P4HB,Protein disulfide-isomerase,40266,0.106641858474989,0.00361139601047842,0.0995635222944512,0.113720194655527,1.35315656587569e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA4,Kallistatin,37781,0.0661007983490277,0.00223331206580196,0.0617235067000558,0.0704780899979995,1.61605582856526e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLA,Alpha-galactosidase A,37642,0.0998393665814493,0.0033735212208066,0.0932272649886683,0.10645146817423,2.00022819680852e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFB1,BPI fold-containing family B member 1,40261,-0.169866378586168,0.00575733904052275,-0.181150763105593,-0.158581994066743,2.73057140008811e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0705073056105145,0.00239245951345547,0.0658180849641418,0.0751965262568872,6.91506190021467e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0521786258322184,0.00177253150895636,0.048704464074664,0.0556527875897729,1.71618168188241e-185
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0507994017578684,0.00172814034899659,0.0474122466738351,0.0541865568419018,7.48398563853897e-185
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCHE,Cholinesterase,37748,0.0775133802108588,0.00263677538169472,0.0723453004627371,0.0826814599589804,4.34188019017805e-184
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNCA,Alpha-synuclein,37671,0.312004561597881,0.0106185167615714,0.291192268745201,0.332816854450561,6.88632488873529e-184
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHMP6,Charged multivesicular body protein 6,37990,0.152451812520403,0.00519869102475556,0.142262378111882,0.162641246928924,2.51918468706432e-183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA1,Ephrin type-A receptor 1,40400,0.0931974335950799,0.00319327661800857,0.0869386114237831,0.0994562557663767,1.79127287276381e-182
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFM,Afamin,38013,0.050639894103845,0.00173995841850546,0.0472295756035743,0.0540502126041157,1.07765533558913e-180
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHBG,Sex hormone-binding globulin,37987,-0.146241085848907,0.00503436616401577,-0.156108443530378,-0.136373728167436,5.05090434550461e-180
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,40411,0.0577506880188671,0.00200010182976739,0.053830488432523,0.0616708876052112,9.69082462932218e-179
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KYNU,Kynureninase,40516,0.120170496223066,0.00417260243075137,0.111992195458793,0.128348796987339,6.90875268955152e-178
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL16,C-C motif chemokine 16,40536,0.142479553902911,0.00495093470288572,0.132775721885255,0.152183385920567,1.23267001430084e-177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,37598,0.226705968473493,0.0078727729295261,0.211275333531621,0.242136603415364,6.969097553807e-177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM20A,Pseudokinase FAM20A,37990,0.0745898357259162,0.00264421018418132,0.0694071837649208,0.0797724876869116,3.62841216147105e-170
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOMO1,Nodal modulator 1,40332,0.0622340126722667,0.00221905372558266,0.0578846673701247,0.0665833579744087,5.81333283004595e-169
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F10,Coagulation factor X,37987,0.0681152556338675,0.00242652328883253,0.0633592699877558,0.0728712412799793,1.41747261137124e-168
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.177938920882,0.00634972097395165,0.165493467773055,0.190384373990945,5.42992547929406e-168
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.217844036145469,0.00778519349540028,0.202585056894484,0.233103015396453,1.59513585220956e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAB2,Stabilin-2,37998,0.0731026968786657,0.00261589074635531,0.0679755510158093,0.0782298427415221,3.91464921079665e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL16,Pro-interleukin-16,40516,0.105469234156644,0.0037830135561769,0.0980545275865374,0.112883940726751,4.3560028684265e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUMB,Protein numb homolog,37598,0.218086606982983,0.00780175596988449,0.202795165282009,0.233378048683957,4.36733063665537e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAPIN,SNARE-associated protein Snapin,37959,0.149535368905198,0.0053663406952553,0.139017341142497,0.160053396667898,3.35695763612369e-166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLUL1,Clusterin-like protein 1,40338,-0.118529931044256,0.0042664189224559,-0.126892112132269,-0.110167749956242,6.43668581372522e-166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREG1,Protein CREG1,40145,0.0938079998831427,0.00337804510202864,0.0871870314831666,0.100428968283119,9.90240327291992e-166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.17529393247821,0.00631310338152672,0.162920249850418,0.187667615106002,1.18563120709496e-165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS8,Prostasin,40293,0.104816696483598,0.00378620669654906,0.097395731358362,0.112237661608834,8.90059254872223e-165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPY30,Protein dpy-30 homolog,40414,0.154237565798755,0.00557236098934168,0.143315738259645,0.165159393337865,9.45719140315923e-165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.361729333796674,0.0130562272053624,0.336139128474163,0.387319539119184,2.35933833102742e-164
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F11R,Junctional adhesion molecule A,40332,0.145836533405034,0.00530187177089645,0.135444864734077,0.156228202075991,9.31994924397031e-163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR5,Cadherin-related family member 5,40359,0.100215277284561,0.00365176063616067,0.0930578264376859,0.107372728131436,4.88346108594715e-162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.186489751303268,0.00679902820409846,0.173163656023235,0.199815846583301,3.04452672515337e-161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C9,Complement component C9,37987,-0.125075727505303,0.00456003660970841,-0.134013399260331,-0.116138055750274,3.06830250826719e-161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL17,C-X-C motif chemokine 17,40516,0.106285293283942,0.0038836251209264,0.0986733880469262,0.113897198520958,3.25199436515974e-161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAT2,Linker for activation of T-cells family member 2,40305,0.313421564551945,0.0114573694842441,0.290965120362827,0.335878008741063,4.97882537381423e-161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTN4R,Reticulon-4 receptor,40489,0.0864917458325753,0.00317805548529715,0.0802627570813929,0.0927207345837577,1.7573485833884e-159
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18R1,Interleukin-18 receptor 1,40516,0.0831187062131137,0.00305480214495205,0.0771312940090077,0.0891061184172197,2.0327101634773e-159
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRP,Gastrin-releasing peptide,37628,0.139001747764897,0.00509987732263423,0.129005988212534,0.14899750731726,3.51686123021921e-159
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.141540674178127,0.00522520544453894,0.131299271506831,0.151782076849423,6.01851019655652e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTYMK,Thymidylate kinase,37990,0.175465311760412,0.0064880202841653,0.162748792003448,0.188181831517376,6.30652458810223e-157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO3,Beta-enolase,37628,0.143631320942746,0.00532208926986404,0.133200025973812,0.154062615911679,3.47919859473893e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYAP1,Synapse-associated protein 1,37671,0.14254214552791,0.00529573650291262,0.132162501982201,0.152921789073618,2.0951216164188e-155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.171276545062825,0.00638023752832281,0.158771279507312,0.183781810618338,1.40389267178852e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL22,C-C motif chemokine 22,40204,0.129400478333931,0.00483134511439057,0.119931041909726,0.138869914758137,1.42489125111917e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0526994133419196,0.00196926337325374,0.0488396571303423,0.0565591695534969,2.21479798119372e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP29,Synaptosomal-associated protein 29,40411,0.228743322184958,0.00855693559804491,0.21197172841279,0.245514915957126,4.84266667234227e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.103986551711444,0.00389483990857404,0.0963526654906393,0.11162043793225,1.1971222668865e-153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCS1,Neuronal calcium sensor 1,40489,0.0713325051763822,0.0026840993179606,0.0660716705131794,0.076593339839585,2.5138153975072e-152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAA80,N-alpha-acetyltransferase 80,37572,0.296733596899345,0.0111387079738707,0.274901729270559,0.318565464528132,2.5420786955305e-152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,40377,0.0990769950376495,0.00374516503462926,0.0917364715697761,0.106417518505523,5.78956783263563e-151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EEF1D,Elongation factor 1-delta,37990,0.227614504950919,0.00859175821823628,0.210774658843175,0.244454351058662,8.06016637598514e-151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTSS1,Protein MTSS 1,37901,0.27479510216781,0.010384938570449,0.25444062256973,0.29514958176589,1.87507865737364e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL13,C-X-C motif chemokine 13,40471,0.157227378921892,0.0059563464087638,0.145552939960715,0.168901817883069,2.41613383234247e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,40305,0.168286526294094,0.00637747409969477,0.155786677058692,0.180786375529495,3.26867578897801e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR2,Cadherin-related family member 2,40305,0.190083047719995,0.00721450975249597,0.175942608605103,0.204223486834887,9.06372883029997e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.218180434579093,0.00834987596415786,0.201814677689344,0.234546191468843,2.27067146867754e-147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0847598224670731,0.00324460487156801,0.0784003969187998,0.0911192480153464,2.43757426619787e-147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.150992122403142,0.00579185174306653,0.139640092986732,0.162344151819553,1.12899853036226e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCLY,Selenocysteine lyase,40434,0.116805683301269,0.00448193857946022,0.108021083685527,0.125590282917011,1.13841295686067e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0497294735444193,0.00191163883791288,0.04598266142211,0.0534762856667285,3.92278112458983e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.139862428666253,0.00537252040362661,0.129332288675145,0.150392568657361,9.83643752426752e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0750420012815837,0.00289010619252549,0.0693773931442338,0.0807066094189337,1.33429422159586e-145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKB,Creatine kinase B-type,37998,-0.147742528630611,0.00569006783840401,-0.158895061593882,-0.136589995667339,4.24167964856512e-145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.193845112294772,0.00748438255609977,0.179175722484816,0.208514502104727,2.24449997912739e-144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH9,Myosin-9,37998,0.273119975642377,0.0105489230909905,0.252444086384035,0.293795864900718,2.65863476482276e-144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FYB1,FYN-binding protein 1,40311,0.221510566132806,0.00859708648548436,0.204660276621257,0.238360855644355,1.88883309367776e-143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MLN,Promotilin,40341,0.21376126045662,0.00834358289363263,0.1974078379851,0.23011468292814,6.86323979102998e-142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0666018630003519,0.00260103039434674,0.0615038434274323,0.0716998825732715,9.66274307639782e-142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,40411,0.0607777093113015,0.0023758989930984,0.0561209472848286,0.0654344713377743,1.73946575366891e-141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YES1,Tyrosine-protein kinase Yes,40305,0.27223375439518,0.0106665006003358,0.251327413218522,0.293140095571838,7.66748535519811e-141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.202084663184345,0.00793480207453186,0.186532451118263,0.217636875250428,1.03604406334826e-139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,40332,-0.09715609757194,0.00382751081890107,-0.104658018776986,-0.0896541763668939,2.26563681514383e-139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.0932728091327704,0.00368138604582193,0.0860572924829594,0.100488325782581,6.64624981458673e-139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NHLRC3,NHL repeat-containing protein 3,37370,0.0760329499209317,0.00300319338448069,0.0701466908873496,0.0819192089545139,4.64091623546435e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSD,Cathepsin D,39243,0.0947020296522594,0.00375564952040028,0.0873409565922749,0.102063102712244,2.1035146441396e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCN2,Ficolin-2,40291,0.0971659349470089,0.00386142467586186,0.0895975425823196,0.104734327311698,4.90974971452267e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YTHDF3,YTH domain-containing family protein 3,40044,0.200491432564985,0.0079728484941667,0.184864649516419,0.216118215613552,8.04560863716771e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEG1,Protein HEG homolog 1,37671,0.062365648121867,0.00248465708455584,0.0574957202361375,0.0672355760075964,7.30447647648601e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,40359,-0.0933390766087787,0.00373148326362313,-0.10065278380548,-0.0860253694120774,1.76678319258736e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROS1,Vitamin K-dependent protein S,38013,0.0588614868877325,0.00236144573206642,0.0542330532528824,0.0634899205225827,3.96711888806553e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MVK,Mevalonate kinase,40044,0.179092919442196,0.00721444404815353,0.164952609107815,0.193233229776577,1.8892782942398e-133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGF,Hepatocyte growth factor,40516,0.0799844737323599,0.003225688954935,0.0736621233806873,0.0863068240840325,3.1229567800271e-133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTBS,Di-N-acetylchitobiase,37819,0.0633237812613052,0.00255005277558295,0.0583256778211626,0.0683218847014477,4.07364313080926e-133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPPC,C-type natriuretic peptide,40341,0.100346754834952,0.00405950172054362,0.092390131462687,0.108303378207218,2.09398126037116e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOST,Sclerostin,40330,0.0899441662468145,0.00363996255802248,0.0828098396330905,0.0970784928605386,2.59234276359692e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA3F,Semaphorin-3F,40359,0.0601288151524091,0.00243637846707573,0.0553535133569407,0.0649041169478775,5.31943251971925e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORD,Sorbitol dehydrogenase,40417,0.155211362872872,0.00629902354127123,0.14286527673198,0.167557449013764,1.3199380733193e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.118727400011038,0.00481093816366247,0.10929796121026,0.128156838811817,1.49778190694637e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.112749265745621,0.00457029634424443,0.103791484910902,0.12170704658034,2.0558539683991e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATRN,"Attractin, Isoform 2",38013,0.0378767712669109,0.00153985909480874,0.0348586474410857,0.040894895092736,9.62983001265201e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLKB1,Plasma kallikrein,37721,0.0582652995749477,0.00237121085807508,0.0536177262931206,0.0629128728567749,2.02508859704389e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGRN,Agrin,40422,0.0763934909497105,0.00312812955516952,0.0702623570215782,0.0825246248778427,2.3594745315873e-129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HJV,Hemojuvelin,37959,0.106176579017497,0.0043412408954632,0.0976677468623887,0.114685411172605,2.65319642109375e-129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXLNA,Alpha-taxilin,40228,0.204951436223381,0.00839514932237991,0.188496943551516,0.221405928895245,3.06909734492466e-129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.18866144566927,0.00773319324705081,0.17350438690505,0.20381850443349,4.19890678964529e-129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KHK,Ketohexokinase,37628,0.148223732012584,0.00606950594676773,0.136327500356919,0.160119963668249,7.3183394993848e-129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUCB2,Nucleobindin-2,40447,0.0852889880842597,0.00349948129257364,0.0784300047508154,0.0921479714177041,7.52275156261992e-129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.166035578941315,0.00681348708431457,0.152681144256059,0.179390013626572,2.49092886174115e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SARG,Specifically androgen-regulated gene protein,37931,0.248792207421789,0.0102260075566594,0.228749232610737,0.268835182232842,5.41156731308599e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK1,Dickkopf-related protein 1,40471,0.136335691872994,0.00562166674149032,0.125317225059673,0.147354158686315,1.25205326091982e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TJAP1,Tight junction-associated protein 1,40411,0.188365252748643,0.00777513758035236,0.173125983091153,0.203604522406134,2.30402672544579e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORT1,Sortilin,40330,0.0827865244914146,0.00342268238915799,0.0760780670086649,0.0894949819741642,5.88827302835709e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINF2,Alpha-2-antiplasmin,37755,0.0309044986242992,0.00127828711133823,0.0283990558860762,0.0334099413625221,2.05706237106152e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0617784919197968,0.00256527313007763,0.0567505565848447,0.066806427254749,6.65801877616162e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.215745491155549,0.00897538446856094,0.198153737597169,0.233337244713928,1.94041847258245e-125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EHBP1,EH domain-binding protein 1,37990,0.168989545716877,0.00703072429574022,0.155209326097226,0.182769765336528,4.80217165933917e-125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.189319872753401,0.00789921314967195,0.173837414980044,0.204802330526758,2.42418768198801e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.102734174532059,0.00428584854923635,0.0943339113755556,0.111134437688562,2.49899871467717e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BECN1,Beclin-1,37628,0.137710750170845,0.00574786537476142,0.126444934036313,0.148976566305377,3.3430768945458e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.218786770198443,0.00915790455496748,0.200837277270707,0.236736263126179,5.91062851676987e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.122020253813331,0.0051174878796138,0.111989977569288,0.132050530057375,1.77871809425805e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,37671,0.166272895842996,0.00696456272933209,0.152622352893505,0.179923438792486,2.28080989598643e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES3,Carboxylesterase 3,40305,0.154130624162526,0.00646758341063464,0.141454160677682,0.16680708764737,2.31828603110679e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD2AP,CD2-associated protein,40359,0.143459696140162,0.00603018497394691,0.131640533591226,0.155278858689098,5.86119746375429e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0839108111793827,0.00354303034673702,-0.0908551506589873,-0.0769664716997781,6.74050777076887e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.185758378555684,0.00783031673507097,0.170410957754945,0.201105799356423,7.22567393502415e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0897511241078832,0.00378971651092363,0.0823232797464729,0.0971789684692935,1.61016880227975e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS9,Galectin-9,40350,0.0717017044894007,0.00303487173581147,0.0657533558872102,0.0776500530915911,2.54803031576109e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.107903787023535,0.0045724237416935,0.098941836489816,0.116865737557255,4.80231908771056e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN1,Dynactin subunit 1,40489,0.14612140019159,0.00620348185659551,0.133962575752663,0.158280224630517,1.24395291901876e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,40341,0.0953404796119741,0.00404920781189924,0.0874040323006516,0.103276926923297,1.60414934067655e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PYY,Peptide YY,37562,0.211438533624835,0.00896384492619975,0.193869397569484,0.229007669680187,1.63054091580728e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0599397442156568,0.00254206910947933,0.0549572887610773,0.0649221996702363,1.72884830235464e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD63,CD63 antigen,40203,0.115671192182352,0.00491820608529693,0.10603150825517,0.125310876109534,3.05371029379812e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.108784719687885,0.00463096849235829,0.0997080214428624,0.117861417932907,5.27836557463053e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FETUB,Fetuin-B,40372,0.0748134299513959,0.00318838683609638,0.068564191752647,0.0810626681501448,1.00693635387369e-119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,40471,0.213162704950249,0.00908634839881621,0.19535346208857,0.230971947811929,1.08888150419522e-119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,39961,0.1744443348997,0.00743881080910772,0.159864265713849,0.189024404085551,1.553737473196e-119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES2,Cocaine esterase,40305,0.118023714368211,0.00504879989458647,0.108128066574822,0.127919362161601,7.5123085508276e-119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP20,Centrosomal protein 20,39980,0.162276878851212,0.00694687545165529,0.148661002965968,0.175892754736456,1.20991242532872e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.100126128185496,0.00428731118063437,0.0917229982714529,0.10852925809954,1.25070082129725e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSO,Cathepsin O,40516,0.0662842034581882,0.00283942971837546,0.0607189212101723,0.0718494857062041,1.47368738194246e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.229328023359665,0.00983029039155239,0.210060654192222,0.248595392527108,2.23599323978759e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAXX,Protein PAXX,37671,0.0998253697431913,0.00427531599376688,0.0914457503954082,0.108204989090974,3.40385498084674e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0658701153828891,0.00282365369001254,0.0603357541504645,0.0714044766153137,5.00934989077848e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.159101254559767,0.00683425190930291,0.145706120817533,0.172496388302,6.42975123980505e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,37942,0.102053288555772,0.00439856603971334,0.0934320991179336,0.11067447799361,8.39013733865808e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0612167845582783,0.00265000174324807,0.0560227811415121,0.0664107879750445,3.69546397683345e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSP1,Lymphocyte-specific protein 1,40341,0.0870707218973901,0.003771438907144,0.0796787016393879,0.0944627421553923,5.05349103182875e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0504313783898676,0.0021879772608203,0.0461429429586598,0.0547198138210754,1.15480004059368e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AXIN1,Axin-1,40341,0.203961521609133,0.00886902165009864,0.18657823917494,0.221344804043327,3.75655216337944e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STC1,Stanniocalcin-1,40471,0.0898673976385603,0.00390983219101359,0.0822041265441737,0.0975306687329469,4.75354273273867e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.0818927592507259,0.00356300193337645,0.074909275461308,0.0888762430401437,5.00463968529209e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EZR,Ezrin,40471,0.0513600945014592,0.00223479250781349,0.0469799011861447,0.0557402878167736,5.0748335860112e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.145320578906096,0.00632268715300297,0.13292811208621,0.157713045725982,5.54640210422157e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP5,Fatty acid-binding protein 5,40432,0.149858300477769,0.0065288169963216,0.137061819164978,0.162654781790559,9.71203214992787e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.242177534054485,0.0105376375429521,0.221523764470299,0.262831303638671,1.20390703700615e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.234625690584383,0.0102220913932956,0.214590391453524,0.254660989715243,2.18272754997691e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.151245745483479,0.00660839869413351,0.138293284042978,0.164198206923981,4.79959495679095e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDUA,Alpha-L-iduronidase,40489,0.0976268121629274,0.00427136381610852,0.0892549390833547,0.1059986852425,8.30405426565911e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL17,C-C motif chemokine 17,40333,0.195040700917039,0.00855285352219776,0.178277108013531,0.211804293820546,2.73186187428673e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.106804132149047,0.00468436745007809,0.0976227719468943,0.1159854923512,3.27888287572937e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.231194558121582,0.0101310980791164,0.211337605886514,0.25105151035665,3.94765691376783e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTD,Biotinidase,38013,0.0445016747913983,0.00195051584291259,0.0406786637392896,0.048324685843507,4.2930026048419e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LBR,Delta(14)-sterol reductase LBR,40471,0.14088192294807,0.00619441378416073,0.128740871931115,0.153022973965025,1.01063464720739e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAB2,Disabled homolog 2,40489,0.23676897039402,0.0104112076865597,0.216363003328363,0.257174937459677,1.04325530975778e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",40305,0.165196137900694,0.00726954789502931,0.150947824026436,0.179444451774951,1.60207332401149e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELP,P-selectin,40403,0.123484458568157,0.00544575137736795,0.112810785868516,0.134158131267799,4.60259827471322e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCAM,Cell surface glycoprotein MUC18,40403,-0.0728353416224615,0.00321460687571008,-0.0791359710988533,-0.0665347121460697,6.80239295811374e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A4,Protein S100-A4,40411,0.123500615484437,0.00545248943615269,0.112813736189577,0.134187494779296,7.97155060203985e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THOP1,Thimet oligopeptidase,40288,0.0639878685868781,0.00282918372953329,0.0584426684769929,0.0695330686967634,1.70622490586895e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0809027029990602,0.00358002962880807,0.0738858449265964,0.087919561071524,2.44186482462306e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.225716271414709,0.0100096919376594,0.206097275216896,0.245335267612521,7.36414336330673e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARF6,ADP-ribosylation factor 6,37901,0.224035623464,0.00992288313488802,0.204586772519619,0.24348447440838,8.1390179360867e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.1168227641025,0.00518167884195373,0.106666673572271,0.126978854632729,9.10401640853437e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPL,N-acetylneuraminate lyase,37990,0.0917111109067912,0.00407347228939507,0.0837271052195769,0.0996951165940055,3.14241528138912e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAMDC4,Apical endosomal glycoprotein,37900,0.116147452359953,0.00515934892779063,0.106035128461484,0.126259776258423,3.39777088427828e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.203258489185411,0.00904975739253241,0.185520964696048,0.220996013674775,1.02886049714229e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0450725998068291,0.00200724888743303,0.0411383919874603,0.0490068076261978,1.269986518764e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.137474958477188,0.00616549689779426,0.125390584557511,0.149559332396865,3.42919377810028e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0610471299995538,0.00274337555059687,0.0556701139203839,0.0664241460787237,9.01756925129674e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP85,Centrosomal protein of 85 kDa,39980,0.132131098115612,0.00595370720019675,0.120461832003227,0.143800364227998,1.86490130816345e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.15715511513472,0.00707521936500144,0.143287685179317,0.171022545090122,2.42402632513733e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTUD7B,OTU domain-containing protein 7B,37959,0.132651277960619,0.00597353955686222,0.120943140429169,0.144359415492069,2.45162031707613e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPY,Pancreatic prohormone,40337,0.211059657719366,0.00953373719988824,0.192373532807585,0.229745782631147,5.59150812253677e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATG16L1,Autophagy-related protein 16-1,37901,0.177309388356849,0.00799826788116954,0.161632783309757,0.192985993403941,5.64310856318171e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD6,T-cell differentiation antigen CD6,40502,0.111134953911537,0.00502314325130742,0.101289593138974,0.120980314684099,7.21749410188777e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTSS2,Protein MTSS 2,37900,0.205914409720452,0.00929369132573151,0.187698774722019,0.224130044718886,7.31693280022549e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBIN,Erbin,40305,0.214086138729297,0.00967611826002867,0.195120946939641,0.233051330518953,7.44685128577205e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNA4,Plexin-A4,40341,0.172169871396885,0.00780032736143848,0.156881229768465,0.187458513025304,2.30984832401421e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGLN1,Egl nine homolog 1,40341,0.110491117433367,0.00501630574034792,0.100659158182285,0.120323076684449,6.15840551625405e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R9B,Neurabin-2,40516,0.195388411262016,0.00887270081398685,0.177997917666602,0.212778904857431,6.60590464230403e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MME,Neprilysin,40305,0.169082826340259,0.00768548255411599,0.154019280534191,0.184146372146326,1.08555960866329e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KAZN,Kazrin,37901,0.215561075988613,0.00981242137596098,0.196328730091729,0.234793421885496,4.05348014774214e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.143116535183033,0.00652283853271738,0.130331771658907,0.155901298707159,4.10124630033597e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.207178327579936,0.00945324254341884,0.188649972194835,0.225706682965037,6.25542898489355e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,37942,0.183869253169358,0.00837966695685708,0.167445105933918,0.200293400404798,6.93486135048391e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.0502384828435506,0.00229280244298424,0.0457445900553015,0.0547323756317997,7.07792290849313e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.17660668772328,0.00806098701533551,0.160807153173222,0.192406222273338,7.65274985926078e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLIN1,Perilipin-1,39961,0.0734027607166726,0.00335132378895432,0.0668341660903221,0.079971355343023,9.43864987504672e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,40396,0.107248240783557,0.00489801203187471,0.0976481372010821,0.116848344366031,9.79802946016301e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.21434335981734,0.00979778143645806,0.195139708201882,0.233547011432797,1.50377769682527e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACE2,Angiotensin-converting enzyme 2,40042,0.101073439472044,0.00462375323726972,0.092010883126995,0.110135995817092,2.31301581001807e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FN1,Fibronectin,38013,0.0541795184635776,0.00247873572755488,0.04932119643757,0.0590378404895852,4.0768533980392e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.121946056663223,0.0056011729800398,0.110967757622345,0.132924355704101,1.43855204588927e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCR,Breakpoint cluster region protein,40341,0.187023135609618,0.00860618212972085,0.170155018635366,0.203891252583871,3.29204387507609e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL5,C-X-C motif chemokine 5,40309,0.235760170668493,0.0108543153959913,0.21448571249235,0.257034628844636,4.1688833099591e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,40422,0.255673733892673,0.0118242392069927,0.232498225046968,0.278849242738379,3.18778947855787e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.151857014659967,0.00701767017645341,0.138102381114118,0.165611648205816,4.64042541452462e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.210405165963599,0.0097293653374689,0.19133560990216,0.229474722025038,6.02732289901647e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFC,Vascular endothelial growth factor C,40411,0.113825374240222,0.00528188637553303,0.103472876944178,0.124177871536267,1.47306036116717e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD5,Programmed cell death protein 5,40471,0.118831938027618,0.00551850264277766,0.108015672847773,0.129648203207462,2.06878568515323e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GH1,Somatotropin,40330,-0.356699510876689,0.0165650881950593,-0.389167083739005,-0.324231938014373,2.13625537540729e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEP,Leptin,40359,0.129943838299932,0.00604403452789888,0.11809753062525,0.141790145974614,4.30159319959418e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP23,Synaptosomal-associated protein 23,40359,0.176719066945542,0.00822469006855337,0.160598674411177,0.192839459479907,5.65972997135561e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BACH1,Transcription regulator protein BACH1,40341,0.147540624249269,0.00686674550221065,0.134081803064937,0.160999445433602,5.69940061672466e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,37562,0.12946320861193,0.00601853431625052,0.117666881352079,0.141259535871781,6.78616893403158e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINH1,Serpin H1,37714,0.26204387190579,0.0121856192909172,0.238160058095592,0.285927685715987,7.41339187752989e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,37959,0.231932140199396,0.010788231012269,0.210787207415349,0.253077072983443,7.78698206790983e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AAMDC,Mth938 domain-containing protein,37628,0.10921772147836,0.00508000129106261,0.0992609189478776,0.119174524008843,8.40328221342068e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLB1,Beta-galactosidase,40228,0.0827405340570177,0.00386102772968642,0.0751729197068323,0.0903081484072031,1.90281229817891e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OXT,Oxytocin-neurophysin 1,40471,0.267798881547651,0.0125154439058012,0.243268611492281,0.292329151603021,3.54640475370919e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRPK2,SRSF protein kinase 2,40341,0.167278248610387,0.00782118779645485,0.151948720529336,0.182607776691439,4.44931823374789e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,40341,0.125416326041369,0.00586613152854583,0.113918708245419,0.136913943837319,5.26696235057983e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGFR,Opioid growth factor receptor,40305,0.0667980736597803,0.00312484650712538,0.0606733745058145,0.072922772813746,5.68245294016361e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPB2,Carboxypeptidase B2,37981,0.0452317765904915,0.00211407661524815,0.0410881864246051,0.0493753667563778,6.59852954679418e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.0886112590413903,0.00414683672703153,0.0804834590564085,0.0967390590263721,6.71718147898806e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.0418440095119874,0.00196379810498557,0.0379949652262157,0.0456930537977591,2.46781518461517e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0883669909260166,0.00415206616569962,0.0802289412412453,0.0965050406107879,4.203359861001e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IKBKG,NF-kappa-B essential modulator,40341,0.184947473964833,0.00869839738824492,0.167898615083873,0.201996332845793,6.04630321263884e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL10,C-X-C motif chemokine 10,40422,0.135889490446524,0.00639151152641767,0.123362127854746,0.148416853038303,6.11606746033674e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.112492387093831,0.00529372026988277,0.10211669536486,0.122868078822801,7.50862765634198e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,40341,0.110119048989807,0.00518686144778109,0.099952800552156,0.120285297427458,1.16956174521972e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP2B,DNA topoisomerase 2-beta,37598,0.159095826833032,0.00748322369307442,0.144428708394607,0.173762945271458,1.20082029187085e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.165480139932886,0.007794772586163,0.150202385664007,0.180757894201765,1.2764057387808e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.169002714375667,0.00795995245247283,0.15340120756882,0.184604221182514,1.96359328145893e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BID,BH3-interacting domain death agonist,40341,0.134349699208115,0.00633681163192443,0.121929548409544,0.146769850006687,2.1265795275219e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLSCR3,Phospholipid scramblase 3,37919,0.120173331109185,0.00566699229580061,0.109066026209415,0.131280636008954,3.37395369540759e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCXR,L-xylulose reductase,40411,0.104739151506276,0.00494612145051618,0.0950447534632646,0.114433549549288,3.5490156345511e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLA2,Src-like-adapter 2,37959,0.206637600069891,0.00976224739035677,0.187503595184791,0.22577160495499,7.4138040258086e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGF,Placenta growth factor,40516,0.0525024835258125,0.00248648995603338,0.0476289632119871,0.0573760038396379,1.22162886585912e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.100373150056694,0.0047547561258141,0.0910538280500988,0.10969247206329,1.50855564988017e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.213855249985449,0.0101326072006987,0.19399533987208,0.233715160098819,2.58807943207431e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCK2,Cytoplasmic protein NCK2,40422,0.208471816263202,0.00989119595800709,0.189085072185508,0.227858560340896,2.75042516657204e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0751560588408932,0.00356315080983192,0.0681722832536226,0.0821398344281637,3.68108408079216e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK11,Serine/threonine-protein kinase STK11,40042,0.14544089777932,0.00690432419165544,0.131908422363676,0.158973373194965,3.73195703866292e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAT,Linker for activation of T-cells family member 1,40516,0.150586771192224,0.00715102338491932,0.136570765357782,0.164602777026665,3.9468596043689e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELN,Elastin,37990,0.0701416436974096,0.00332783485043477,0.0636190873905575,0.0766642000042618,4.62699192569944e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0733219203505994,0.00348538128983504,0.0664905730225227,0.0801532676786761,1.0668511149018e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPD52L2,Tumor protein D54,37671,0.21496694212185,0.0102195906318722,0.19493654448338,0.234997339760319,1.19852878950302e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL7,C-C motif chemokine 7,40341,0.120938835446616,0.00575835422541232,0.109652461164808,0.132225209728424,1.27909640598899e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0456002190740416,0.00217256452962238,0.0413419925959818,0.0498584455521015,1.67903662598544e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOK2,Docking protein 2,40359,0.239622750974379,0.0114240886952456,0.217231537131697,0.26201396481706,2.22040738419065e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFA,Vascular endothelial growth factor A,40456,0.11663249018536,0.00556119535318718,0.105732547293113,0.127532433077607,2.30310120045846e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.188980256216773,0.00902189090940145,0.171297350034346,0.206663162399199,3.92730416941771e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0785896698213178,0.00375139421604924,0.0712369371578613,0.0859424024847743,6.41485097553568e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL5,C-C motif chemokine 5,40403,0.198447356609563,0.00948499128750977,0.179856773686044,0.217037939533083,6.50075487916627e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,40489,0.0733396487235664,0.00350611233278937,0.0664676685512992,0.0802116288958335,7.02932014686036e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.187304936428027,0.00896145698664522,0.169740480734203,0.204869392121852,1.03200726862112e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.137884181349852,0.00659699902014604,0.124954063270366,0.150814299429338,1.0709998775503e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MINK1,Misshapen-like kinase 1,37942,0.183506774720557,0.00877069470283825,0.166316213102994,0.20069733633812,1.09304080568002e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,40305,0.272147557895462,0.0130294753536587,0.246609786202291,0.297685329588633,1.35615190280346e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFC,Platelet-derived growth factor C,39980,0.0586960989414488,0.00281309035800432,0.0531824418397604,0.0642097560431373,2.24265375201159e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD5,T-cell surface glycoprotein CD5,40470,0.0659993386289326,0.00316641936889405,0.0597931566659003,0.072205520591965,3.19394941229076e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.190276560356784,0.00913562870620816,0.172370728092616,0.208182392620952,4.73856444578417e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.225523574638785,0.0108187188728316,0.204318885648035,0.246728263629535,5.26718669390029e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.151802233664373,0.00729693472046759,0.137500241612256,0.166104225716489,1.20719494258564e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSME1,Proteasome activator complex subunit 1,40216,0.0740635732338185,0.00356987270440666,0.0670666227331815,0.0810605237344556,2.3775869421092e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USO1,General vesicular transport factor p115,40305,0.177892205486179,0.00857716156370604,0.161080968821315,0.194703442151043,2.67541086095056e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEXIM1,Protein HEXIM1,40341,0.160141559589542,0.00773395697801334,0.144983003912636,0.175300115266448,5.27974269351119e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUOM,Fucose mutarotase,37671,0.122507898687129,0.0059107354835342,0.110922857139402,0.134092940234856,6.20379165710582e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,40536,0.131665803280091,0.00639606642355489,0.119129513089924,0.144202093470259,5.83413064496174e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.177360900700058,0.00861363671171345,0.1604781727451,0.194243628655016,8.90937025641062e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN2,CCN family member 2,40358,0.112001561296774,0.00545694812278849,0.101305942976109,0.122697179617439,2.03975827034271e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,40042,0.0668092719851014,0.00325706907575343,0.0604254165966247,0.0731931273735782,2.76739024258145e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFX1,Transcriptional repressor NF-X1,37562,0.132097428227901,0.00643686366792545,0.119481175438767,0.144713681017035,3.81513573199765e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTDH,Protein LYRIC,37598,0.1773546646437,0.00867292805847274,0.160355725649094,0.194353603638307,1.6095342318282e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXO1,Forkhead box protein O1,40341,0.16360747773271,0.00801187922949469,0.1479041944429,0.17931076102252,1.63530557230117e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.133565104067401,0.00653513152513122,0.120756246278144,0.146373961856658,1.8534516862855e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIAE,Sialate O-acetylesterase,40374,0.0904484498224823,0.00443715126809796,0.0817516333370103,0.0991452663079543,3.35017149930194e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CMIP,C-Maf-inducing protein,37900,0.158752624568983,0.00778274705694013,0.14349844033738,0.174006808800585,4.14011751587338e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP43,Centrosomal protein 43,39934,0.133106764788172,0.00653756156340426,0.120293144123899,0.145920385452444,5.82382841847175e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.0852121151237101,0.00418819751233299,0.0770032479995374,0.0934209822478827,7.30037192509226e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSZ,Cathepsin Z,40345,0.0597309164447425,0.00294533214695042,0.0539580654367197,0.0655037674527654,2.68297750305968e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.124140021541323,0.00611843943622477,0.112147880246322,0.136132162836323,3.47301909585818e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCTN3,Tectonic-3,37990,0.0561025805002169,0.0027666814639685,0.0506798848308386,0.0615252761695951,4.36275661525117e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.209082552481284,0.0103175079737548,0.188860236852724,0.229304868109843,5.76264670886098e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.147673249407717,0.00729159687499689,0.133381719532723,0.161964779282711,7.24947694592543e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNMBP,Dynamin-binding protein,40228,0.118093623635068,0.0058380413844847,0.106651062521478,0.129536184748658,7.58703716223438e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARSB,Arylsulfatase B,40305,0.105063487403245,0.00520266297665006,0.0948662679690109,0.115260706837479,1.46999538578622e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0380021275887886,0.00188183756290525,0.0343137259654943,0.0416905292120829,2.29051441666885e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.213241450922725,0.0105868471148128,0.192491230577692,0.233991671267758,4.07885561261664e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH2,Cadherin-2,40359,0.0672797359661786,0.00334166841733902,0.0607300658681941,0.0738294060641631,4.81136308952568e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST3,Cystatin-C,40372,0.0535742421531683,0.00266103060623693,0.0483586221649439,0.0587898621413927,4.86660281118211e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.145102167846409,0.00720979318919684,0.130970973195584,0.159233362497235,5.66560033652406e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.138128762691839,0.00685591823859775,0.124691162944187,0.151566362439491,5.80094143961379e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,40192,0.0453579646857963,0.00225485104230464,0.0409384566428792,0.0497774727287134,7.01949267003743e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.110250339533174,0.00547689614011396,0.0995156230985506,0.120985055967797,8.14021970534117e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.0544131857958485,0.00271192498800373,0.0490978128193612,0.0597285587723358,1.82238469314073e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,37671,0.150259193588595,0.00748545515207437,0.135587701490529,0.16493068568666,2.59095367936402e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNCG,Gamma-synuclein,40228,0.12717336693533,0.00634487235811454,0.114737417113425,0.139609316757234,2.88118996863077e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.118602107669873,0.00591158409308224,0.107015402847432,0.130188812492314,3.01602916980614e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBPL,FK506-binding protein-like,37901,0.11211147006417,0.00559021967570257,0.101154639499793,0.123068300628547,3.53851751294917e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.121849058646358,0.0060824862962351,0.109927385505737,0.133770731786979,3.69771489128098e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELE,E-selectin,40536,0.0948672230669626,0.0047383805936135,0.0855799971034801,0.104154449030445,4.26629536156362e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP3B1,AP-3 complex subunit beta-1,37901,0.145114391904615,0.00723956707015994,0.130924840447102,0.159303943362129,4.3270325175047e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA1,GDNF family receptor alpha-1,40453,0.052803570615124,0.00264021099009188,0.0476287570745439,0.0579783841557041,6.55067422141822e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA5,Integrin alpha-5,40332,0.0472325601276119,0.00236184257243799,0.0426033486856335,0.0518617715695904,6.88132902195666e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.173957059044957,0.00869929945508192,0.156906432112997,0.191007685976918,7.41735526324934e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL13,C-C motif chemokine 13,40483,0.132092179714149,0.00660730191813043,0.119141867954613,0.145042491473685,7.61128995041206e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC13,Mucin-13,39961,0.0950496340238821,0.0047580779518715,0.085723801238214,0.10437546680955,1.1149084984301e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,37959,0.143618806322809,0.00718824745016611,0.129529841320483,0.157707771325134,1.51499445578265e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.194214743945236,0.00972947821813677,0.175144966637688,0.213284521252784,2.18465144632922e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC27,Cell division cycle protein 27 homolog,39980,0.114924720364691,0.00577215688629999,0.103611292867543,0.126238147861839,4.04700446582315e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0504482685658197,0.00253443870271527,0.0454807687084978,0.0554157684231417,4.48113828421826e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.171875099094138,0.00863264839367429,0.154955108242537,0.18879508994574,5.89562111803403e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EREG,Proepiregulin,40192,0.151269005391375,0.00761041484711294,0.136352592291034,0.166185418491717,7.52837762122349e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QDPR,Dihydropteridine reductase,40290,0.0824981531192306,0.00415335130556615,0.0743575845603209,0.0906387216781402,9.65060884956908e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.159239446788126,0.00801747617302549,0.143525193488997,0.174953700087256,1.63223692826179e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.126983679914531,0.00640363355260161,0.114432558151432,0.139534801677631,1.92939976128375e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP2,Methionine aminopeptidase 2,40453,0.11063264719045,0.00558132066197265,0.0996932586929841,0.121572035687917,2.09121715246832e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOLM2,Protein GOLM2,40471,0.0420938905979331,0.00212821439011986,0.0379225903932982,0.0462651908025681,4.79632416241736e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,40536,0.040595610981702,0.00205303624375684,0.0365716599439386,0.0446195620194654,5.28727725808663e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.133756956366056,0.00675759501475408,0.120512070137138,0.147001842594974,5.91364645970403e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAO1,Hydroxyacid oxidase 1,40489,0.244324621817309,0.0123661915117617,0.220086886454256,0.268562357180362,7.25200457606531e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.209112524689001,0.0105881025771705,0.188359843637747,0.229865205740256,8.7912860089678e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAG1,Dystroglycan,40422,0.0886415442711267,0.004489144718136,0.0798428206235801,0.0974402679186733,9.1834446983137e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NIT2,Omega-amidase NIT2,37936,0.141595545534125,0.00716807268706672,0.127546123067475,0.155644968000776,1.20779179864748e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.114335803807011,0.0057982226834864,0.102971287347378,0.125700320266645,1.64503842285816e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,37987,0.050603193233701,0.00256743457543861,0.0455710214658414,0.0556353650015607,2.78641740305756e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCBP2,Poly(rC)-binding protein 2,37959,0.134200262170292,0.00681046484658511,0.120851751070985,0.147548773269598,3.06234538165523e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0554756655971749,0.00282225762509787,0.0499440406519831,0.0610072905423667,5.16709928573277e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYDGF,Myeloid-derived growth factor,37990,0.187276543086257,0.00952429499122877,0.168608924903449,0.205944161269066,6.80914889295984e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THPO,Thrombopoietin,40042,0.0710139691136408,0.00362147548939341,0.0639158771544298,0.0781120610728519,1.34814439638581e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0517779910103374,0.00264428037335249,0.0465952014785665,0.0569607805421083,2.20301900711355e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0779397974634534,0.0039814202069829,0.0701362138577669,0.0857433810691399,2.4042461099243e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASHC3,WASH complex subunit 3,37942,0.139263304596208,0.00711536715570919,0.125317184971018,0.153209424221398,3.90566885778301e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,40305,0.109810008383142,0.00562542122673501,0.0987841827787409,0.120835833987542,7.10928569070007e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,37598,0.164491186588149,0.00841850539214905,0.147990916019537,0.180991457156761,7.83868570845309e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOD,Apolipoprotein D,37345,-0.0825903972821297,0.00423085537463486,-0.090882873816414,-0.0742979207478454,1.16947469303582e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAMBP,STAM-binding protein,40192,0.119385296062148,0.00613484436559923,0.107361001105574,0.131409591018723,2.2748650923846e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYTL4,Synaptotagmin-like protein 4,37990,0.135165014241834,0.00694880592477125,0.121545354629282,0.148784673854385,3.84227400130083e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD36,Platelet glycoprotein 4,37598,0.0819438076090082,0.00421277811744192,0.0736867624988221,0.0902008527191944,4.17026117323154e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.107351198907903,0.00552637797818995,0.0965194980706506,0.118182899745155,4.29246095506747e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,A1BG,Alpha-1B-glycoprotein,38013,0.0323197661863003,0.00166284576043733,0.0290605884958431,0.0355789438767574,5.09684527000768e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VNN1,Pantetheinase,37987,0.133504821494115,0.00687054702894175,0.120038549317389,0.146971093670841,5.62569435282609e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISM1,Isthmin-1,40341,0.0717921460743811,0.00369976616174556,0.0645406043973598,0.0790436877514024,6.43000104524257e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,40422,0.157747845236521,0.00813068944656647,0.141811693921251,0.173683996551791,6.72949316200433e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0592303464239547,0.00305796037756241,0.0532367440839324,0.0652239487639771,1.26637351648159e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEC31A,Protein transport protein Sec31A,37628,0.140768622328535,0.007265791311702,0.126527671357599,0.155009573299471,1.7827007907887e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.190289292090459,0.00983633352960867,0.171010078372426,0.209568505808492,1.9472157663254e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,37990,0.165377074828353,0.00854304049743195,0.148632715453387,0.18212143420332,2.25300979950521e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0935578604257916,0.00483531633606316,0.0840806404071078,0.103035080444475,2.72762502393388e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NSFL1C,NSFL1 cofactor p47,40471,0.121859236119059,0.00632684219835925,0.109458625410275,0.134259846827844,9.63410939820361e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.128227308707753,0.00665510436801213,0.115183304146449,0.141271313269056,1.32933080460315e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNST,Consortin,40359,0.196763913594289,0.0102305747338354,0.176711987115972,0.216815840072607,1.64987821586963e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,37901,0.174146190365523,0.00904524265207813,0.15641751476745,0.191874865963597,1.66504946532881e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD99L2,CD99 antigen-like protein 2,40332,0.0433992770145921,0.00225783151876582,0.0389739272378111,0.0478246267913731,2.04727926175474e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNB3,Plexin-B3,40310,0.085045962958895,0.00442867093338977,0.0763657679294511,0.093726157988339,2.89054079823605e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX15,Sorting nexin-15,37671,0.0988858638001483,0.00514691091490975,0.0887979184069252,0.108973809193371,3.69050686568558e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PXN,Paxillin,39961,0.0941756723364316,0.00490828480587792,0.0845554341169108,0.103795910555952,4.1248042963522e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGCC,Regulator of cell cycle RGCC,37959,0.136538167123782,0.00711052259033702,0.122601542846722,0.150474791400843,4.25182345512824e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.096128232219925,0.00500742972601365,0.0863136699569383,0.105942794482912,4.89815618142245e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,40332,0.0950016109740475,0.00495443300077705,0.0852909222925244,0.10471229965557,4.91872784049089e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,37598,0.0886375246111265,0.00462067284702508,0.0795810058309574,0.0976940433912957,6.54347735629936e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.162519356260652,0.00848675005082463,0.145885326161035,0.179153386360268,1.14770919361578e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.189450310939811,0.00990977483897072,0.170027152255429,0.208873469624194,1.4317404386677e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMMD1,COMM domain-containing protein 1,37628,0.111879857766611,0.00584823291760268,0.10041732124811,0.123342394285112,1.72833387532019e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELOA,Elongin-A,40305,0.0923383201954119,0.00483897974658926,0.0828539198920969,0.101822720498727,2.81620126277783e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.0893006992711246,0.00469003744607256,0.0801082258768224,0.0984931726654268,6.10096858062875e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5E,5'-nucleotidase,40411,0.104455661192194,0.00549171716047384,0.0936918955576648,0.115219426826722,8.78059539614763e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.166325693824144,0.00874386593247101,0.149187716596501,0.183463671051787,8.96866008495689e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMA,Granzyme A,40516,0.0635541545484468,0.00334168515517687,0.0570044516443001,0.0701038574525934,8.99394907538346e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE4,Ribonuclease 4,37575,0.0494560461835026,0.00259859465573865,0.0443628006582549,0.0545492917087503,1.09631109782071e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TALDO1,Transaldolase,37966,0.0806609302935584,0.00424063315978288,0.0723492893003839,0.0889725712867328,1.25099836671954e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0574979576127858,0.00302525730651522,0.051568453292016,0.0634274619335557,1.65944652699631e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAX1BP1,Tax1-binding protein 1,37942,0.115723348022965,0.00609074114112206,0.103785495386366,0.127661200659564,1.85811535093644e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AZI2,5-azacytidine-induced protein 2,37959,0.0993769415019822,0.00523267767713279,0.0891208932548019,0.109632989749162,2.16008270316812e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MITD1,MIT domain-containing protein 1,40228,0.173808688969525,0.00917004052934126,0.155835409532016,0.191781968407034,3.10521734710313e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,40305,0.0620709239800202,0.00327660421578885,0.055648779717074,0.0684930682429663,3.72368983552225e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0889031224172089,0.00468908627564943,0.079712513316936,0.0980937315174818,4.19424070323286e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0563411377572432,0.00297324081247571,0.0505135857647908,0.0621686897496956,5.00425348774878e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYN,Tyrosine-protein kinase Lyn,40305,0.150670595114391,0.0079603385399551,0.135068331576079,0.166272858652703,5.01305256562253e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS1,Galectin-1,40359,0.0604297494323715,0.00319465978517304,0.0541682162534324,0.0666912826113107,6.19825455337293e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.109798187707265,0.00580848885195635,0.098413549557431,0.1211828258571,7.88534185529189e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0971209718267112,0.00513805815726949,0.087050377838463,0.107191565814959,7.99285427347502e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.105212935899524,0.00556510326737546,0.0943053334954685,0.11612053830358,1.11076269692715e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLK1,Protein delta homolog 1,40536,0.0949965020448573,0.00503266406325085,0.0851324804808856,0.104860523608829,1.27030711958302e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.0369609074472625,0.00196036470010262,0.0331185926350613,0.0408032222594636,1.95882096393803e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCC,Tubulin-specific chaperone C,40228,0.145193837806578,0.00771204949850617,0.130078220789506,0.16030945482365,3.26981934722912e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAS6,Growth arrest-specific protein 6,40429,-0.0459110537181113,0.00244087098422709,-0.0506951608471964,-0.0411269465890262,4.41500823029068e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,37608,0.101277896726766,0.00538046506312782,0.0907321852030359,0.111823608250497,5.14101361255584e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,37598,0.174595008991304,0.00928827614001211,0.156389987756881,0.192800030225728,8.28873583844231e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1S,Complement C1s subcomponent,38013,0.0370350907658946,0.00197101658077148,0.0331718982675825,0.0408982832642067,8.86660736485524e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.116960852831239,0.00623818199123589,0.104734016128416,0.129187689534061,1.88585481076687e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMN,Protein amnionless,40044,0.0847062447335498,0.00452289861032432,0.0758413634573142,0.0935711260097855,2.05482714750817e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COCH,Cochlin,37990,0.0829497624327844,0.00443028648158409,0.0742664009288796,0.0916331239366892,3.01225834307246e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDRKH,Tudor and KH domain-containing protein,39961,0.150894039203929,0.00807189830076016,0.135073118534439,0.166714959873419,3.91448131592723e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTNB,Dystrobrevin beta,37878,0.074215708390381,0.003967787817117,0.0664388442688317,0.0819925725119303,4.32608420784049e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.178238117153785,0.00953972846220219,0.159540249367868,0.196935984939701,4.48911666915815e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM5,Tripartite motif-containing protein 5,40341,0.150827382052051,0.0080813506096625,0.134987934857113,0.16666682924699,6.49260533737764e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C3,Complement C3,37360,0.0834635548908992,0.00446810093070103,0.0747060770667252,0.0922210327150732,7.41863391384345e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MENT,Protein MENT,37671,-0.0384674224694232,0.00206131478081475,-0.0425075994398201,-0.0344272454990263,9.81142501719852e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.0478454928302213,0.00256662888733559,0.0428149002110436,0.0528760854493991,9.83662231701121e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0941306786531905,0.00504801648097091,0.0842365663504875,0.104024790955893,1.23104575462374e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAT2,Signal transducer and activator of transcription 2,37598,0.136008301792603,0.00730177349127059,0.121696825749713,0.150319777835493,1.87403182460383e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0825892331542014,0.00445237036024463,0.0738625872481219,0.0913158790602809,7.25716636661156e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH2B3,SH2B adapter protein 3,39980,0.171692377799856,0.00927593020599677,0.153511554596102,0.189873201003609,1.12783087277832e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASAH2,Neutral ceramidase,40228,0.0922703566404054,0.00498968424157889,0.0824905755269108,0.1020501377539,1.49799843696679e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,37671,0.14466486561409,0.00781903284983475,0.129339561228414,0.159990169999766,1.79219287753652e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRKL,Crk-like protein,40374,0.186577555137267,0.0101169281900337,0.166748375884801,0.206406734389733,3.65506413140025e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM13A,Protein FAM13A,37901,0.1181474229035,0.00640058519255049,0.105602275926101,0.130692569880899,3.74312475221245e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0581959069911759,0.00315866606690257,0.0520049215000469,0.064386892482305,5.03404610344309e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL3,C-C motif chemokine 3,40341,0.10762006890616,0.00584455862363504,0.0961647340038352,0.119075403808485,6.13253523760926e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.125980986254379,0.00684420566861473,0.112566343143894,0.139395629364863,6.93040417157156e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0452040338173433,0.00246094876612166,0.0403805742357448,0.0500274933989417,1.36062020935714e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.185548372497871,0.0101025711475785,0.165747333048617,0.205349411947125,2.03532542042119e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,40042,0.130179817031114,0.00709915758200207,0.11626546817039,0.144094165891838,2.51527536346187e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.138124390624575,0.0075325922063142,0.1233605099002,0.152888271348951,3.33163221528683e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGKA,Diacylglycerol kinase alpha,37598,0.0946936740964456,0.00516545296150082,0.084569386291904,0.104817961900987,3.83891442295085e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.131547980538895,0.00718875552834868,0.117458019703332,0.145637941374459,4.87207347915885e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.187340468849546,0.0102414819662434,0.167267164195709,0.207413773503383,7.40754849910846e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OCLN,Occludin,37959,0.0758486050382175,0.00414688353061586,0.0677207133182104,0.0839764967582246,7.65187254987304e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.138897844779678,0.00760922161388265,0.123983770416468,0.153811919142888,1.09049893582394e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.109931063863178,0.00602284677776806,0.0981262841787523,0.121735843547603,1.16646538450314e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGA,Protein O-GlcNAcase,37901,0.121721805700428,0.00667386927562475,0.108641021920203,0.134802589480652,1.95335572533761e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRAP,BRCA1-associated protein,37778,0.189721073373345,0.0104074250803377,0.169322520215883,0.210119626530806,2.34352766704549e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.115811544682461,0.00636820392238119,0.103329864994594,0.128293224370329,3.63216386100101e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,40332,0.0912424827780333,0.00502084697617222,0.0814016227047357,0.101083342851331,4.66374982115176e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IST1,IST1 homolog,37812,0.173133698995063,0.00952021253406524,0.154474082428295,0.191793315561831,5.06068723801265e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDHD2,Phospholipase DDHD2,37959,0.114413035354449,0.00629270499435741,0.102079333565508,0.126746737143389,5.32271108811037e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS8,Galectin-8,40471,0.104223537798206,0.00573957492287569,0.0929739709493693,0.115473104647042,5.89832336600669e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL11,Eotaxin,40516,0.0649264904542704,0.00357623119038405,0.0579170773211177,0.0719359035874231,6.27746763215153e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNLR1,Interferon lambda receptor 1,40341,0.0645229087808776,0.0035549596355513,0.0575551878951971,0.0714906296665582,6.97607817718656e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.199769713896226,0.0110075382673862,0.178194938892149,0.221344488900303,7.21353522371887e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,40422,0.227361293312471,0.0125368572231472,0.202789053155102,0.251933533469839,8.9868282316056e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.254311079833961,0.0140153210679596,0.22684105054076,0.281781109127162,1.02973829470636e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.134135895568013,0.00740879771890359,0.119614652038962,0.148657139097064,1.57818570870425e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.134784365655761,0.00744587619001801,0.120190448323326,0.149378282988196,1.71159162319301e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB27B,Ras-related protein Rab-27B,37990,0.141219496814317,0.00779768536756181,0.125936033493896,0.156502960134738,1.88482595891139e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS1BP3,HCLS1-binding protein 3,37628,0.154035518314464,0.00850740188519134,0.137361010619489,0.170710026009439,2.14815201185084e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.117489480568091,0.00649640602528833,0.104756524758526,0.130222436377657,2.95565444441601e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.149774969827481,0.00829376710913451,0.133519186293577,0.166030753361385,3.5252869946033e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUS,RNA-binding protein FUS,39960,0.0676079109339636,0.00374794899605286,0.0602619309017,0.0749538909662272,5.27084127524265e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMOX2,Heme oxygenase 2,39961,0.0781230596265986,0.00433335414478381,0.0696296855028223,0.0866164337503749,6.32877682779754e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.146629493009958,0.00813121263254441,0.130692316250171,0.162566669769745,7.81552036093927e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.124397513107881,0.00691288232199264,0.110848263756775,0.137946762458986,1.08856121518501e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.106274537121351,0.00590202897304649,0.0947065603341794,0.117842513908522,1.261676985267e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D23,TBC1 domain family member 23,40305,0.153013561941144,0.00851225064133784,0.136329550684122,0.169697573198167,1.54890592145858e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.0540288575425082,0.00300867682783439,0.0481318509599528,0.0599258641250636,2.10629679572114e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18,Interleukin-18,40292,0.0808398749865262,0.0045041083811429,0.0720118225594861,0.0896679274135662,2.52751029018686e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,40307,0.111721041733229,0.00622473952436847,0.0995205522654667,0.123921531200991,2.52921737384717e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0599011527744049,0.0033338406949562,0.0533668250122908,0.0664354805365191,2.56441981043655e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.167394599544945,0.00932862659423507,-0.185678707669646,-0.149110491420244,2.68675205203911e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASC3,Protein CASC3,37572,0.070018815557889,0.00389895385051707,0.0623768660108756,0.0776607651049025,2.93694235538732e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.153450570377287,0.00854716358486766,0.136698129750947,0.170203011003628,3.19280129599546e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0758489655781551,0.0042299278437682,0.0675583070043694,0.0841396241519407,3.49324491527667e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOLGA3,Golgin subfamily A member 3,37959,0.13359572188708,0.00745341218155283,0.118987034011236,0.148204409762924,5.07433356688667e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.205093036376576,0.0114562924770934,0.182638703121473,0.227547369631679,5.93974849545076e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMPR2,GMP reductase 2,37671,0.115498891688547,0.00645106310591971,0.102854808000944,0.128142975376149,7.53830603454822e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBNL,Drebrin-like protein,40422,0.156661931903261,0.00877337282489347,0.139466121166469,0.173857742640052,1.2492416286399e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,40359,0.134521363149616,0.00753448397577252,0.119753774557102,0.149288951742131,1.31181678667419e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0775987496012131,0.00435297130592417,0.0690669258416017,0.0861305733608245,2.12995631601016e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEFTY2,Left-right determination factor 2,40453,0.0877285348019817,0.00493693250204447,0.0780521470979746,0.0974049225059889,5.68713352386478e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RWDD1,RWD domain-containing protein 1,40471,0.108640971207574,0.00612305159861981,0.0966397900742787,0.120642152340868,9.08311537110259e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.0537271016001852,0.0030280479403441,0.0477921276371108,0.0596620755632597,9.09595311206911e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TWF2,Twinfilin-2,37998,0.139929389226244,0.0078852411645,0.124474316543824,0.155384461908664,1.14062048116202e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.150624974714297,0.00850022464722382,0.133964534405738,0.167285415022856,1.37421202886608e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NIT1,Deaminated glutathione amidase,37628,0.0836783280579585,0.00472213115489773,0.074422950994359,0.0929337051215581,1.86052370575019e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.0804077661457515,0.0045385749903844,0.071512159164598,0.0893033731269049,1.91995325021289e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPART,Spartin,37671,0.129989363243222,0.00734301343507516,0.115597056910474,0.144381669575969,2.52789106851942e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL3,C-X-C motif chemokine 3,40350,0.156453928406729,0.00884980363242335,0.139108313287179,0.173799543526279,2.80935966243865e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPHN1,Oligophrenin-1,37942,0.179663880385973,0.0101675484647132,0.159735485395135,0.199592275376811,4.255169574648e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.0886246854742404,0.00502397571510104,0.0787776930726424,0.0984716778758384,5.67831800353609e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST13,Hsc70-interacting protein,37671,0.0954641528116747,0.00542310069438086,0.0848348754506882,0.106093430172661,1.40679030144806e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0961344631617613,0.00547089041873752,0.0854115179410358,0.106857408382487,1.81135759580686e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0946182416014285,0.00538580100440798,0.0840620716327889,0.105174411570068,1.91773862812778e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0574579531061187,0.00327174102912372,-0.0638705655232012,-0.0510453406890362,2.13455426252957e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.137790871794527,0.00784663215671249,0.12241147276737,0.153170270821683,2.85162618255669e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FMNL1,Formin-like protein 1,39961,0.0999515707889563,0.00569624219725117,0.088786936082344,0.111116205495569,2.86483591279522e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17RB,Interleukin-17 receptor B,40126,-0.0891518701504049,0.00508139557770165,-0.0991114054827001,-0.0791923348181097,2.92766990118759e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICA1,Islet cell autoantigen 1,40044,0.132031840490894,0.00753691112112243,0.117259494693494,0.146804186288294,4.67881314945633e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0789343789834817,0.0045077138921545,0.0700992597548589,0.0877694982121046,6.63752537058026e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBXN1,UBX domain-containing protein 1,37671,0.115170310020174,0.00657733414158869,0.102278735102661,0.128061884937688,6.9801603649448e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS2,Trypsin-2,40403,0.0834709921844274,0.00477250050682907,0.0741168911910425,0.0928250931778124,7.33619242902574e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.139509654695969,0.00798220736428821,0.123864528261964,0.155154781129974,9.11959766425072e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,37959,0.196989880956604,0.0112641859004096,0.174912076591801,0.219067685321407,9.81669774842499e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFB2,BPI fold-containing family B member 2,37951,0.112959983122612,0.00646433409999154,0.100289888286628,0.125630077958595,1.2454245420726e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GASK1A,Golgi-associated kinase 1A,37562,0.0721679877140469,0.00412965356690912,0.0640738667229051,0.0802621087051888,1.28239263422535e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,40228,0.131811013691471,0.00755355252692833,0.117006050738691,0.14661597664425,1.47750676784172e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNPY4,Protein canopy homolog 4,40305,0.123927542947524,0.00710548593618943,0.110000790512593,0.137854295382456,1.71519290361158e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUB1,NEDD8 ultimate buster 1,40341,0.138267706375364,0.00793693720115185,0.122711309461106,0.153824103289622,2.4228477624033e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPB1,Carboxypeptidase B,40536,0.0932809545213531,0.00535760142582265,0.0827800557267407,0.103781853315965,2.81890737314052e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAX,Protein max,39961,0.172758118634886,0.00992906690746984,0.153297147496245,0.192219089773527,3.62964199523537e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD1,Sushi domain-containing protein 1,40042,0.0814472206063583,0.00468361497371694,0.0722673352578731,0.0906271059548435,4.23210479102549e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.058357421683089,0.00335911415061701,0.0517735579478796,0.0649412854182983,5.49726475537957e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESYT2,Extended synaptotagmin-2,37942,0.134964319363494,0.00776357444848835,0.119747713444457,0.150180925282531,5.81475171276832e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMPR,GMP reductase 1,40516,0.0842987646658184,0.00485365533002709,0.0747856002189653,0.0938119291126715,5.8824358300676e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.146105319867861,0.00842917045656762,0.129584145772988,0.162626493962733,1.13135750470825e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GTPBP2,GTP-binding protein 2,37572,0.131812763415054,0.00760398136220485,0.116908959945132,0.146716566884975,1.41748259054685e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.117232162324278,0.00678190234992691,0.103939633718421,0.130524690930134,2.410572056391e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.045497269446056,0.00263257721912938,0.0403374180965624,0.0506571207955496,2.58510048263895e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3GLB2,Endophilin-B2,37942,0.110119665934876,0.00637492377960873,0.0976248153268425,0.122614516542909,3.80321719966858e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESM1,Endothelial cell-specific molecule 1,40357,-0.0556181376160482,0.00322335647046711,-0.0619359162981638,-0.0493003589339327,4.12055833285451e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.110348466108904,0.00640410686006975,0.097796416663167,0.12290051555464,8.13894140785093e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEP1A,Meprin A subunit alpha,37901,0.112119731567724,0.00651638838209623,0.0993476103388149,0.124891852796632,1.20946335998233e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.131851626052718,0.00766443584419542,0.116829331798095,0.146873920307341,1.31301219201321e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF2,TNF receptor-associated factor 2,40341,0.11630613690577,0.00676963629302531,0.10303764977144,0.129574624040099,1.45149885242504e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0821510679071286,0.00478765518825751,0.0727672637381439,0.0915348720761133,2.08961944173294e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0797290237595636,0.00464720458697552,0.0706205027690916,0.0888375447500356,2.25918124577536e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0567256395669928,0.00330769834187193,0.0502425508169238,0.0632087283170618,2.42436812400605e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTBDN,Retbindin,40305,0.0476877264626525,0.00278299513335906,0.0422330560012687,0.0531423969240362,3.123596981611e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0940749642481895,0.00548770265547003,0.0833190670434683,0.104830861452911,3.49598275800222e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,40044,0.065978502653196,0.00385365618918122,0.0584253365224008,0.0735316687839912,4.07128907157055e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,40516,0.110368154525886,0.00645843430028767,0.0977096232973219,0.12302668575445,6.71201296628851e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM2,Paralemmin-2,37942,0.0601949220899812,0.003519859094475,0.0532959982648102,0.0670938459151522,6.97321733532709e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRY2,Protein sprouty homolog 2,40044,0.149539345815006,0.00875835224977038,0.132372975405456,0.166705716224556,8.99918966023494e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA4D,Semaphorin-4D,40471,0.048441934477545,0.00283884228162977,0.0428778036055507,0.0540060653495394,1.02636793924809e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,39980,0.150541767256068,0.00882533765766766,0.133244105447039,0.167839429065096,1.18430056868013e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RILPL2,RILP-like protein 2,37990,0.158044673043692,0.00926165014830463,0.139891838753015,0.176197507334369,1.29232944460155e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0523672549915856,0.00307328598376315,0.0463436144634098,0.0583908955197614,1.56969537523213e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0974646224755788,0.00572340419961577,0.0862467502443319,0.108682494706826,1.90917082024592e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDC4,Syndecan-4,40359,0.0732709230451069,0.00430437524284267,0.0648343475691353,0.0817074985210785,2.08119056877192e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX4,Syntaxin-4,40305,0.0963720367568248,0.00568025894221522,0.085238729230083,0.107505344283567,5.36642707095677e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53,Cellular tumor antigen p53,39980,0.0693629768181618,0.00410051148638159,0.0613259743048539,0.0773999793314697,1.27946692856804e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD22,B-cell receptor CD22,40516,0.0658875127613234,0.00389980137151669,0.0582439020731507,0.0735311234494961,1.72712683207031e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0520438706259041,0.00308110102443412,0.0460049126180133,0.058082828633795,1.86987686690428e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRADD,Death domain-containing protein CRADD,40192,0.122928665659503,0.0072865555440166,0.108647016793231,0.137210314525776,2.66310464773156e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOK1,Docking protein 1,37942,0.219154333790487,0.0129817160723338,0.193710170288713,0.244598497292261,2.7321182617412e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,37959,0.0984219094967414,0.00583335203031982,0.0869885395173145,0.109855279476168,3.19223511634553e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CETN3,Centrin-3,37901,0.12325072648547,0.00731049050771162,0.108922165090356,0.137579287880585,3.9743833627005e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM17,Splicing factor 45,37959,0.122449107826301,0.00726922530584628,0.108201426226843,0.13669678942576,5.02723166118228e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.137172402627335,0.0081496092558591,0.121199168485851,0.153145636768819,5.16400050508279e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YWHAQ,14-3-3 protein theta,37671,0.118214750552167,0.00702855958896405,0.104438773757798,0.131990727346537,7.93312052469632e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PENK,Proenkephalin-A,37671,0.0494283375585734,0.00293931197086881,0.0436672860956706,0.0551893890214763,8.32320260993461e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.134537464346886,0.00800309018460193,0.118851407585066,0.150223521108706,9.13074677858023e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.123721943046467,0.00737306626797416,0.109270733161237,0.138173152931696,1.17900114602777e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARB2,Lysosome membrane protein 2,40011,0.0493048394596735,0.00293873426141036,0.0435449203073092,0.0550647586120378,1.26404432180524e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD69,Early activation antigen CD69,40288,0.140311223201684,0.00836610578380472,0.123913655865427,0.156708790537941,1.36990264805879e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA11,Annexin A11,40312,0.107281239104171,0.00640670563757097,0.0947240960545323,0.119838382153811,2.10963403239274e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIFBP,KIF-binding protein,40305,0.131014897458261,0.00783403630890755,0.115660186292802,0.14636960862372,3.00197485907491e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLG,Plasminogen,37705,0.0357331801673032,0.00213530821764569,0.0315479760607176,0.0399183842738887,3.19651194238556e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.108530683865274,0.00649659797249128,0.0957973518391913,0.121264015891357,5.19497530188539e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPI,Glucose-6-phosphate isomerase,37987,0.0744988676759946,0.00446039931025547,0.0657564850278939,0.0832412503240953,5.26117659354245e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",40042,0.147765210300902,0.00885638186104206,0.13040670185326,0.165123718748545,5.84372828375192e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0714638501805029,0.00428501520156503,0.0630652203854355,0.0798624799755704,6.46134898934136e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.165787765112745,0.00994746009488946,0.146290743326762,0.185284786898729,7.71143211699785e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.0927853428230124,0.0055693024494653,0.0818695100220605,0.103701175623964,8.54501988516249e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,37901,0.0934755674166556,0.00560802622209636,0.0824838360213467,0.104467298811964,9.29014851196592e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.175117472160262,0.0105200258008484,0.1544982215906,0.195736722729925,1.06878337762267e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDCP1,CUB domain-containing protein 1,40228,0.07688109206397,0.00462170561478851,0.0678225490589845,0.0859396350689554,1.30582589609002e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0575606946096496,0.00346052007015723,0.0507780752721414,0.0643433139471578,1.32287492901998e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.163382565733705,0.00982678207556551,0.144122072865597,0.182643058601814,1.84527148273213e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATOX1,Copper transport protein ATOX1,40411,0.113358330207203,0.00682478903873504,0.0999817436912826,0.126734916723124,1.94063358800255e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDC,Nuclear migration protein nudC,40516,0.0998950313491063,0.00601840641144508,0.088098954782674,0.111691107915539,2.32656382326044e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PF4,Platelet factor 4,37934,0.15390753755496,0.00926586007321728,0.135746451811454,0.172068623298466,2.39173670217883e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0909496085277636,0.00548420375857006,0.0802005691609663,0.101698647894561,3.80249471612802e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.122534233777224,0.00739123229758139,0.108047418473964,0.137021049080483,4.15256319930055e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YJU2,Splicing factor YJU2,37900,0.0504893230516711,0.0030509257945628,0.044509508494328,0.0564691376090142,6.52344405394435e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2,Microtubule-associated protein 2,37942,0.0722372189215643,0.00436881064596503,0.0636743500554728,0.0808000877876558,8.17048436704165e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPBP,Platelet basic protein,37934,0.132098466641752,0.00799241274999466,0.116433337651763,0.147763595631742,9.12912031918642e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX8,Syntaxin-8,40341,0.0767370064653906,0.00464922087693246,0.067624533546603,0.0858494793841782,1.0744177279419e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD72,B-cell differentiation antigen CD72,37671,0.0667023853018457,0.00403861453691581,0.0587867008094907,0.0746180697942007,1.13660563904833e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.133245812739248,0.00807591324473361,-0.149074602698926,-0.11741702277957,1.18354646959094e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.151188447203267,0.00916872030959102,0.133217755396469,0.169159139010066,1.38857488689789e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.122194636837074,0.00741424551632558,0.107662715625075,0.136726558049072,1.63869754195213e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0666008547146146,0.00404626707329929,0.058670171250948,0.0745315381782812,2.29886500607857e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLG4,Disks large homolog 4,37942,0.109938047668233,0.00668008538084279,0.0968450803217812,0.123031015014685,2.85883263798983e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKD2,Polycystin-2,37562,0.0935024280298535,0.00568280773830396,0.0823641248627778,0.104640731196929,3.17116925144861e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA1,Carboxypeptidase A1,40536,0.089487682709782,0.00544671933357888,0.0788121128159674,0.100163252603597,3.62636883890342e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.0877314186328495,0.00534047372677492,0.0772640901283706,0.0981987471373283,3.80734273879009e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0967648905529508,0.00588762395001949,0.0852251476109126,0.108304633494989,4.08043428063181e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.132219789780119,0.00805230883249653,0.116437264468425,0.148002315091812,4.40501104195248e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APPL2,DCC-interacting protein 13-beta,37671,0.174722882807048,0.0106374570770258,0.153873466936077,0.195572298678019,4.95597727475811e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RFC4,Replication factor C subunit 4,37900,0.032148378765883,0.00195791644399424,0.0283108625356543,0.0359858949961117,5.29864191463341e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0857875158676443,0.00523075552222375,0.0755352350440857,0.0960397966912028,5.93344013370966e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMSB10,Thymosin beta-10,40332,0.118540219602559,0.00722956466979241,0.104370272849765,0.132710166355352,6.28422457846868e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRAS,Ras-related protein R-Ras,37572,0.203967932023756,0.012430781118467,0.179603601031561,0.228332263015951,6.58308161079702e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,37419,0.083881504561512,0.00511433908129779,0.0738573999621684,0.0939056091608557,7.49537278963567e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.151013321514675,0.00921099926880159,0.132959762947824,0.169066880081526,7.87514448184831e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACYBP,Calcyclin-binding protein,37642,0.159973170391701,0.00976900154883685,0.140825927355981,0.179120413427421,1.10745735759846e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0981457853650791,0.00600615831269437,0.0863737150721982,0.10991785565796,1.52972609049415e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,37671,0.195159447964045,0.0119332081571964,0.17177035997594,0.21854853595215,1.55528073702316e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0404517534664967,0.00247516376726927,0.035600432482649,0.0453030744503445,1.87195577087711e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0442621799591364,0.002712569439003,0.0389455438586905,0.0495788160595822,2.24177691160916e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPACT,Protein IMPACT,37942,0.0884765235246825,0.00542234315503728,0.0778487309408094,0.0991043161085556,2.75801438157097e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPARC,SPARC,40411,0.109826824064609,0.00673804560053075,0.096620254687569,0.12303339344165,2.99427319968326e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.111852704436634,0.00685676827050098,0.0984134386264519,0.125291970246816,3.0636911872584e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JAM3,Junctional adhesion molecule C,37671,0.0787429641065205,0.00482737767631134,0.0692813038609503,0.0882046243520908,3.08238573875363e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0847416033832865,0.00520561369328448,0.0745386005444489,0.0949446062221241,4.27947663393483e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN3,Ataxin-3,37942,0.0966766720696836,0.00594149727408654,0.085031337412474,0.108322006726893,5.73067278819524e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP2B1,AP-2 complex subunit beta,37572,0.0758229319651706,0.00466459725986852,0.0666803213358283,0.0849655425945129,7.72967471032726e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRAP2,GRB2-related adapter protein 2,40359,0.195786938907436,0.0120760153097594,0.172117948900308,0.219455928914565,1.20703103166076e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED8,Protein TMED8,37901,0.158734554867342,0.00978490737763356,0.139556136407181,0.177912973327504,1.26058137042776e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPP,Lipoma-preferred partner,37562,0.103866099732703,0.00640385472187574,0.0913145444778262,0.116417654987579,1.36803793983914e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBKS,Ribokinase,39991,0.0766818427082975,0.00473161418122549,0.0674078789130955,0.0859558065034995,1.37591714712341e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.065348769597701,0.00402959638972974,0.0574507606738307,0.0732467785215713,1.39377076156562e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,37572,0.125222057110006,0.00772667569509101,0.110077772747628,0.140366341472385,1.67765908507686e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SULT2A1,Bile salt sulfotransferase,40341,0.0820274901243302,0.00507030609924494,0.0720896901698101,0.0919652900788503,2.11043135086087e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTRK3,NT-3 growth factor receptor,40471,-0.0336120525610904,0.00207913505399412,-0.0376871572669188,-0.0295369478552619,2.52031639568089e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.15190972986526,0.00941205881855528,0.133462094580892,0.170357365149629,3.97308217039995e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.117658320099461,0.00729022919779045,0.103369470871792,0.131947169327131,4.01921920529169e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.083569421666951,0.00518759293597958,0.073401739512431,0.093737103821471,6.30903165348007e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF19,Fibroblast growth factor 19,40422,0.117577033402308,0.00729892238821408,0.103271145521408,0.131882921283207,6.32675385114987e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASSF2,Ras association domain-containing protein 2,39980,0.0843909619266251,0.00523886450521099,0.0741227874964115,0.0946591363568386,6.53590673587581e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,40536,0.110206604633518,0.0068436092976097,0.0967931304102028,0.123620078856833,6.8265436705491e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UROD,Uroporphyrinogen decarboxylase,37671,0.108115553116428,0.00670913156185606,0.0949656552551905,0.121265450977666,7.15371533588503e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCB,Tubulin-folding cofactor B,40228,0.154988977632557,0.00962750228789843,0.136119073148276,0.173858882116838,7.54336718614329e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.0985844447992188,0.00612688156703904,0.0865757569278223,0.110593132670615,1.02794322745586e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNM3,Dynamin-3,37959,0.0841197212869455,0.00522933050101453,0.0738702335049571,0.094369209068934,1.09536482880704e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK24,Serine/threonine-protein kinase 24,39961,0.0944470035855522,0.0058799667247224,0.0829222688050963,0.105971738366008,1.36162531845519e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEXN,Nexilin,37987,0.104627340283476,0.0065114520855487,0.0918648941958008,0.117389786371152,1.45142685468657e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,37901,0.127449412549102,0.00793559463368818,0.111895647067074,0.143003178031131,1.65299460090435e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,40341,0.0503145831480525,0.00313564410998562,0.0441687206924807,0.0564604456036243,1.72453206577531e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.149497321078821,0.00931007774850653,0.131249568691749,0.167745073465894,1.77449489394835e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0966831601209692,0.00602723457396258,0.0848697803560025,0.108496539885936,2.29503137882946e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MIF,Macrophage migration inhibitory factor,40307,0.105225592436142,0.00656518981836362,0.0923578203921497,0.118093364480135,2.30612802857293e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD274,Programmed cell death 1 ligand 1,40228,0.052928113068803,0.00331033465455569,0.0464398571458738,0.0594163689917321,4.2987611640339e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.132185527601617,0.00826564831970283,0.115984856894999,0.148386198308235,4.86086731879641e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.130267091524284,0.00814855826935975,0.114295917316339,0.146238265732229,5.28440221795901e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,37959,-0.068950192261089,0.00432040387753649,-0.0774181838610605,-0.0604822006611174,8.1230629711596e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.158030628417241,0.00990229139561836,0.138622137281829,0.177439119552653,8.36146322485908e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F13B,Coagulation factor XIII B chain,37934,0.0392650472794786,0.00246140313655999,0.034440697131821,0.0440893974271362,9.07336045335312e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.102925371729225,0.00645588105800418,0.0902718448555364,0.115578898602913,1.08777961725536e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADD1,Alpha-adducin,37671,0.106598874352834,0.00669479338475304,0.0934770793187183,0.11972066938695,1.47945272824584e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,37671,0.179763395148949,0.0112976390960487,0.157620022520693,0.201906767777204,1.75969855258816e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LACTB2,Endoribonuclease LACTB2,40359,0.0999119652208164,0.00628829186103967,0.0875869131731786,0.112237017268454,2.06493905724935e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINE2,Glia-derived nexin,37990,0.0973074650629318,0.00612239225101093,0.0853075762509504,0.109307353874913,2.26467787144398e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.100751289374399,0.00634193957229688,0.0883210878126975,0.113181490936101,2.59630586960544e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UMOD,Uromodulin,40502,-0.0819910148127232,0.00516548185337428,-0.0921153592453368,-0.0718666703801096,2.61888617756982e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RILP,Rab-interacting lysosomal protein,40434,0.0910800706270146,0.00573949694062387,0.0798306566233919,0.102329484630637,2.79436090702413e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGF,Pro-epidermal growth factor,40324,0.155169599042817,0.00978789222964596,0.135985330272711,0.174353867812923,3.60291310547939e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARK7,Parkinson disease protein 7,40332,0.0808614611472411,0.00510104371744224,0.0708634154610543,0.0908595068334279,3.67376910955713e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.102403862308265,0.00646875537018655,0.0897251017826994,0.115082622833831,5.12815647387318e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.0745061696589278,0.00470648376002636,0.0652814614892761,0.0837308778285795,6.22546568446376e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0930587855745899,0.00588500229297126,0.0815241810803663,0.104593390068814,8.02887265215758e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0870449859801373,0.00551256617103975,0.0762403562848994,0.0978496156753752,9.84850143338542e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0968587204130084,0.0061360278756257,0.084832105776782,0.108885335049235,1.26352015498024e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0990031067309583,0.00628267972406615,0.0866890544717886,0.111317158990128,1.57826707116164e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPC5,Glypican-5,40228,0.084000928139236,0.00533537431227787,0.0735435944871714,0.0944582617913007,1.99012818234946e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F2R,Proteinase-activated receptor 1,40396,0.0861474042893098,0.00547495778065727,0.0754164870392215,0.0968783215393981,2.27831396343851e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD226,CD226 antigen,37598,0.062961112200767,0.0039985623312759,0.0551239300314663,0.0707982943700678,2.34523735306707e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN2L,Ataxin-2-like protein,37959,0.0724822823744586,0.00460407900186058,0.0634582875308119,0.0815062772181053,2.37821950879634e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSS,Cathepsin S,37057,0.036986613783362,0.0023511514425507,0.0323783569559626,0.0415948706107613,3.09223550897341e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0706453724737464,0.00449563918181007,0.0618339196773986,0.0794568252700941,3.12484332693695e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH9,Protocadherin-9,37901,0.0507315570146603,0.00322626244754495,0.0444080826174722,0.0570550314118484,3.18389635111618e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPI,Mannose-6-phosphate isomerase,40305,0.128380650500367,0.00817371128661224,0.112360176378607,0.144401124622127,3.55492642935207e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXJ3,Forkhead box protein J3,37598,0.0654159958980696,0.00416849909791511,0.057245737666156,0.0735862541299833,5.33040167369033e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP10,Caspase-10,39961,0.107174219471764,0.00683465929365797,0.093778287256194,0.120570151687333,5.39526566313407e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.0862942556226026,0.00550436631865558,0.0755056976380377,0.0970828136071676,5.71000796628895e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSTB,Cystatin-B,40097,0.0625387566555136,0.00399071288547346,0.0547169593999856,0.0703605539110415,6.23890706466002e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12A_IL12B,Interleukin-12,40305,0.116842919618233,0.00746669715135315,0.10220819320158,0.131477646034885,8.73381716274975e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA4,Protein disulfide-isomerase A4,37998,0.0902803705586602,0.0057686621898343,0.078973792666585,0.101586948450735,9.98755465411098e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0700574017225021,0.00448254499572394,0.0612716135308832,0.0788431899141211,1.38607890670034e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,40287,0.13229638356485,0.00847672028084286,0.115682011814398,0.148910755315302,1.6606882352055e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0672696786220086,0.00431234237047956,-0.0757218696681485,-0.0588174875758687,1.85012448420342e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD244,Natural killer cell receptor 2B4,40516,0.0395567966641091,0.00253750636587699,0.0345832841869902,0.044530309141228,2.169494267314e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMOT,Angiomotin,37671,0.0621014940177922,0.00398207486818946,0.0542966272761409,0.0699063607594436,2.38918607933606e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0573683585475596,0.00368277578349777,0.050150118011904,0.0645865990832152,3.08193881443481e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIAPIN1,Anamorsin,40411,0.0945031493935828,0.00607841100329343,0.0825894638271277,0.106416834960038,4.13510733585359e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHRL,Appetite-regulating hormone,40359,0.11682121446763,0.00751484638456891,0.102092115553875,0.131550313381385,4.27391085049538e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0908654750619197,0.0058481486580907,0.079403103692062,0.102327846431777,4.81247146610095e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0573845364087609,0.00369158319140634,0.0501490333536045,0.0646200394639174,5.08040985012382e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.0641869774143671,0.00414011114195374,0.0560723595761378,0.0723015952525964,9.57985644233224e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.056569445171854,0.00365179629729837,0.0494119244291492,0.0637269659145588,9.83644445057665e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBI,Acyl-CoA-binding protein,40270,0.116480056633326,0.00752034998802649,0.101740170656794,0.131219942609858,1.02620964861035e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.134876635915074,0.00870332730976583,0.117818114387933,0.151935157442215,1.08173556271545e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CETN2,Centrin-2,39961,0.0990930627900636,0.00639949439995652,0.0865500537661489,0.111636071813978,1.11303112689085e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0805178502101777,0.00520158434524278,0.0703227448935019,0.0907129555268536,1.40803681040043e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0571351096728781,0.00369100147089016,0.0499007467899334,0.0643694725558228,1.41509457608043e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.118232231133713,0.00764109130961399,0.103255692166869,0.133208770100556,1.51464720834499e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCA,Calcitonin,40192,0.0810902888255687,0.00524404397914225,0.0708119626264499,0.0913686150246876,1.51915194936238e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDT,D-dopachrome decarboxylase,37998,0.0604113661011849,0.00390571664756461,0.0527561614719583,0.0680665707304115,1.64966617742781e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.110897561690727,0.00717824818285209,0.0968281952523368,0.124966928129117,1.91278976391381e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0911398141836616,0.00589821430435157,0.0795793141471325,0.102700314220191,2.14546207827371e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALB2,Calretinin,39961,0.0463372690725934,0.00300175830217461,0.0404538228003312,0.0522207153448557,2.31171541508056e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0457064190991992,0.00295961131755221,0.0399055809167968,0.0515072572816015,2.41402941671838e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,37987,0.106268784710429,0.0068824604121777,0.092779162302561,0.119758407118298,2.4883142180372e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2,Complement C2,40372,0.035256861644798,0.00228494942323144,0.0307783607752643,0.0397353625143316,2.50041902052093e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPSE,Heparanase,37848,0.136898519434646,0.00886891321135594,0.119515449540388,0.154281589328903,2.70390672235129e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK10,Kallikrein-10,40354,0.0577503563847193,0.00374513829370386,0.0504098853290597,0.0650908274403788,2.91351275588738e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP7,Caspase-7,37942,0.123188497706161,0.00798846413475907,0.107531108002033,0.138845887410288,3.37155014384831e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.136577627509833,0.00885716276769241,0.119217588485155,0.15393766653451,3.40730723221856e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOF,Apolipoprotein F,37987,-0.0354480169019307,0.00230427424768808,-0.0399643944273994,-0.0309316393764621,5.9149028114719e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THTPA,Thiamine-triphosphatase,37884,0.129893790992501,0.00845111493022777,0.113329605729255,0.146457976255748,7.32486354815969e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPP1,Tripeptidyl-peptidase 1,40255,0.065452286737891,0.00426195753070259,0.0570988499777139,0.073805723498068,7.61665187550428e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BIN2,Bridging integrator 2,40332,0.132729197680621,0.00864995404499325,0.115775287752434,0.149683107608808,9.21691381530469e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSNL1,Visinin-like protein 1,37942,0.0548534796246984,0.00357536470108394,0.0478457648105739,0.0618611944388229,1.11397168444054e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APP,Amyloid-beta precursor protein,40309,0.0979100191806185,0.00638769980768134,0.0853901275575631,0.110429910803674,1.18719916954548e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0557313519082143,0.00363629839385364,0.0486042070562612,0.0628584967601675,1.20117280994786e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REEP4,Receptor expression-enhancing protein 4,37959,0.0909317878799676,0.00593082108168026,0.0793073785598743,0.102556197200061,1.29422327693296e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0595368025688713,0.00388558007671948,0.0519210656185011,0.0671525395192414,1.49939346641273e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.137231285753538,0.00896520273348078,0.119659488395916,0.15480308311116,1.62459081321069e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARF1,Scavenger receptor class F member 1,40536,0.0617662307592675,0.00403581415306575,0.0538560350192586,0.0696764264992764,1.67155316762605e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB6,Serpin B6,40433,0.0871052814387494,0.00569440001506492,0.0759442574092222,0.0982663054682767,1.89343329334715e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.145662846506066,0.00951984523638362,0.127003949842754,0.164321743169378,2.13852822488456e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTF1,Cardiotrophin-1,40042,0.123121964954535,0.00805876884822324,0.107326778012017,0.138917151897052,2.56420212703419e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.136071740302288,0.00890394463920707,0.118620008809442,0.153523471795134,2.81989087917129e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL11,C-X-C motif chemokine 11,40471,0.115620646182457,0.0075769281327737,0.100769867042221,0.130471425322694,3.3110559017993e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD207,C-type lectin domain family 4 member K,40029,0.05581383238343,0.00366240040501019,0.04863552758961,0.0629921371772499,4.5768685837811e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP2,Caspase-2,40341,0.0981384238302258,0.00644015935210435,0.0855157115001013,0.11076113616035,4.58120221007033e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1RL,Complement C1r subcomponent-like protein,37993,0.028220729268179,0.00185139024032688,0.0245920043971383,0.0318494541392197,4.95192318582451e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNA4,Ephrin-A4,40203,0.0427767624154342,0.00280816910645169,0.0372727509667889,0.0482807738640795,5.01680638153915e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,40471,0.0648978456609159,0.00426287271608209,0.056542615137395,0.0732530761844368,5.66532729571247e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPB1,Heat shock protein beta-1,40116,0.0983421365023377,0.00646129490144649,0.0856779984955026,0.111006274509173,6.11106202013172e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.042200650208975,0.00277333654039564,0.0367649105897996,0.0476363898281505,6.31954867416015e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0861348811024751,0.0056606323203862,0.0750400417545181,0.097229720450432,6.51062380569248e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.130420319255183,0.00856839347259444,0.113626268048898,0.147214370461469,6.88505692067882e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MESD,LRP chaperone MESD,40332,0.175469799920667,0.0115371170489085,0.152857050504806,0.198082549336528,7.1332694664593e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP3R1,Calcineurin subunit B type 1,40228,0.0598960057624315,0.0039383115154957,0.0521769151920599,0.067615096332803,7.23822468001171e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G15,Phospholipase A2 group XV,40411,0.0372488026337625,0.00245258967411991,0.0324417268724875,0.0420558783950375,9.83417807657555e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.053991319127251,0.00355847652753236,0.0470167051332876,0.0609659331212145,1.22448159252052e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,40167,0.0406656520120134,0.00268250185450651,0.0354079483771806,0.0459233556468461,1.51546163587554e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAP3,Cytosol aminopeptidase,40044,0.0708814731539813,0.00468378173003187,0.0617012609631188,0.0800616853448437,2.25975247739232e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1R2,Interleukin-1 receptor type 2,40330,0.0281498745258394,0.00186159646760598,0.0245011454493317,0.0317986036023472,2.66534949937774e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0415194940787383,0.00274687761194194,0.0361356139593321,0.0469033741981445,3.44348368703932e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPT1,Angiopoietin-1,40263,0.122151565325716,0.00808733643790523,0.106300385907422,0.13800274474401,3.4651574471726e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,37901,0.126370749616984,0.00836773313701563,0.109969992668434,0.142771506565535,4.11226754134751e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6AP2,Renin receptor,39980,0.0599867960728513,0.0039772111870409,0.0521914621462511,0.0677821299994514,4.84380534523612e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.158188723554295,0.0104922884141981,0.137623838262466,0.178753608846123,5.18187455777362e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG6,Large proline-rich protein BAG6,40042,0.0515981012053989,0.00342391140172305,0.0448872348580217,0.0583089675527761,5.83542463803494e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.13629712129115,0.00904538417105955,0.118568168315873,0.154026074266427,5.93564747789894e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIP,Gastric inhibitory polypeptide,37628,0.07443127117115,0.00493791058267474,0.0647529664291076,0.0841095759131925,6.43314756973236e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS3BP,Galectin-3-binding protein,38013,0.0425510359561489,0.00282749835474756,0.0370091391808437,0.0480929327314541,9.0025068889929e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD83,CD83 antigen,40341,0.0481315778457733,0.00320614020149696,0.0418475430508392,0.0544156126407073,1.3554773802987e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0391349280524522,0.00260865948252374,0.0340219554667057,0.0442479006381987,1.58233404858473e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,37978,0.0692617243369277,0.00461606393831424,0.0602142390178318,0.0783092096560236,1.74721309689039e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM106A,Transmembrane protein 106A,37900,0.100324290750463,0.00668964270805712,0.087212591042671,0.113435990458255,1.96427937627882e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.140146456834862,0.0093459402984051,0.121828413849988,0.158464499819736,1.99669754435699e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINC1,Antithrombin-III,37981,0.0210692419747266,0.0014053441941961,0.0183147673541023,0.023823716595351,2.09515382115666e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB33A,Ras-related protein Rab-33A,37562,0.0954883508080687,0.00637221616767083,0.0829988071194339,0.107977894496704,2.39757156761504e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MGLL,Monoglyceride lipase,40396,0.123121815138843,0.00822564993602764,0.106999541264229,0.139244089013457,2.60859696071496e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL8,C-C motif chemokine 8,40470,0.0860695226129363,0.0057571639961827,0.0747854811804183,0.0973535640454544,3.39621161812024e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANG,Angiogenin,40309,0.0490816354132798,0.00328593461355134,0.0426412035707192,0.0555220672558405,4.15528258198216e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0571552766308216,0.00382485016279699,0.0496585703117395,0.0646519829499037,4.32745540435317e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP10,Stromelysin-2,40341,-0.0853793229473988,0.00571709851127915,-0.0965848360295059,-0.0741738098652917,4.32789956731466e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D5,TBC1 domain family member 5,40341,0.111517498918679,0.00746903826857372,0.0968781839122742,0.126156813925083,4.55067215001009e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0420697680653361,0.00281826660239478,0.0365459655246424,0.0475935706060299,4.78947371339533e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0757099756391728,0.00507311927395719,0.0657666618622167,0.0856532894161288,5.77949223360581e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.051134200725491,0.00343173438612978,0.0444080013286766,0.0578604001223054,7.24235950854878e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F2,Prothrombin,38013,0.0209262436231918,0.00140501083079253,0.0181724223948385,0.0236800648515452,8.91559386633145e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.1056159460996,0.0070933395741202,0.0917130005343245,0.119518891664876,9.54838434905672e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0868756276296999,0.00583430209098781,0.0754403955313638,0.098310859728036,9.60911358649061e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0923577774372056,0.00620522852261186,0.0801955295328864,0.104520025341525,1.04282735027384e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSAP,Prosaposin,37901,0.0404450270986231,0.00271749711022311,0.0351187327625858,0.0457713214346604,1.05320913968997e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.104363102335157,0.00701369452924107,0.0906162610578443,0.118109943612469,1.12615362722528e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARSA,Arylsulfatase A,40332,0.0632098074657255,0.00425185560662942,0.0548761704767319,0.0715434444547192,1.17481673704889e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSL,Cathepsin L1,40359,0.0343616798499462,0.00231178793871124,0.0298305754900721,0.0388927842098202,1.22131365706579e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,39980,0.0644446597039869,0.00433626024744663,0.0559455896189915,0.0729437297889823,1.2789975120806e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TADA3,Transcriptional adapter 3,37900,0.0552330796354501,0.00371660812589642,0.0479485277086931,0.062517631562207,1.45616265280935e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DXO,Decapping and exoribonuclease protein,37942,0.0649903524053917,0.00437455337489325,0.056416227790601,0.0735644770201825,1.5558289051266e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.142312849554734,0.00958860723121767,0.123519179381548,0.161106519727921,1.68500565260163e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMG3,Proteasome assembly chaperone 3,40341,0.0724963673454369,0.00488657083674366,0.0629186885054193,0.0820740461854544,1.84125905418529e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL4,C-C motif chemokine 4,40376,0.0957002759861177,0.00645237805678901,0.0830536149948112,0.108346936977424,1.95103353694707e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATG4A,Cysteine protease ATG4A,39980,0.0841436219084097,0.00567868698511933,0.0730133954175758,0.0952738483992436,2.45499082574918e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MICALL2,MICAL-like protein 2,37572,0.0967441920593289,0.00653744440016314,0.0839308010350092,0.109557583083649,3.7303623558815e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.094859105706943,0.0064104907991848,0.0822945437405408,0.107423667673345,3.78753305753877e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.13043007064071,0.0088256008318441,0.113131893010296,0.147728248271125,4.9780217755378e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF6,SLAM family member 6,39980,0.0535679569943128,0.00362701245154937,0.046459012589276,0.0606769013993495,4.98051732948885e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA2,Apolipoprotein A-II,37987,-0.0671176917730173,0.00454343887421188,-0.0760228319664726,-0.058212551579562,5.30843465980314e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.107863023428499,0.00730635093891465,0.0935425755882265,0.122183471268772,5.35088907722188e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYO9B,Unconventional myosin-IXb,40044,0.0933570428036122,0.00632391844410687,0.0809621626531627,0.105751922954062,5.47126040664789e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0436462017187502,0.00295694192501276,0.0378505955457252,0.0494418078917752,5.5455182861145e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.133065516587542,0.00901175099549596,0.11540248463637,0.150728548538714,5.88390059285542e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0671556550932471,0.00454836934829752,0.058240851170584,0.0760704590159102,5.94787729098047e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EHD3,EH domain-containing protein 3,37628,0.165169213425417,0.0111895599308229,0.143237675961004,0.18710075088983,6.42239198725131e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CERT,Ceramide transfer protein,39961,0.0863308827070825,0.00586457368697191,0.0748363182806176,0.0978254471335475,1.01130562711151e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRB1,Chymotrypsinogen B,40332,0.0747417690207215,0.00507982503496715,0.0647853119521859,0.0846982260892571,1.10521646878602e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.102975060565702,0.00699812758157118,0.0892587305058224,0.116691390625581,1.25435297843117e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP7,Matrilysin,40015,0.0676755224936124,0.00460389198432143,0.0586518942043424,0.0766991507828825,1.37206615873177e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMFG,Glia maturation factor gamma,37990,0.100486188248898,0.00684773245261503,0.0870646326417721,0.113907743856023,2.21259452268672e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCA,Tubulin-specific chaperone A,37671,0.122074007994509,0.00832236327380497,0.105762175977851,0.138385840011167,2.47011766855919e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA1,Apolipoprotein A-I,38013,-0.0386271154445693,0.00263508822592289,-0.0437918883673781,-0.0334623425217604,2.77113424533984e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP3,Caspase-3,40536,0.122940898319479,0.00839396302496757,0.106488730790542,0.139393065848415,2.90757539291277e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0528449232810523,0.00360775411455617,0.0457737252165222,0.0599161213455824,2.92025485687815e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREML2,Trem-like transcript 2 protein,40332,0.0468424241734641,0.00319962685813862,0.0405711555315124,0.0531136928154158,3.21901093729632e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGH,Gamma-glutamyl hydrolase,40077,0.0478047284293107,0.00326870009519877,0.0413980762427211,0.0542113806159003,4.04641102876757e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.138216159601999,0.00945739558945445,0.119679664246669,0.15675265495733,5.26777038300888e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSC22D1,TSC22 domain family protein 1,37959,0.093878580733623,0.00642799681343205,0.0812797069792962,0.10647745448795,6.08410270296906e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA3,Annexin A3,40442,0.0973463106613186,0.00667335223046654,0.0842665402896042,0.110426081033033,6.8680763244721e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMT,Catechol O-methyltransferase,39877,0.118326941822278,0.0081136361274401,0.102424215012496,0.134229668632061,7.42384627250009e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.150441230088267,0.0103111077033936,0.130231458989615,0.170651001186918,7.52062088244106e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L1,Bcl-2-like protein 1,37942,0.138995648873901,0.0095278948762353,0.12032097491648,0.157670322831323,7.71242727648045e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.131260304770164,0.00900551300921442,0.113609499272104,0.148911110268225,8.19122215342635e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0805183713906835,0.00552600993531783,0.0696873919174605,0.0913493508639064,8.90378736131433e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL18,C-C motif chemokine 18,40172,0.0976508310280913,0.00670461383363656,0.0845097879141636,0.110791874142019,9.6353191401809e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYBB1,Beta-crystallin B1,37990,0.0900566361941589,0.0061894054391107,0.0779254015335019,0.102187870854816,1.33270723530233e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRGN,Neurogranin,37987,0.125736476160961,0.00864982999498908,0.108782809370783,0.14269014295114,1.6264465602726e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL16,C-X-C motif chemokine 16,40517,0.0328729113901926,0.00226593460809317,0.02843167955833,0.0373141432220552,2.1668823705313e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.121042390418407,0.00834062700477448,0.104694761489049,0.137390019347765,2.33802572886494e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP170,Centrosomal protein of 170 kDa,37628,0.107044875302306,0.0073871744879308,0.0925660133059613,0.12152373729865,3.20232703422579e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,37900,0.0759641651041184,0.00525038041354742,0.0656734194935654,0.0862549107146713,4.335787280139e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP5,Platelet glycoprotein V,37671,0.0495964554691257,0.00343036598844491,0.0428729381317736,0.0563199728064777,5.09114446026022e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL2,C-C motif chemokine 2,40203,0.0729009015213681,0.00504690759429406,0.0630089626365517,0.0827928404061844,5.40830203193963e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NBN,Nibrin,40044,0.0701723733478744,0.00485944367944079,0.0606478637361704,0.0796968829595783,5.78834595756216e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUGT1,Protein SGT1 homolog,39980,0.112102928102564,0.0077669491315435,0.0968797078047388,0.127326148400389,6.42437273529619e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0699439905739112,0.00484414871978609,0.0604494590831305,0.0794385220646919,6.60689176574584e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0637321938930051,0.00441366009720786,0.0550814201024777,0.0723829676835325,6.63106918344165e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTD,Deoxycytidylate deaminase,37671,0.130163312756587,0.00902390820916806,0.112476452666617,0.147850172846556,8.24997220668265e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRD1,Natural killer cells antigen CD94,40516,0.062690427012252,0.00435113755753655,0.0541621973994804,0.0712186566250237,9.04107807554701e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.15427096945989,0.0107079247985741,0.133283436854685,0.175258502065095,9.34498573327706e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMPER,BMP-binding endothelial regulator protein,37671,0.0309451222433948,0.00214769311167568,0.0267356437445105,0.0351546007422791,1.03250317044826e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F12,Coagulation factor XII,38013,0.0574456688072033,0.00398996923516171,0.0496253291062863,0.0652660085081202,1.18377080428909e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POSTN,Periostin,37998,-0.0521297676077099,0.00362099259899214,-0.0592269131017345,-0.0450326221136853,1.20147432260042e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0439695313876514,0.003056580832277,0.0379786329563885,0.0499604298189144,1.25025473690449e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.11094359220039,0.00772389974643407,0.0958047486973794,0.126082435703401,1.70996356747983e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.08321076539871,0.00579658603161292,0.0718494567767487,0.0945720740206713,1.93121151268551e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0490115899236773,0.00341204854391254,0.0423239747776087,0.0556992050697459,1.9500733694946e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3C,Protein FAM3C,40330,0.0406384155163237,0.00283138371387966,0.0350889034371196,0.0461879275955279,1.99604766987324e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.0836949748035559,0.00583381920374452,0.0722606891642167,0.0951292604428952,2.18328840412509e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.0898091428622638,0.00625970065235281,0.0775401295836523,0.102078156140875,2.1957907858582e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",37628,0.118936200943883,0.00828765515328152,0.102692396843451,0.135180005044314,2.34677245366061e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFB,Complement factor B,37770,0.0448980081674313,0.00313494106203089,0.0387535236858507,0.0510424926490118,3.52141924363708e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12B,Interleukin-12 subunit beta,40516,0.0740983392823727,0.00517784025025006,0.0639497723918826,0.0842469061728628,3.60839554043267e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.048064374073621,0.00335685738043501,0.0414849336079683,0.0546438145392736,3.67462588901588e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0874002516042384,0.00610861497785166,0.0754273662476492,0.0993731369608277,3.78749821963899e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL7,Interleukin-7,40341,0.087916397999783,0.00614466993523568,0.0758728449267211,0.0999599510728449,3.7878296655358e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.139760033951245,0.00979114032947304,0.120569398905478,0.158950668997012,6.97068247658629e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FIS1,Mitochondrial fission 1 protein,40354,0.105071340013352,0.00736626742254519,0.0906334558651636,0.119509224161541,7.05292703387063e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMMT,MICOS complex subunit MIC60,37900,0.0606201799278005,0.0042477564209261,0.0522945773427853,0.0689457825128156,7.16144939079156e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.0434689693150118,0.00305351782847334,0.0374840743712041,0.0494538642588195,1.05545251772969e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.100583489871313,0.00707291037944642,0.0867205855275983,0.114446394215028,1.44553685347272e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMVK,Phosphomevalonate kinase,39951,0.150107303376113,0.0105634803324182,0.129402881924573,0.170811724827652,1.53387186587215e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP6,Platelet glycoprotein VI,40311,0.119284441470954,0.00839710974499925,0.102826106370755,0.135742776571152,1.61271880122868e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK13,Kallikrein-13,40032,0.0587444927519961,0.00414113378339721,0.0506278705365376,0.0668611149674546,2.15615586007914e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMTN,Smoothelin,37905,0.130518739099737,0.00919991422148377,0.112486907225629,0.148550570973845,2.34265537570051e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP5,Microfibrillar-associated protein 5,40536,0.0554474888085094,0.00391310336363435,0.0477778062157861,0.0631171714012328,2.64315911009557e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0774538946798272,0.00546618899440655,0.0667401642507904,0.088167625108864,2.65220903765748e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB9,Serpin B9,40228,0.0453283935241521,0.0032021552652731,0.0390521692042168,0.0516046178440874,3.26218816344665e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNMT,Histamine N-methyltransferase,40147,0.0626317636358547,0.00442708128885023,0.0539546843097082,0.0713088429620011,3.67082379688598e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.0717395108278443,0.00507807348191613,0.0617864868032887,0.0816925348523999,5.49859856881531e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIF1,Allograft inflammatory factor 1,39980,0.0710409685420725,0.00503627711712877,0.0611698653925001,0.0809120716916449,6.61841662974438e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LARP1,La-related protein 1,37900,0.0855228748338354,0.00606721950826419,0.0736311245976376,0.0974146250700332,8.38698265350812e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STXBP1,Syntaxin-binding protein 1,37959,0.104039152389582,0.00739202253634996,0.0895507882183365,0.118527516560828,1.12649652896391e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPB6,Heat shock protein beta-6,40489,0.0489461679334237,0.0034821070022591,0.0421212382089959,0.0557710976578516,1.29342791047258e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WDR46,WD repeat-containing protein 46,37900,0.0478463906595201,0.00340204417885303,0.0411783840689681,0.054514397250072,1.30820979072817e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEPR,Leptin receptor,40359,-0.041133971610353,0.00292720134224396,-0.0468712862411512,-0.0353966569795549,1.37750124660622e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.0400020910619188,0.0028467983381667,0.0344223663191121,0.0455818158047255,1.40084673929452e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.107080543003594,0.00761913626831953,0.0921470359176881,0.122014050089501,1.52559316981106e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL32,Interleukin-32,40341,-0.0571543039589407,0.00407563327159622,-0.0651425451712693,-0.0491660627466121,2.06215480970855e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.0801353038055656,0.00572131105232595,0.0689215341430067,0.0913490734681245,2.61450051706512e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,37880,0.117070076716532,0.00836437863969132,0.100675894582737,0.133464258850327,3.35746278387741e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.070629508275793,0.00504722778917988,0.0607369418090004,0.0805220747425856,3.52535266704278e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0528297498550841,0.00377784326373243,0.0454251770581686,0.0602343226519997,3.96109644003344e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERMAP,Erythroid membrane-associated protein,37598,0.0599576763311157,0.00429401498139051,0.0515414069675903,0.0683739456946411,5.39691085667263e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLNK,B-cell linker protein,37598,0.0510798636530766,0.00366700689463051,0.0438925301396008,0.0582671971665523,8.57262308814141e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,40411,0.111053384875546,0.00798401517649951,0.0954047151296074,0.126702054621485,9.98767422619411e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0273540059594156,0.00196789914208703,-0.0312110882779062,-0.023496923640925,1.13611619543345e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.102242063703262,0.00735539245658712,0.0878254944883517,0.116658632918173,1.26349113947431e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XCL1,Lymphotactin,40489,0.0747140114985615,0.00538213780851927,0.0641650213938637,0.0852630016032593,1.45804092275282e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.157270697920515,0.0113361388786057,0.135051865718448,0.179489530122582,1.64220033611839e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0555374908930401,0.0040049196806328,0.0476878483189998,0.0633871334670803,1.78554502081752e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,37998,0.0409589892353509,0.002955916594176,0.035165392710766,0.0467525857599359,2.29254434178328e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.093259980838409,0.00673417987735605,0.0800609882787911,0.106458973398027,2.56909866174622e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",40314,0.144569443791114,0.01044526269183,0.124096728915127,0.165042158667101,2.58639549940431e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.145819546250914,0.0105502840654012,0.125140989482727,0.1664981030191,3.40471666443098e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCN1,Ficolin-1,37967,0.0743761018530996,0.00539336085321963,0.0638051145807891,0.08494708912541,5.6954981750516e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACYP1,Acylphosphatase-1,37622,0.0871141230281923,0.00632463189561604,0.0747178445127849,0.0995104015435997,7.26222616358519e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RP2,Protein XRP2,40305,0.0541905612639648,0.00394155144825948,0.0464651204253762,0.0619160021025534,9.1432454208149e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0890367713741677,0.00648050644459604,0.0763349787427595,0.101738564005576,1.05129055919692e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BDNF,Brain-derived neurotrophic factor,37998,0.108667314228051,0.00790811675353394,0.0931674053911248,0.124167223064978,1.11093841166609e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.0594253139004926,0.00432903362759218,0.050940407990412,0.0679102198105733,1.37056997119004e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCG2,Secretogranin-2,40392,0.0421838876479406,0.0030798662810742,0.0361473497370351,0.048220425558846,1.84891581261267e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3B,Protein FAM3B,40305,0.0471886680435181,0.0034456125820838,0.0404352673826338,0.0539420687044023,1.8894116916559e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS3,Galectin-3,40374,0.0386652121744796,0.00282374910123459,0.0331306639360598,0.0441997604128994,1.94818994330166e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFA,Protransforming growth factor alpha,40341,0.0626083174518103,0.00457429792497097,0.0536426935188672,0.0715739413847534,2.11296698537026e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,40355,0.0473976628443848,0.0034636920605751,0.0406088264056576,0.054186499283112,2.19491856703522e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0798069640994614,0.00583827656718875,0.0683639420277715,0.0912499861711514,2.66375851220629e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.16397858784677,0.0120053643828562,0.140448073656372,0.187509102037168,3.41167960867621e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0638286479668149,0.00467367924970429,0.0546682366373945,0.0729890592962353,3.55443662543934e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABHD14B,Protein ABHD14B,40171,0.0762024864551377,0.00558644568960074,0.0652530529035203,0.0871519200067551,3.98917390527999e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.0995541125069033,0.00729538916340677,0.085255149746626,0.113853075267181,4.04989071979666e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FADD,FAS-associated death domain protein,40359,0.0993899091738974,0.00728776306495725,0.0851058935665812,0.113673924781214,4.11034373478337e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN2,Nectin-2,40330,0.0375894250175435,0.00275965460747294,0.0321805019868966,0.0429983480481905,5.16953437804104e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.0724831799301992,0.005325510768721,0.0620451788235061,0.0829211810368924,6.61444082706908e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.0473864524340552,0.00348406792194467,0.0405576793070436,0.0542152255610667,7.56259510715189e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0920320952161889,0.00677281939298109,0.078757369205946,0.105306821226432,8.81068885894081e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDK,Midkine,40352,0.065715852682032,0.00483991224774831,0.0562296246764453,0.0752020806876187,9.25664509325899e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C19orf12,Protein C19orf12,39961,0.0804438180325272,0.00593045995638844,0.0688201165180058,0.0920675195470485,1.12373730070523e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.064156304410237,0.00472688905674001,0.0548916018590266,0.0734210069614474,1.12522131141921e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGXT,Serine--pyruvate aminotransferase,40359,0.0994096750596691,0.00733617975385268,0.0850307627421179,0.11378858737722,1.33711496242664e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.079296479407625,0.00585084499793723,0.067828823211668,0.090764135603582,1.44812161613031e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0408351584598755,0.00301687907933116,-0.0467482414553646,-0.0349220754643865,1.62776456042371e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.114649070602234,0.0084657083861736,0.0980562821653338,0.131241859039134,1.62922028397603e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.112935882149079,0.00834676871347293,0.096576215470672,0.129295548827486,1.92886657172963e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.139397025710111,0.0103132417465308,0.11918307188691,0.159610979533311,2.41013334625363e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.118404487204777,0.0087689149500253,0.101217413902728,0.135591560506827,2.54591838864597e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXO3,Forkhead box protein O3,39980,0.124998657400421,0.00926060750296348,0.106847866694613,0.143149448106229,2.75064930203622e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGR,Tyrosine-protein kinase Fgr,39961,0.0711469802409399,0.00527713239478801,0.0608038007471554,0.0814901597347245,3.39999500694595e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.0470163322476185,0.00349255875456526,0.0401709170886706,0.0538617474065664,4.88585923315459e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.034243482277527,0.00254629209059244,0.0292527497799658,0.0392342147750882,5.26850171379506e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0989537223166233,0.00736223792879724,0.0845237359761807,0.113383708657066,6.41090560927532e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0718200569083722,0.00536441308191775,0.0613058072678134,0.082334306548931,1.30486861204838e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0870591913991038,0.00650295819559028,0.0743133933357468,0.0998049894624607,1.31953914057084e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0626857604769312,0.00468584015199979,0.0535015137790116,0.0718700071748508,1.36969627083299e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0399669470379393,0.00298903569084798,0.0341084370838773,0.0458254569920014,1.46729398723692e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,37572,0.0551830558788327,0.00412687206740695,0.047094386626715,0.0632717251309503,1.63069281843768e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,37901,0.124940802033931,0.0093541544413109,0.106606659328961,0.1432749447389,1.95839766385135e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPXM1,Probable carboxypeptidase X1,40411,0.0874542484925928,0.00656239887431647,0.0745919466989325,0.100316550286253,2.66333628243394e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFA2,BPI fold-containing family A member 2,37150,-0.14163114297515,0.0106284731192369,-0.162462950288855,-0.120799335661446,3.05907050138988e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.042099979666573,0.00316266823704722,0.0359011499219604,0.0482988094111855,3.25318525828022e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0526417823147515,0.00395937247466093,0.044881412264416,0.0604021523650869,4.44597498060021e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APLP1,Amyloid-like protein 1,40359,-0.0660082522631184,0.00496943324509949,-0.0757483414235134,-0.0562681631027234,4.75692441169481e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0726381269008046,0.00547246444517799,0.0619120965882557,0.0833641572133535,5.46947014472295e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0838570135510649,0.00632477843417653,0.0714604478200789,0.0962535792820509,6.62563256320832e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.0841122393812268,0.00634838191809695,0.0716694108217568,0.0965550679406968,7.48885744945591e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAM2,Neural cell adhesion molecule 2,40332,-0.0341812895713323,0.00258158936308619,-0.0392412047229813,-0.0291213744196834,8.33382312872133e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,37628,0.0708350460902216,0.0053525960600948,0.0603439578124358,0.0813261343680075,1.00368073434937e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN9,Septin-9,40305,0.0355303293228897,0.00268775328417544,0.0302623328859059,0.0407983257598736,1.10047336201717e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM1,Intercellular adhesion molecule 1,40291,0.0360042175423341,0.00272427933534547,0.030664630045057,0.0413438050396112,1.14960261642321e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEMIP2,Cell surface hyaluronidase,37598,0.0427617604194822,0.00323378092724947,0.0364235498020732,0.0490999710368912,1.15079256845628e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTF2,Transcription termination factor 2,37572,0.061557123429888,0.00465619642775437,0.0524309784314895,0.0706832684282866,1.19809055223621e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,40422,0.109808936862995,0.00831421765896305,0.0935130702514274,0.126104803474563,1.28351895296491e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0598660814774339,0.00453115076341125,0.0509850259811478,0.0687471369737199,1.33365894206555e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0377578067016169,0.00285810971687437,0.0321559116565432,0.0433597017466907,1.33682532830912e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ING1,Inhibitor of growth protein 1,39925,0.0559732139799765,0.00426311960062651,0.0476174995627485,0.0643289283972045,3.60703375943329e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB10,Ras-related protein Rab-10,37990,0.0672887004348411,0.0051329630224424,0.057228092910854,0.0773493079588282,5.04480381916072e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0871431253756519,0.0066604085448894,0.0740887246276687,0.100197526123635,7.14272461438429e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRG1,Scrapie-responsive protein 1,37990,0.0342927078468834,0.0026265861306229,0.0291445990308625,0.0394408166629042,1.00621239577273e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.0453975358618207,0.00347959508921821,-0.0522175422366883,-0.038577529486953,1.15056339567243e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100P,Protein S100-P,40042,0.0667864790360903,0.00512310719882521,0.0567451889263929,0.0768277691457877,1.21076959364983e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.066818874511316,0.00513769556584628,0.0567489912022573,0.0768887578203747,1.78881515379409e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0704994228380272,0.0054247546707432,0.0598669036833705,0.0811319419926839,2.22518559393566e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTX3,Pentraxin-related protein PTX3,40341,-0.0608907434129958,0.00469454102449585,-0.0700920438210076,-0.0516894430049839,2.81193955107234e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.0477341066986477,0.00368224023181948,0.0405169158442816,0.0549512975530139,3.08925078655932e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWC2,Brorin,40167,0.0481532778302144,0.00371529337795278,0.040871302809427,0.0554352528510019,3.20319707962093e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.112596977479912,0.00869070021214876,0.0955632050641009,0.129630749895724,3.66577690852519e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PQBP1,Polyglutamine-binding protein 1,39980,0.0682683526599904,0.0052732114212579,0.0579328582743249,0.0786038470456558,3.88593085523701e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,39980,0.0652186138818753,0.00503907575787101,0.0553420253964481,0.0750952023673025,4.07472905794644e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDHB,Succinate dehydrogenase,37901,0.0881458789027966,0.00680817783244437,0.0748018503512057,0.101489907454388,4.12357867046533e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA2,Carboxypeptidase A2,40398,0.0791851227699178,0.00612362189814224,0.067182823849559,0.0911874216902766,4.66856863356179e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0597193071441402,0.00461933048880461,0.0506654193860832,0.0687731949021973,4.84035872209024e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0628225434686984,0.00486016976835572,0.0532966107227212,0.0723484762146756,4.97087198678139e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",37942,0.130476768002723,0.0100941528757998,0.110692228366155,0.150261307639291,5.39860644295548e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0505593236748979,0.00391464858037201,0.0428866124573688,0.058232034892427,5.74587929124757e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP1,Guanylate-binding protein 1,37931,0.0795949320111947,0.00616184829769084,0.0675177093477207,0.0916721546746688,6.03105476000999e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MIA,Melanoma-derived growth regulatory protein,40411,0.0456025858608963,0.00353323062579993,0.0386774538343284,0.0525277178874641,6.38111446820648e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0611444863000418,0.00473566460945748,0.0518625836655051,0.0704263889345784,6.49758948910512e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD164,Sialomucin core protein 24,40332,0.0326740414133115,0.00253668059344453,0.0277021474501602,0.0376459353764628,8.94427521094063e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NADK,NAD kinase,40359,0.0658132644190267,0.00511531854615222,0.0557872400685683,0.075839288769485,1.07923065826289e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAL,Integrin alpha-L,37598,0.0536919570322334,0.00417621248363608,0.0455065805643067,0.0618773335001602,1.33010173560993e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRN1,Secernin-1,40341,0.0690196792005687,0.00537146274215635,0.0584916122259422,0.0795477461751951,1.33524524594927e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASAH1,Acid ceramidase,37882,0.0567663030021331,0.00441769330896608,0.0481076241165595,0.0654249818877066,1.43600664506011e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.106021847745265,0.00825320131911261,0.0898455731598042,0.122198122330726,1.50042364227988e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLO1,Lactoylglutathione lyase,40042,0.0726637188586892,0.00565956819585885,0.0615709651948059,0.0837564725225726,1.53446079169522e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0531465465641604,0.00414060401043024,0.0450309627037171,0.0612621304246037,1.74244080094158e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FEN1,Flap endonuclease 1,39980,0.0759965483544827,0.00592429655093073,0.0643849271146585,0.087608169594307,1.77238743964087e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0849481429845723,0.00662336492861913,0.0719663477244788,0.0979299382446658,1.80163058794901e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAP18,Chromatin complexes subunit BAP18,37942,0.0795487877078622,0.00620045102429657,0.067395903700241,0.0917016717154835,1.85512643054179e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,39980,0.0493946919314305,0.00385783811505869,0.0418333292259155,0.0569560546369456,2.41413910863431e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBN1,Drebrin,37598,0.0633793177723355,0.00495412604344075,0.0536692307271917,0.0730894048174794,2.98270707628e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.149578066340229,0.011702509227575,0.126641148254182,0.172514984426276,3.16440596928896e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.0382104344500047,0.00299047197773924,-0.0440717595263736,-0.0323491093736358,3.53342040933117e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNRD2,Protein ZNRD2,37901,0.083148920992631,0.00651103599122794,0.0703872904498243,0.0959105515354378,3.93854083766123e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNF,Tumor necrosis factor,40014,0.048533760646633,0.00380411124729621,0.0410777026019324,0.0559898186913336,4.30240332922976e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0547802190433145,0.00429670091580243,0.0463586852483417,0.0632017528382872,5.2049555320464e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0456177056668994,0.00358258533547931,0.03859583840936,0.0526395729244389,5.87946297442467e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA6,Integrin alpha-6,40341,0.0645369454829909,0.00507711212197942,0.0545858057239113,0.0744880852420706,7.73013655738066e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0845020356886347,0.00664882598083219,0.0714703367662037,0.0975337346110658,7.93900149547584e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,37598,0.106473366744098,0.00838769848128042,0.0900334777207883,0.122913255767408,1.04832324974448e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACRBP,Acrosin-binding protein,37900,0.0459916223815052,0.00362445559812455,0.0388876894091811,0.0530955553538293,1.10072286387294e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSNAX,Translin-associated protein X,37562,0.0479654582350988,0.00378142637217434,0.0405538625456371,0.0553770539245605,1.18339814661045e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLF4,Krueppel-like factor 4,37541,0.0475350197942677,0.00374798176002517,0.0401889755446184,0.0548810640439171,1.20933300447283e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX9,Sorting nexin-9,40359,0.0830772551680505,0.00656148527416008,0.0702167440306968,0.0959377663054043,1.45338948739523e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASET2,Ribonuclease T2,40465,0.0318983285121009,0.00252400838296373,0.026951272081492,0.0368453849427098,1.94626827610616e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TST,Thiosulfate sulfurtransferase,39923,0.0913452150134772,0.00724166921595716,0.0771515433502012,0.105538886676753,2.67321177188826e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL1,Growth-regulated alpha protein,40329,0.117081785326392,0.00929199660661558,0.0988694719774258,0.135294098675359,3.13626023299839e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPCAL1,Hippocalcin-like protein 1,40516,0.0882617214527674,0.00700598354438651,0.0745299937057698,0.101993449199765,3.21060938358157e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADM,Pro-adrenomedullin,40489,0.0324195893754902,0.00257392019647836,0.0273747057903926,0.0374644729605877,3.32075760858593e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0718829190113884,0.0057062612103536,0.0606986470390953,0.0830671909836815,3.49067158497546e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0363260453004593,0.00288643744360339,0.0306686279109967,0.041983462689922,4.06954299815702e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA13,Carbonic anhydrase 13,40173,0.124513161220125,0.00989836174040901,0.105112372208924,0.143913950231327,4.10323353978046e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL26,C-C motif chemokine 26,40341,0.106735768191042,0.00848869347618577,0.090097928977718,0.123373607404366,4.36624157005461e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF2,Fibroblast growth factor 2,40341,0.0793612770551635,0.00632522076038356,0.0669638443648117,0.0917587097455153,6.12721346228881e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.0535931522149748,0.00427150353994214,0.0452210052766882,0.0619652991532614,6.6490438246497e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.0766619146031834,0.0061129477865283,0.064680536941588,0.0886432922647789,6.65860202989822e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN4,CCN family member 4,40489,0.0489841328558738,0.00391178034290188,0.0413170433837861,0.0566512223279615,8.30033664231363e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.0546065411567353,0.00435898424514261,0.0460629320362558,0.0631501502772148,8.37995361028729e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CORO1A,Coronin-1A,39990,0.107659171881979,0.00860045307198273,0.0908022838608926,0.124516059903065,8.87279083085593e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGES2,Prostaglandin E synthase 2,37484,0.0654948144258303,0.00523599315671344,0.055232267838672,0.0757573610129886,1.07423771244972e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD84,SLAM family member 5,40341,0.0367521743858647,0.00294269576276544,0.0309844906908444,0.0425198580808849,1.25552150067978e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.104778873509487,0.00839496681542333,0.0883247385512577,0.121233008467717,1.39944336919197e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD40LG,CD40 ligand,40516,0.0912505648753096,0.00731276439568993,0.0769175466597573,0.105583583090862,1.43420346156254e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0621285588105121,0.00498039433160853,0.0523669859205593,0.0718901317004648,1.611279786685e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0806637549822612,0.00647516382341536,0.0679724338883671,0.0933550760761553,2.02192200535324e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPPK1,Epiplakin,37628,0.0875316586369996,0.00704719435256525,0.0737191577059717,0.101344159568027,3.17383261917704e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3BP1,SH3 domain-binding protein 1,37901,0.055558304871308,0.00447423889393148,0.0467887966392023,0.0643278131034137,3.28011128008031e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.141905193713113,0.011433502132773,0.119495529532878,0.164314857893348,3.29900201614023e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD302,CD302 antigen,40305,0.0356745571786617,0.00287465773176315,0.0300402280244059,0.0413088863329174,3.36006319830504e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,37990,0.0321995958133395,0.00259431829412362,0.0271147319568572,0.0372844596698218,3.51325000625374e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.073060238455934,0.00588899091757344,0.0615178162574901,0.084602660654378,3.54843861560836e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0355017809254117,0.00286234049405766,0.0298915935570587,0.0411119682937647,3.65969889412415e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB2B,Ras-related protein Rab-2B,37900,0.0728583776424579,0.00587836030406197,0.0613367914464964,0.0843799638384193,4.35926928087731e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN2,Dynactin subunit 2,40305,0.111213546159688,0.00898323979453938,0.0936063961623906,0.128820696156985,4.86184249781057e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGMN,Legumain,40422,0.0419929349475281,0.00339343776363779,0.035341796930798,0.0486440729642582,5.18069739795152e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0510317949918836,0.00412437832943618,0.0429480134661887,0.0591155765175785,5.2959976094542e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FST,Follistatin,40396,0.0614560472174949,0.00496770656806394,0.0517193423440896,0.0711927520909002,5.42162445884247e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB8,Serpin B8,40516,0.0644653322506399,0.0052119962000767,0.0542498196984895,0.0746808448027902,5.57366891409114e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F11,Coagulation factor XI,37810,0.0358408539057091,0.00289754072970091,0.0301616740754953,0.0415200337359228,5.94423935660622e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFASC,Neurofascin,40516,0.0321718011903683,0.00260223619377138,0.0270714182505764,0.0372721841301602,5.96535336602811e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRMD4B,FERM domain-containing protein 4B,37562,0.0833560110415733,0.0067505150250243,0.0701250015925256,0.0965870204906209,7.78877225475043e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0905955141675613,0.00734192294534375,0.0762053451946876,0.104985683140435,8.08276232869275e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.137422218387171,0.0111442613160405,0.115579466207732,0.159264970566611,9.47747991397105e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPLAH,5-oxoprolinase,37628,0.0800605495061661,0.00652318239391205,0.0672751120140985,0.0928459869982337,1.94436174837516e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0965411622622779,0.00787004608919981,0.0811158719274463,0.11196645259711,1.95195663652032e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0747151881733284,0.00609079655682119,-0.0866531494246979,-0.0627772269219589,2.10075490394113e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1F,Protein phosphatase 1F,37990,0.0612623101429298,0.005008452793305,0.051445742668052,0.0710788776178076,3.18692863123077e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1R,Complement C1r subcomponent,38013,0.0232864022712577,0.00190659879923819,0.0195494686247509,0.0270233359177646,3.97429901231366e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARD3,Partitioning defective 3 homolog,37714,0.0867901541317951,0.00711508473724642,0.0728445880467921,0.100735720216798,4.84437825589283e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLMH,Bleomycin hydrolase,40536,0.0376064141893082,0.00308725716066976,0.0315553901543955,0.043657438224221,5.52782638342979e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK4,Dickkopf-related protein 4,40203,0.0530649264678344,0.00435880668231914,0.0445216653704889,0.0616081875651799,6.06105162324366e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0784284241937118,0.00643992146010828,0.0658061781318996,0.091050670255524,6.14301982225266e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP1,Interstitial collagenase,39757,0.108046264404482,0.00889112139263953,0.0906196664749083,0.125472862334055,7.99854497016188e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NID1,Nidogen-1,40355,0.045938370351463,0.00378079468810683,0.0385280127627736,0.0533487279401524,8.05622892304067e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0836303422164224,0.0068846406026508,0.0701364466352269,0.097124237797618,8.41933105659341e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD46,Membrane cofactor protein,40250,0.0332631637819619,0.00274007568831169,0.027892615432871,0.0386337121310528,9.2196892918206e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GET3,ATPase GET3,37990,0.065287329101246,0.00537870784958251,0.0547450617160643,0.0758295964864277,9.93066238770018e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DMD,Dystrophin,37628,0.0604641393643938,0.00498439789161199,0.0506947194968343,0.0702335592319533,1.09828768214149e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.110330893418859,0.00910824097413446,0.0924787411095552,0.128183045728162,1.26734323068627e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BGLAP,Osteocalcin,37998,0.105694260523837,0.00874181330872037,0.0885603064387455,0.122828214608929,1.75997214136282e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.0550143210155083,0.00455676336746736,0.0460830648152723,0.0639455772157443,2.06751048912936e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLRX,Glutaredoxin-1,40260,0.0653653554129974,0.00541513594769018,0.0547516889555246,0.0759790218704701,2.11150179787345e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF23,Fibroblast growth factor 23,40469,0.0711225418526622,0.00589529354398021,0.059567766506461,0.0826773171988634,2.27529169606708e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0854620585006933,0.00708597902318194,0.0715735396152567,0.0993505773861299,2.38889721103156e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.0434605654679281,0.00360292707318669,0.0363988284044822,0.050522302531374,2.47130365411248e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0796151259888706,0.00660052091527888,0.066678104994924,0.0925521469828172,2.51762483932703e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGS10,Regulator of G-protein signaling 10,37959,0.0691631797481534,0.00573898497124027,0.0579147692045224,0.0804115902917843,2.82252009549896e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.0529009278823686,0.00439363135289277,0.0442894104306988,0.0615124453340384,3.22620753125696e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.134443845594589,0.011172116726167,-0.156341194377876,-0.112546496811302,3.29629529037914e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SWAP70,Switch-associated protein 70,37901,0.0405422985557289,0.00336848605151339,0.0339400658947627,0.0471445312166952,3.41332703122102e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FXN,"Frataxin, mitochondrial",40489,0.0850109516894903,0.00706989722245985,0.071153953133469,0.0988679502455116,3.67532413515145e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.137039846831025,0.0113993522817711,0.114697116358754,0.159382577303297,3.80478902091596e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0452510102435852,0.00376353527136104,0.0378744811117175,0.0526275393754528,3.94520783277895e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKN3,Serine/threonine-protein kinase N3,37714,0.0887639981510239,0.00739765930002524,0.0742645859229745,0.103263410379073,5.33364017454746e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.100593437324736,0.008404205233033,0.0841211950679915,0.117065679581481,7.10574380252245e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COLEC12,Collectin-12,40357,0.0292258246222785,0.00244394483382065,0.0244356927479901,0.034015956496567,8.10736709735831e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.035791705038242,0.00299507313942967,0.0299213616849599,0.0416620483915242,9.49753330216234e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0498081906227847,0.00416961929073268,0.0416357368129486,0.0579806444326207,1.00333125869598e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTC,Probetacellulin,39980,0.0860673833798351,0.00720764482111695,0.0719403995304459,0.100194367229224,1.00474420089388e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX7,Syntaxin-7,37598,0.0576314159547245,0.00482454709488743,0.0481753036487451,0.0670875282607038,1.0126288592113e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0423283812756096,0.003549864683058,0.0353706464968159,0.0492861160544032,1.30914563424647e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN6,Dynactin subunit 6,39961,0.0803907710028336,0.00676442494686721,0.0671324981069739,0.0936490438986933,1.97395239942626e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.100873657796165,0.00848891363534516,0.0842353870708888,0.117511928521442,1.99176871408312e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP25,Synaptosomal-associated protein 25,37541,0.0532834432367336,0.00448788920685351,0.0444871803913007,0.0620797060821664,2.40404637244254e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE6,Ribonuclease K6,37917,0.0334841154753618,0.00282718579945672,0.0279428313084266,0.039025399642297,3.35492306014875e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSME2,Proteasome activator complex subunit 2,40152,0.041943048426076,0.00354336559484268,0.0349980518601844,0.0488880449919677,3.44123081810843e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0562705102830091,0.00475785940673598,0.0469451058458066,0.0655959147202116,3.89570275363555e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH7,Protocadherin-7,37901,0.0393874072013325,0.00334130644160815,0.0328384465757805,0.0459363678268845,6.45981043213377e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0587404001913628,0.00498549268635102,0.0489688345261148,0.0685119658566108,6.53413212642628e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BGN,Biglycan,39956,-0.137063244642855,0.0116326420297875,-0.159863223021239,-0.114263266264472,6.56203901400199e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MARCO,Macrophage receptor MARCO,40359,0.0298681313567381,0.00254086159674234,0.0248880426271231,0.0348482200863531,8.99614175221251e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0643200408954668,0.00547398619786531,0.0535910279476508,0.0750490538432828,9.60894441275072e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0553309189202768,0.00470735292295266,0.0461045071912896,0.064557330649264,9.61341297798954e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDZD2,PDZ domain-containing protein 2,37562,0.0692428131862429,0.00589057724722889,0.0576972817816743,0.0807883445908115,9.62300335846458e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNAS,Neuroendocrine secretory protein 55,37959,0.101497054313763,0.00864717500232291,0.0845485913092099,0.118445517318316,1.1651266616577e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGL1,Fibrinogen-like protein 1,37987,-0.0704787414394594,0.00601477861913618,-0.0822677075329663,-0.0586897753459525,1.47105241975101e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNC79,Protein unc-79 homolog,37482,0.0633617494142699,0.00542118481283969,0.0527362271811041,0.0739872716474357,2.11059566647038e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.102318094037538,0.00875553010300618,0.0851572550356456,0.11947893303943,2.14413513479724e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0993631004830675,0.00852114586708322,0.0826616545835844,0.116064546382551,2.8763626147244e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.104787286207854,0.00901184720574559,0.0871240656845926,0.122450506731115,3.99170502742706e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA2,Annexin A2,37441,0.0796906085464782,0.0068561830741497,0.0662524897211448,0.0931287273718116,4.47728070277396e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGRN,Neugrin,37942,0.0245227708159599,0.00211073013289334,0.020385739755489,0.0286598018764309,4.68434470930315e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFRP1,Secreted frizzled-related protein 1,40178,0.0483745890048039,0.00416896401079849,0.0402034195436388,0.0565457584659689,5.29043261515435e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,40536,0.0380622514172136,0.0032810380109408,0.0316314169157696,0.0444930859186576,5.43175210939064e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0311041926746971,0.00268537948043167,0.0258408488930511,0.0363675364563432,7.12030763781145e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SF3B4,Splicing factor 3B subunit 4,40305,0.0811453141796287,0.00701262807742752,0.0674005631478707,0.0948900652113866,7.66122501761462e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0358937295222087,0.00310106453099155,0.0298156430414653,0.0419718160029521,7.7380458783251e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NID2,Nidogen-2,40332,0.0815966925018234,0.00706001326656639,0.0677590664993533,0.0954343185042935,8.97369822510939e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPON2,Spondin-2,40267,-0.0381464481379465,0.00330338652934253,-0.0446210857354578,-0.0316718105404351,1.00719693923379e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA9,Serpin A9,40228,0.0796147984081976,0.00689457760063809,0.0661014263109469,0.0931281705054483,1.01055473641125e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0454485152656079,0.00393953500144536,0.037727026662775,0.0531700038684408,1.20356521085357e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADA,Adenosine deaminase,40516,0.0374728577108599,0.00325220708325481,0.0310985318276805,0.0438471835940393,1.34374755045835e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCS,Copper chaperone for superoxide dismutase,40228,0.053159334599881,0.00461801906383736,0.0441080172347597,0.0622106519650022,1.53273159076304e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,40203,0.0435871143441244,0.0037940019162764,0.0361508705882226,0.0510233581000261,1.99394220795318e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.0336167211268441,0.00292639343687393,-0.0393524522631171,-0.0278809899905712,2.01069061736107e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0594628381990259,0.00518658083036619,0.0492971397715082,0.0696285366265436,2.62634560834762e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.0641859682516548,0.00560120317484822,0.0532076100289523,0.0751643264743573,2.91372017399195e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,37987,0.0283409197397069,0.00247726011742637,0.0234854899095512,0.0331963495698626,3.61313020645675e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.045814371704821,0.0040073010090915,0.0379600617270016,0.0536686816826403,3.78381952429456e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL1,Fc receptor-like protein 1,40359,0.0492153570784145,0.00430766607096992,0.0407723315793135,0.0576583825775156,4.10743346440419e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.076309959335864,0.00668891850704743,0.0631996790620511,0.089420239609677,4.97768482830853e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX16,Syntaxin-16,39980,0.0644476700724711,0.00565481604780432,0.0533642306187747,0.0755311095261676,5.69661199698869e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPA1,Inositol monophosphatase 1,40228,0.0663252697265914,0.0058272475450698,0.0549038645382546,0.0777466749149283,6.7307066784959e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA4,Annexin A4,40279,0.0779612183198741,0.00686213213228608,0.0645114393405934,0.0914109972991549,8.52244036174621e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARFIP1,Arfaptin-1,37959,0.0747229050805768,0.00658362808251147,0.0618189940388543,0.0876268161222993,1.01332018766054e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIGR,Polymeric immunoglobulin receptor,40154,0.0380554442699191,0.00336722687840699,0.0314556795882414,0.0446552089515968,1.67285203889783e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_E,,40341,0.0311322922897524,0.00275669719741937,0.0257291657828105,0.0365354187966944,1.83340123699561e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.0291808618722915,0.00258563359526391,0.0241130200255742,0.0342487037190088,2.08655507549417e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF22,Kinesin-like protein KIF22,37562,0.132294262224219,0.0117328116055957,0.109297951477252,0.155290572971187,2.36442347799084e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0440961093941282,0.00391417973964519,0.0364243171044237,0.0517679016838328,2.64135908754241e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,40044,0.0734523934690417,0.00652829521753765,0.0606569348426679,0.0862478520954155,2.95546149125865e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOLA1,BolA-like protein 1,37541,0.0591738375853541,0.00526130619182283,0.0488616774493814,0.0694859977213269,3.26228075444861e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPR,Nucleoprotein TPR,37562,0.0505420213651869,0.00450570469020168,0.0417108401723916,0.0593732025579822,4.54635429078791e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0325580281245947,0.00290571281801633,0.0268628310012827,0.0382532252479067,4.95205788562766e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0577984749446354,0.00516724096437354,0.0476706826544632,0.0679262672348075,6.1410680920124e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,39925,0.070723914277322,0.00632291815260738,0.0583309946982116,0.0831168338564325,6.21219760989716e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARA5,Scavenger receptor class A member 5,40471,0.0313537748075656,0.00280367471229564,0.0258585723714662,0.0368489772436651,6.31400221853499e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0695341338623568,0.00621843054669939,0.057346009990826,0.0817222577338877,6.74357204913954e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA14,Carbonic anhydrase 14,40489,-0.036915686163719,0.00330346325021862,-0.0433904741341475,-0.0304408981932905,6.92264045318779e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.0316895429113132,0.00283685799431953,-0.0372497845801795,-0.0261293012424469,7.26793562707188e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRK5,G protein-coupled receptor kinase 5,40042,0.0562590795507368,0.00503653856694618,0.0463874639595223,0.0661306951419513,7.34356115169641e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSE,Cathepsin E,37671,0.0552236216393203,0.0049428286277543,0.0455356775289219,0.0649115657497187,7.48795953987012e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTA,Lymphotoxin-alpha,40341,0.043012678005816,0.00385154447170239,0.0354636508412794,0.0505617051703527,7.51955718546945e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0439312382281158,0.00393564856975029,0.0362173670314052,0.0516451094248263,8.33543135621489e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL14,C-C motif chemokine 14,40309,0.0416241653702388,0.00373059965122103,0.0343121900538456,0.048936140686632,8.42534060146409e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.0624120451582457,0.0056071429065935,0.0514220450613225,0.073402045255169,1.13583417796591e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP8,Caspase-8,40434,0.0658829162834478,0.00592074595707821,0.0542782542075745,0.0774875783593211,1.17516805864498e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO2,Gamma-enolase,40471,0.0699734656605875,0.00629070802720964,0.0576436779272567,0.0823032533939184,1.23021159398485e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.0254313876892265,0.00228921123987812,0.0209445336590654,0.0299182417193876,1.44213902265288e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,37714,0.0369839290922285,0.00333503922460401,0.0304472522120047,0.0435206059724524,1.88139096871013e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.120359191458298,0.0108583812018975,0.099076764302579,0.141641618614017,1.9817668047171e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0726027093631409,0.00655045651778816,0.0597638145882762,0.0854416041380057,1.99786849587191e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL20,C-C motif chemokine 20,40516,0.0940092081194942,0.0084849714783846,0.0773786640218604,0.110639752217128,1.99972222734208e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA4,Carbonic anhydrase 4,40536,-0.0247523526980208,0.00223524776813658,-0.0291334383235686,-0.0203712670724731,2.13291249272933e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.0257805441774185,0.00232966599963339,-0.0303466895367,-0.0212143988181371,2.32068690233835e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP12,Macrophage metalloelastase,40346,0.0547973521405923,0.00495446759668404,0.0450865956510916,0.064508108630093,2.48262556282306e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREH,Trehalase,37998,0.0789187829406179,0.00713644348188016,0.0649313537161328,0.092906212165103,2.63356726654033e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL24,C-C motif chemokine 24,40396,0.0876439606742528,0.0079317397788513,0.0720977507077042,0.103190170640801,2.78354499365979e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0713313251698188,0.00646220488649815,0.0586654035922824,0.0839972467473552,3.31846702923246e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0428507929051206,0.00389631627301791,0.0352140130100055,0.0504875728002357,5.18820002700652e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL25,C-C motif chemokine 25,40516,0.05131238948672,0.00467506397829286,0.042149264089266,0.060475514884174,6.28107822403465e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0400334910781782,0.0036476227999345,0.0328841503903066,0.0471828317660499,6.63442049055663e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCF2,Neutrophil cytosol factor 2,40324,0.0868963224109635,0.00795331890195317,0.0713078173631353,0.102484827458792,1.0889882378827e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0235927263192858,0.00216017306612746,0.019358787109676,0.0278266655288956,1.13818123912879e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAGED1,Melanoma-associated antigen D1,39980,0.0507959136741645,0.00465402676234687,0.0416740212199646,0.0599178061283644,1.23953501881803e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,37714,0.073222724016298,0.00670735085630241,0.0600763163379453,0.0863691316946507,1.25603297646657e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFRP4,Secreted frizzled-related protein 4,37671,0.0437857402506683,0.00401171988557073,0.0359227692749497,0.0516487112263869,1.28951198534979e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0596674875079517,0.00546700317365786,0.0489521612875823,0.0703828137283211,1.29549189962707e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCOF1,Treacle protein,37990,0.0315823882877911,0.00289840325810436,0.0259015179019066,0.0372632586736757,1.55871970255875e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX6,Syntaxin-6,39980,0.0718240684909194,0.00659340880393356,0.0589009872352096,0.0847471497466292,1.56019642882601e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMOTL2,Angiomotin-like protein 2,37855,0.0502475259541343,0.00461404663910458,0.0412039945414894,0.0592910573667793,1.67483423461911e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.0647671168047162,0.00595282923119873,0.0530995715115667,0.0764346620978657,1.86346516311782e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENAH,Protein enabled homolog,40044,0.0489959784739165,0.00452856603013944,0.0401199890548432,0.0578719678929898,3.48288613280683e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREML1,Trem-like transcript 1 protein,37987,0.0546786557626546,0.00505613768729842,0.0447686258955497,0.0645886856297595,3.80205353898978e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMOX1,Heme oxygenase 1,40184,-0.0485045655169177,0.00448905364072987,-0.0573031106527483,-0.0397060203810872,4.05515351654228e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AK1,Adenylate kinase isoenzyme 1,40359,0.0659916299584473,0.0061179214928383,0.0540005038324843,0.0779827560844104,4.93903217657714e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS27,Serine protease 27,40314,0.0417386842655262,0.00387219006505843,0.0341491917380117,0.0493281767930407,5.35993684516809e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXN,Thioredoxin,37819,0.0459625480422142,0.00427365341770628,0.0375861873435099,0.0543389087409185,7.24088805064711e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM,Paralemmin-1,37824,0.0301996385228519,0.00280999567789104,0.0246920469941855,0.0357072300515183,7.86009407282645e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERI1,3'-5' exoribonuclease 1,37714,0.0345999685097987,0.00322639157949072,0.0282762410139969,0.0409236960056005,1.01009097787722e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0576068054514821,0.00537555438333497,0.0470707188601456,0.0681428920428187,1.09432230426338e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0383722351419746,0.00358228273591579,0.0313509609795797,0.0453935093043696,1.10665082911438e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPMT,Thiopurine S-methyltransferase,39980,0.0758921054589892,0.00708566257046711,0.0620042068208737,0.0897800040971047,1.12418829160212e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK4,Serine/threonine-protein kinase 4,40359,0.0880830716954721,0.00822472489622686,0.0719626108988674,0.104203532492077,1.13189491139333e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,37959,0.036183621139303,0.00337829454132775,0.0295621638383006,0.0428050784403054,1.16114318303403e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.0311468709391179,0.00290800056194492,0.0254471898377059,0.03684655204053,1.16664032521353e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPT,Dermatopontin,40536,0.0270561510255383,0.0025343854691508,0.0220887555060028,0.0320235465450739,1.62390523665504e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0293719514232699,0.00275056178301286,0.0239808503285647,0.0347630525179751,1.64682038255171e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0552717021091998,0.00519090629594646,0.0450975257691448,0.0654458784492549,2.27022351909211e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.0256246462892476,0.0024110597677226,0.0208989691445113,0.0303503234339839,2.80370816786132e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRSF1,G-rich sequence factor 1,37402,0.0805128500345758,0.00757517607748096,0.0656655049227131,0.0953601951464384,2.81746650002665e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0294940531722851,0.00277760161288716,0.0240499540110263,0.034938152333544,2.99448446051237e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,40359,0.035638758736901,0.00336341404764426,0.0290464672035183,0.0422310502702838,3.80089483263382e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DENR,Density-regulated protein,37598,0.0585582451110072,0.00552598911131764,0.0477273064528246,0.0693891837691897,3.92707022553483e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.0246448592150245,0.00233146635821738,0.0200751851529184,0.0292145332771305,4.98113119632101e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP6,Bone morphogenetic protein 6,40024,0.0428084629490581,0.00405159511750995,0.0348673365187386,0.0507495893793776,5.25585788792476e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPG,Macrophage-capping protein,40185,0.0586577584778491,0.00555261418667773,0.0477746346719607,0.0695408822837374,5.34814384974885e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.0351441668726084,0.00332685453914241,0.0286235319758893,0.0416648017693275,5.35697761311954e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APRT,Adenine phosphoribosyltransferase,40216,0.048915044899313,0.00463887086527197,0.03982285800338,0.0580072317952461,6.56229900846742e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDGF,Hepatoma-derived growth factor,40471,0.0962916731854914,0.00914048206008025,0.0783763283477341,0.114207018023249,7.26741448946981e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA6,Carbonic anhydrase 6,40295,-0.0642786128703492,0.00610807200487701,-0.0762504339999082,-0.0523067917407903,8.18661916639681e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL15,C-C motif chemokine 15,40536,0.0447265445687985,0.00425805506157971,0.0363807566481023,0.0530723324894947,1.00313455901535e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNM1,Dynamin-1,37901,0.114264648518418,0.0108781902533721,0.0929433956218089,0.135585901415028,1.04102037084512e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR3,Toll-like receptor 3,40516,0.0611275389752671,0.00582841828267725,0.0497038391412197,0.0725512388093145,1.1890192224609e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STXBP3,Syntaxin-binding protein 3,39980,0.0443758597458205,0.00423199807337687,0.0360811435220018,0.0526705759696391,1.22289190099346e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIT,Citron Rho-interacting kinase,37572,0.0453651388441317,0.00432537393199012,0.0368874059374311,0.0538428717508324,1.23685821116168e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0606476200199586,0.00578571070862862,0.0493076270310465,0.0719876130088707,1.30558191136942e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0528494373719604,0.00504316693276949,0.0429648301837322,0.0627340445601886,1.30794064263463e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL19,C-C motif chemokine 19,40471,0.131120955243909,0.0125388313717936,0.106544845755193,0.155697064732624,1.64106290795515e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.0379398838361139,0.00362870943702255,0.0308276133395497,0.0450521543326781,1.6735794200818e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOL1,Apolipoprotein L1,37987,0.0652463564435402,0.00623970430107402,0.0530165360134351,0.0774761768736453,1.70850397408305e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR2,TGF-beta receptor type-2,40411,0.0315393358657354,0.00302114506510451,0.0256178915381306,0.0374607801933403,1.97579744687832e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA2,Integrin alpha-2,37671,0.0338981652230915,0.00324756343066526,0.0275329408989876,0.0402633895471954,2.08657961410025e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGR1,Prostaglandin reductase 1,37990,0.079390181580728,0.00761772212644016,0.0644594462129053,0.0943209169485507,2.45938390924432e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.041229788564812,0.00395854289764115,0.0334710444854353,0.0489885326441886,2.54286184010534e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL8,Interleukin-8,40209,0.0675104438092204,0.00649175818862121,0.0547865977595229,0.080234289858918,3.01116316150482e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PVR,Poliovirus receptor,40471,0.0365686329246546,0.00351746012483648,0.0296744110799751,0.0434628547693341,3.10022036280379e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAA10,N-alpha-acetyltransferase 10,37562,0.0512419471218283,0.00492949927964868,0.0415801285337169,0.0609037657099397,3.27524824700074e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAST,Gastrin,37942,0.129534832600644,0.0124862294294855,0.105061822918852,0.154007842282435,4.03794468519411e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD248,Endosialin,37998,-0.0398069397738196,0.00384502839575569,-0.0473431954295008,-0.0322706841181384,5.03642681235504e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0522334474717109,0.005049749883191,-0.0621309572427653,-0.0423359377006566,5.36175551240263e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSR,"Glutathione reductase, mitochondrial",37944,0.0219494787519172,0.00212366275095144,0.0177870997600524,0.0261118577437821,6.02134871489429e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.0480232946479902,0.00465590082229761,0.0388977290362869,0.0571488602596935,7.25979161594673e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDA,Cytidine deaminase,37970,0.0453550277832801,0.00439764940162983,0.0367356349560857,0.0539744206104746,7.5716335613109e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTN,Pleiotrophin,40042,0.0495060141938144,0.00480816157214603,0.0400820175124082,0.0589300108752206,8.79584511250064e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBD,Thrombomodulin,40359,0.0273493525651358,0.00265696223292992,0.0221417065885931,0.0325569985416784,9.01903954640776e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0289942068639462,0.00281949112252008,0.0234680042638069,0.0345204094640856,1.00114766890059e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PZP,Pregnancy zone protein,38013,0.0640925767918969,0.00625367294615542,0.0518353778174323,0.0763497757663615,1.47275751930807e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0949923159785577,0.0092852789368297,0.0767931692623715,0.113191462694744,1.72589055420179e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPME1,Protein phosphatase methylesterase 1,40305,0.0599992839221175,0.00586543123209916,0.0485030387072031,0.0714955291370318,1.74630919344241e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.0605753463637134,0.00592643532347582,0.0489595331297007,0.072191159597726,1.96734037069153e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPL14,60S ribosomal protein L14,37628,0.040545050197169,0.00396970972190722,0.0327644191422309,0.0483256812521072,2.12465948371263e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.0282787464461813,0.00277107556056429,0.0228474383474753,0.0337100545448873,2.2401124845567e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.077678621960994,0.00761202738125987,0.0627590482937247,0.0925981956282634,2.31690494661877e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,40341,0.0597188529004561,0.00585911076711787,0.048234995796905,0.0712027100040071,2.54522153680408e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POMC,Pro-opiomelanocortin,37628,0.0665581224738584,0.00654754098441353,0.0537249421444079,0.0793913028033089,3.47627375737277e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C7orf50,Uncharacterized protein C7orf50,37942,0.0213848920033893,0.00210604222801452,0.0172570492364808,0.0255127347702977,3.88131795944358e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMM2,Phosphomannomutase 2,37562,0.0589385397311397,0.00580754230771654,0.0475557568080152,0.0703213226542641,4.12601921095209e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0682865433569353,0.0067303898884102,0.0550949791756513,0.0814781075382193,4.2349565756376e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,37628,0.0516576918077103,0.00510003189171034,0.0416616292999581,0.0616537543154626,5.03601455702604e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.0319614770834934,0.00316713426591026,-0.0381690602446775,-0.0257538939223093,7.30726673317264e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0393656982827329,0.00390343754586942,0.0317149606928288,0.047016435872637,7.62630959226458e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.0536243517963934,0.00531948485110312,0.0431981614882313,0.0640505421045556,8.18924082523833e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0553322838062598,0.0054935723507119,0.0445648819988645,0.0660996856136551,8.67057957181601e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPAG1,Sperm-associated antigen 1,37959,0.0555732225348412,0.00552531226380181,0.0447436104977896,0.0664028345718927,1.02719249153259e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPPB,Natriuretic peptides B,40042,-0.123188742774126,0.0123004790184145,-0.147297681650218,-0.0990798038980333,1.54344349941838e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0274369463514502,0.00274105833917223,0.0220644720066726,0.0328094206962277,1.67928898484262e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.052448998069602,0.00525282736242083,0.0421534564392572,0.0627445396999469,2.14074909795227e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C7,Complement component C7,37678,-0.0301253951966932,0.00302289376246921,-0.0360502669711328,-0.0242005234222535,2.60092093826092e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSB,Cathepsin B,40353,-0.0514044758613416,0.00517005819950164,-0.0615377899323648,-0.0412711617903184,3.17131926484236e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPQ,Carboxypeptidase Q,37986,0.034815826818256,0.00350694173173465,0.0279422210240561,0.041689432612456,3.78525048173022e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MET,Hepatocyte growth factor receptor,40375,-0.0190965108673375,0.00192420490346018,-0.0228679524781194,-0.0153250692565555,3.80765230936051e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLTA,Clathrin light chain A,40042,0.0450510557595216,0.00454006566076873,0.0361525270644149,0.0539495844546284,3.8726118355081e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0361662985076639,0.00364861758626258,0.0290150080385892,0.0433175889767386,4.32915993891178e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDF1,Endothelial differentiation-related factor 1,37959,0.0659477691608499,0.00667956062980601,0.0528558303264301,0.0790397079952697,6.51233463036334e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0207498347973756,0.00210272547423557,0.0166284928678739,0.0248711767268774,6.66555529149054e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLB,Beta-klotho,39961,-0.0694911602306315,0.00704436829144149,-0.0832981220818568,-0.0556841983794062,6.90906855371235e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BST2,Bone marrow stromal antigen 2,40471,0.0505581984953167,0.00512728792266002,0.040508714166903,0.0606076828237303,7.16499581655197e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ULBP2,UL16-binding protein 2,40228,0.0351068250248936,0.00357043484421842,0.0281087727302255,0.0421048773195617,9.46838491631561e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMB1,Laminin subunit beta-1,37628,0.0278610091090856,0.00283385658213027,0.0223066502081103,0.0334153680100609,9.86519329324826e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0507611365480786,0.00516526187666004,0.0406372232698249,0.0608850498263322,1.02772106764317e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.052364341495734,0.0053314692894674,0.0419146616883779,0.0628140213030901,1.05358012315252e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEPH,Hephaestin,37990,0.0235772660791873,0.00240513313230644,0.0188632051398667,0.0282913270185079,1.30099982491789e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLN4,Cerebellin-4,40489,0.0295516334602445,0.00301666046147509,0.0236389789557533,0.0354642879647357,1.35349922309771e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRK1,Protein BRICK1,39961,0.041422352043717,0.00423159808164766,0.0331284198036876,0.0497162842837465,1.46174004218687e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,40273,0.031546080442907,0.0032235849953465,0.0252278538520279,0.0378643070337862,1.49802965484129e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,40341,0.0497276645964763,0.00508186295498668,0.0397672132047024,0.0596881159882502,1.50745581830944e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TF,Serotransferrin,38013,0.0204767074053701,0.0020927999791122,0.0163748194463102,0.02457859536443,1.56038246897165e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMS,Spermine synthase,37541,0.060102747691892,0.00614272638268291,0.0480630039818335,0.0721424914019505,1.56976343445513e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD80,T-lymphocyte activation antigen CD80,37990,0.0319513934233957,0.00326642270480514,0.0255492049219776,0.0383535819248138,1.6010202141437e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMA4,Laminin subunit alpha-4,40422,0.0306784175035372,0.00314155703145601,0.0245209657218835,0.036835869285191,1.83253566151555e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300E,CMRF35-like molecule 2,40436,0.0373683017172757,0.00382714330241505,0.0298671008445422,0.0448695025900092,1.8564471273723e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHCY,Adenosylhomocysteinase,40359,0.0633327094471304,0.00649116768641156,0.0506100207817638,0.0760553981124971,1.99491933240428e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300A,CMRF35-like molecule 8,37671,0.0276845051322949,0.00284029468159151,0.0221175275563755,0.0332514827082143,2.25866648187725e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0371345176503323,0.00381021906052276,0.0296664882917077,0.0446025470089569,2.27296040512202e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN1,Contactin-1,40536,-0.025755426664156,0.00264469687437846,-0.0309390325379378,-0.0205718207903743,2.38102809171473e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XRCC4,DNA repair protein XRCC4,39961,0.0347328699268391,0.00356712222900486,0.0277413103579896,0.0417244294956887,2.43067041589112e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPING1,Plasma protease C1 inhibitor,37981,0.0173827029066568,0.0017849184693326,0.0138842627067649,0.0208811431065487,2.44227055327413e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPO,Myeloperoxidase,40332,0.0435395192949861,0.00448128342985869,0.0347562037724631,0.0523228348175091,2.97640167557213e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPCAM,Epithelial cell adhesion molecule,40358,-0.0928980538358914,0.00956165863414458,-0.111638904758815,-0.074157202912968,2.98080515177114e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0585992937487634,0.00603039058661025,0.0467797281990073,0.0704188592985195,3.02341306546596e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELOB,Elongin-B,37562,0.0374770459875083,0.00385740171742872,0.029916538621348,0.0450375533536686,3.07424582474482e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRL,Prolactin,40471,-0.0713124277799621,0.00734839344922427,-0.0857152789404416,-0.0569095766194825,3.32128424967359e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0812749235159012,0.00837883272549284,0.0648524113739352,0.0976974356578671,3.57129050553433e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS7_LGALS7B,Galectin-7,40270,0.0372607793837259,0.00384791573643768,0.029718864540308,0.0448026942271437,4.08710139569385e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0288739847197591,0.00298795489817107,0.0230175931193438,0.0347303763201744,4.94986279941956e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASS1,Argininosuccinate synthase,37562,0.0745690389220502,0.00771516736331696,0.0594473108899489,0.0896907669541514,5.01644137945762e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0283231076055208,0.00293063269598301,0.0225790675213941,0.0340671476896475,5.0262165927758e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH5,Cadherin-5,40536,-0.0280934580878317,0.002909219419048,-0.0337955281491658,-0.0223913880264976,5.28342499433783e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRIB,Protein scribble homolog,37628,0.0862409933813577,0.00893554283769314,0.0687273294194791,0.103754657343236,5.72925130610818e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK3,Dickkopf-related protein 3,40536,-0.0272091904016021,0.00282064327505284,-0.0327376512207057,-0.0216807295824985,5.83560324935784e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.0207250294578682,0.00214908191702045,0.0165128289005082,0.0249372300152283,6.1499865623705e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD1,Programmed cell death protein 1,40455,0.0404132484797398,0.00419289546846958,0.0321951733615395,0.0486313235979402,6.30670588054418e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0385336945066647,0.00399857178353591,0.0306964938109343,0.046370895202395,6.57773909874648e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0442268016545315,0.00459308369040755,0.0352243576213327,0.0532292456877303,7.09201424411926e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLIT2,Slit homolog 2 protein,39961,0.0482425454924806,0.00502355455921616,0.0383963785564169,0.0580887124285443,8.90428736268798e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD2,Sushi domain-containing protein 2,40332,-0.0263273304242611,0.00274524824599436,-0.0317080169864101,-0.0209466438621122,1.00727333063383e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRZB,Secreted frizzled-related protein 3,40176,0.0244575266011548,0.00255241247275124,0.0194547981545624,0.0294602550477473,1.08966896218419e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.0308814105319189,0.00324301498983243,0.0245251011518474,0.0372377199119905,1.92948186257585e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.037950551265501,0.00398729865522948,0.0301354459012512,0.0457656566297508,2.07124903711068e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRN,Progranulin,40262,0.0220398366699428,0.00232605320395604,0.0174807723901889,0.0265989009496966,3.03128863904509e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAX,Apoptosis regulator BAX,39934,0.080891963819898,0.00855301921476965,0.0641280461589495,0.0976558814808465,3.59025866592159e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.092417313807321,0.00978419461022672,0.0732402923712766,0.111594335243365,4.10920213343652e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0654488539315648,0.00693573089362107,0.0518548213800675,0.0790428864830621,4.37708393634133e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0531751637552956,0.00563503464107287,0.0421304958587928,0.0642198316517985,4.48041656350445e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.0311676189417356,0.00330658112294991,0.0246867199407538,0.0376485179427174,4.83976483555174e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFP,Alpha-fetoprotein,40182,0.0627563258651565,0.00666009387957556,0.0497025418611884,0.0758101098691246,4.99293853266254e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0596653104024132,0.00633872251965396,0.0472414142638914,0.0720892065409349,5.47236708760604e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOBR,Apolipoprotein B receptor,37628,-0.0383205989945654,0.00407403575327827,-0.0463057090709908,-0.03033548891814,5.99189050073787e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0685392052797145,0.00728715082963318,0.0542563896536335,0.0828220209057956,6.01815329639297e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,39980,0.032405631710404,0.00344936526083977,0.0256448757991581,0.03916638762165,6.5222655880541e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.0452691842695028,0.00482328903037141,0.0358155377699749,0.0547228307690308,7.27151527847139e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYGD,Gamma-crystallin D,37942,0.0863722552364606,0.0092106787486212,0.0683193248891631,0.104425185583758,7.82396063434074e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAM,Signal transducing adapter molecule 1,37900,0.0337828467757235,0.00360517995090425,0.0267166940719512,0.0408489994794958,8.34223411346214e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA2,Carbonic anhydrase 2,40291,0.063401279626731,0.00677412407662272,0.0501239964365504,0.0766785628169115,9.07818112019554e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.0283941402200603,0.00303534428439712,-0.0343434150174787,-0.022444865422642,9.49370998762965e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0599523430830529,0.00640769539133972,0.047393260116027,0.0725114260500787,9.5406952701695e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMD,Osteomodulin,40422,-0.0396968257331655,0.00424733844950513,-0.0480216090941955,-0.0313720423721354,1.02534099913672e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0340442372571752,0.00364623886765546,0.0268976090765704,0.0411908654377799,1.12406833746109e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHI3L1,Chitinase-3-like protein 1,40054,0.0664772724070441,0.0071285347065155,0.0525053443822737,0.0804492004318145,1.24961757926965e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.023079531863479,0.00247639368590354,0.0182258002391081,0.02793326348785,1.31451122002341e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL2,Fc receptor-like protein 2,40442,0.0433733071644156,0.00466272175784668,0.0342343725190362,0.0525122418097951,1.55086904343653e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C4BPB,C4b-binding protein beta chain,40411,0.0366861298403329,0.00395073854967499,0.0289426822829699,0.0444295773976959,1.80575779813691e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,40396,-0.04045452805272,0.00437176675050288,-0.0490231908837056,-0.0318858652217344,2.44079131059475e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A12,Protein S100-A12,40139,0.0677899784216636,0.00732856677579248,0.0534259875411103,0.0821539693022168,2.52614264826918e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0484187456555599,0.00523910363846378,0.0381501025241709,0.0586873887869489,2.79024010489054e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN3,Calsyntenin-3,37942,0.0270834960408638,0.00293537154871302,0.0213301678053863,0.0328368242763413,3.2033833422333e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX5,Sorting nexin-5,37628,0.02656334197515,0.00288040223232969,0.0209177535997839,0.0322089303505162,3.35084490401655e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PER3,Period circadian protein homolog 3,37598,0.104509786240837,0.0113420266927301,0.0822794139230856,0.126740158558588,3.60012023316377e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CR1,Complement receptor type 1,37959,0.0320123914809235,0.00347874015560002,0.0251940607759475,0.0388307221858996,4.01144387538979e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNGR2,Interferon gamma receptor 2,40228,0.0453954233166419,0.00494398288584276,0.03570521686039,0.0550856297728937,4.7487952576556e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,40330,0.0642061856665003,0.00699391381233959,0.0504981145943147,0.0779142567386859,4.8186335409258e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA7,Thyroxine-binding globulin,38013,0.016479331872389,0.00179557691524436,0.01296000111851,0.0199986626262679,5.03041250486552e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG4,Regenerating islet-derived protein 4,40379,0.0427592209423439,0.00466173514563098,0.0336222200569072,0.0518962218277806,5.18199710182633e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300C,CMRF35-like molecule 6,40471,0.0299569372049295,0.00326714619760457,0.0235533306576246,0.0363605437522345,5.33573440439485e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18BP,Interleukin-18-binding protein,40403,0.0267866139158199,0.00292209078767818,0.0210593159719706,0.0325139118596691,5.44828915364997e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6,Interleukin-6,40305,0.0639577210735055,0.00698954874194566,0.050258205539292,0.077657236607719,6.3449297340517e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.0339023323184666,0.00372008969775353,0.0266109565108697,0.0411937081260635,8.92859127475508e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0505911412196822,0.00555643718015286,0.0397005243465826,0.0614817580927818,9.65676730437891e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C5,Complement C5,38013,0.0133693409399182,0.00146826910949952,0.0104915334852991,0.0162471483945372,9.77069825088088e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSNK1D,Casein kinase I isoform delta,37598,0.0557259888743276,0.00612219400389727,0.043726488626689,0.0677254891219663,1.01040022269774e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP6,Gastrotropin,40017,0.0485314967247796,0.00535457062232356,0.0380365383050254,0.0590264551445338,1.41024726552294e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.0336045864607643,0.0037108584803892,-0.0408778690823271,-0.0263313038392015,1.51110114686594e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0304290983198295,0.00336225622275272,0.0238390761232342,0.0370191205164249,1.59336491287645e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0437155075979392,0.00483904340434171,0.0342309825254295,0.053200032670449,1.88429692390725e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0411246353213188,0.0045566275713624,0.0321936452814485,0.0500556253611891,2.03246183467301e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0581927877308859,0.00645359446877635,0.0455437425720843,0.0708418328896876,2.19618968115241e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0568904013506199,0.00631123982020145,0.0445203713030251,0.0692604313982148,2.24894133708677e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP3,Stromelysin-1,40332,-0.0417470669834381,0.00463389223269614,-0.0508294957595225,-0.0326646382073536,2.31020250851397e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSTL3,Follistatin-related protein 3,40293,0.0269730533741677,0.00299442067907718,0.0211039888431764,0.032842117905159,2.33824179201086e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0319848156828145,0.00355176692643561,0.0250233525070007,0.0389462788586283,2.44024580406375e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHCHD6,MICOS complex subunit MIC25,37900,0.0250514309824233,0.00278543014107812,0.0195919879059102,0.0305108740589365,2.70540856761714e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA3,Protein disulfide-isomerase A3,37671,0.0220456914908701,0.00245418866984341,0.0172354816979771,0.0268559012837632,2.99080398442075e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,39980,0.039480580008065,0.00439672746712139,0.0308629941725071,0.0480981658436229,3.02580664955887e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNB2,Plexin-B2,40472,0.0200456074994428,0.00223320324263005,0.015668529143888,0.0244226858549977,3.10921927338504e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRR3,Small proline-rich protein 3,37942,0.0613803229243548,0.00683713920982622,0.0479795300730954,0.0747811157756142,3.13238249280629e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BSG,Basigin,40502,0.0173505006429908,0.00193459677173652,0.0135586909703872,0.0211423103155943,3.33056297885463e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA11,Integrin alpha-11,40341,-0.0292467756848927,0.00326349588231231,-0.0356432276142248,-0.0228503237555606,3.54328939594575e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0418121932646084,0.00467744553923189,0.0326444000077139,0.0509799865215029,4.34672533248523e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIPF,Gastric triacylglycerol lipase,37628,0.0513294419641952,0.00574171911077281,0.0400756725070805,0.0625832114213099,4.41478274205545e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MATN2,Matrilin-2,40379,0.0254147635637302,0.00284391733259196,0.01984068559185,0.0309888415356105,4.44807405980071e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALCAM,CD166 antigen,40536,0.0165775393131877,0.00185842127387063,0.0129350336164013,0.0202200450099742,5.14552737557178e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0469019890185682,0.005261500328158,0.0365894483753785,0.0572145296617578,5.44038924698061e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.0323629826787082,0.00363639675191055,0.0252356450449635,0.0394903203124529,6.18557364270173e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL2A1,Collagen alpha-1(II) chain,37628,0.0703282009174564,0.00790641160294591,0.0548316341756824,0.0858247676592303,6.59020889802626e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLGN,Calmegin,37572,0.037949932283539,0.00427115552714936,0.0295784674503262,0.0463213971167517,7.20532401779418e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBS,Cystathionine beta-synthase,37628,0.0432464698215824,0.00487939069779351,0.0336828640539071,0.0528100755892577,8.77135744261024e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL5,Insulin-like peptide INSL5,37901,0.0798531341616302,0.00902086832387211,0.0621722322468409,0.0975340360764196,9.65551741944072e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KITLG,Kit ligand,40359,-0.0308425137861868,0.00348749018479233,-0.0376779945483798,-0.0240070330239938,1.02109630249283e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNA1,Ephrin-A1,40303,0.0231183661639035,0.00261829213759635,0.0179865135742147,0.0282502187535924,1.15907418937958e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD59,CD59 glycoprotein,39665,0.0190443509424745,0.00216380799580603,0.0148032872706946,0.0232854146142543,1.49566197210266e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX6,Peroxiredoxin-6,40489,-0.0503805689597728,0.00573051830862602,-0.0616123848446798,-0.0391487530748658,1.62138863364346e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0354165444276059,0.00402939478606937,0.02751893064691,0.0433141582083019,1.65283345135818e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.0234058687981579,0.00267066682010291,0.0181713618307562,0.0286403757655596,2.06982481009975e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0357427381461351,0.00408171009216651,0.0277425863654887,0.0437428899267814,2.20714946789208e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,37990,-0.0274970626349689,0.0031401790532652,-0.0336518135793687,-0.0213423116905691,2.24990200795696e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0214367330443999,0.00245559283813879,-0.026249695007152,-0.0166237710816479,2.84736804244941e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAPK2,Death-associated protein kinase 2,37598,0.0438927845858036,0.00503293458882416,0.0340282327917083,0.053757336379899,3.08272207763009e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0611493979739902,0.00701498413956435,0.047400029060444,0.0748987668875363,3.1428846018849e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.0341384754575798,0.00391956497906711,0.0264561280986083,0.0418208228165514,3.34289913845673e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0296844137808007,0.00341756271609872,0.0229859908572472,0.0363828367043542,4.19939908642326e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS4,Galectin-4,40357,0.0438880762614422,0.00506140554053556,0.0339677214019925,0.0538084311208919,4.68602659867703e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYM,Ketimine reductase mu-crystallin,37541,0.064286305618605,0.0074123424528895,0.0497581144109416,0.0788144968262684,4.70580874624871e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.0389913609692412,0.00451296487598549,0.0301459498123096,0.0478367721261727,6.17166629059725e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.028264358645264,0.00327438508348908,-0.0346821534089026,-0.0218465638816254,6.60631809120637e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP9,Caspase-9,37598,0.0517725644288403,0.00600286079428057,0.0400069572720504,0.0635381715856302,7.15955623600051e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.0345916411071793,0.00401693133233432,-0.0424648265185546,-0.026718455695804,7.88328766152035e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMNB2,Lamin-B2,37942,0.0226244049243601,0.00262739120386997,0.0174747181647749,0.0277740916839452,8.03997065365286e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBP1,Z-DNA-binding protein 1,37598,0.0333371904193733,0.00387139945708688,0.025749247483483,0.0409251333552636,8.04995064661118e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0392909412445499,0.00457140096402015,0.0303309953550705,0.0482508871340294,9.11733752995203e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,40422,0.0222592871910579,0.00259481656401666,0.0171734467255852,0.0273451276565305,1.04955715683492e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0270523666804914,0.00315678568609196,0.0208650667357512,0.0332396666252316,1.1317211686524e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0517850418162262,0.006042844869236,0.0399410658725236,0.0636290177599288,1.13245617138085e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIMAP8,GTPase IMAP family member 8,37482,0.0425080944928814,0.00497609735558041,0.0327549436759438,0.052261245309819,1.45882197061757e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,40411,0.0195267055130883,0.00229370925474005,0.0150310353737978,0.0240223756523788,1.84146018515838e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP7,Dipeptidyl peptidase 2,40251,0.0473113638979074,0.00555754091290282,0.0364185837086179,0.058204144087197,1.84545268162283e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,40359,-0.0218687818839833,0.00257599181993437,-0.0269177258510547,-0.0168198379169119,2.25706887633454e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGMB,RGM domain family member B,40471,0.0210810742488793,0.00248815571962106,0.016204289038422,0.0259578594593366,2.60654108388792e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE3,Eosinophil cationic protein,40288,0.0879353097864757,0.0104119257797512,0.0675279352581634,0.108342684314788,3.28345362528056e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,37942,0.0291210583042616,0.00345022740305652,0.0223586125942708,0.0358835040142524,3.48445035718382e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSDE1,Cold shock domain-containing protein E1,37562,0.0949902227880236,0.0112569542938795,0.0729265923720199,0.117053853204027,3.55325164045196e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0309389861848458,0.0036706146105513,0.0237445815481653,0.0381333908215264,3.79500132886547e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRDT,Bromodomain testis-specific protein,37562,0.0300356510438794,0.00358087293715585,0.0230171400870539,0.0370541620007049,5.45614956910707e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSTN,Growth/differentiation factor 8,40042,0.0410853887951736,0.0049032143010606,0.0314750887650949,0.0506956888252524,5.77499216729024e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL21,C-C motif chemokine 21,40422,0.0341132199328326,0.00407538639459481,0.0261254625994267,0.0421009772662384,6.20527762995041e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEL1L,Protein sel-1 homolog 1,37628,0.02612781640458,0.00312170653642624,0.0200092715931846,0.0322463612159754,6.35364176128281e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2orf69,UPF0565 protein C2orf69,37572,0.0485105764141734,0.00579685965320245,0.0371487314938966,0.0598724213344502,6.42627679120273e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX2,Sorting nexin-2,37900,0.0625579735369998,0.00749481528423799,0.0478681355798934,0.0772478114941063,7.69121682260304e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINI2,Serpin I2,37901,0.0448488318475598,0.00537561143247656,0.0343126334399058,0.0553850302552139,7.94207741923424e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHPS,Deoxyhypusine synthase,37900,0.0329906207604558,0.00395735090284346,0.0252342129908826,0.040747028530029,8.38697995397832e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0302492325448505,0.00363283603174054,0.0231288739226391,0.037369591167062,8.98317764264849e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.0222842695780738,0.0026791510653448,0.017033133489998,0.0275354056661496,9.68791632980511e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0192116315719038,0.00232032153555977,0.0146638013622067,0.023759461781601,1.33276413180622e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0455851334364941,0.00551716521415219,0.0347714896167559,0.0563987772562324,1.56014587711244e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGR2,Anterior gradient protein 2 homolog,39839,0.0801128903137284,0.00971537519824582,0.0610707549251666,0.0991550257022902,1.76924484532594e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0355901827389703,0.00432799095604207,0.0271073204651278,0.0440730450128127,2.13229900230551e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS22,Brain-specific serine protease 4,37598,0.0279493080193722,0.00340028539350311,0.0212847486481061,0.0346138673906383,2.23025593412377e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRG,Histidine-rich glycoprotein,37934,0.0248715297397698,0.00302687308659055,0.0189388584900523,0.0308042009894872,2.27741756839458e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0659035212531972,0.00802819599479163,0.0501682571034056,0.0816387854029888,2.40428800098817e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFD,Vascular endothelial growth factor D,40483,-0.0261537628342836,0.00319185237838021,-0.0324097934959089,-0.0198977321726584,2.71792785892166e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COPB2,Coatomer subunit beta',37562,0.0339363389871752,0.00415704171631992,0.0257885372231882,0.0420841407511622,3.54778380577762e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0278118860586818,0.00340831125353433,0.0211315960017545,0.0344921761156091,3.59907919545962e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO1,Roundabout homolog 1,40379,0.0188010685156865,0.00230876271756859,0.0142758935892521,0.023326243442121,4.12730090801535e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0503252456549981,0.00618084408376783,0.0382107912508132,0.0624397000591831,4.1769164826544e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A11,Protein S100-A11,40207,0.0350485497314709,0.00430982686762383,0.0266012890709282,0.0434958103920136,4.52565778455814e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0373258904255827,0.00459126200806619,0.028327016889773,0.0463247639613924,4.62337652884342e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEPACAM2,HEPACAM family member 2,37942,-0.0318149167881703,0.00391299342026323,-0.0394843838918862,-0.0241454496844543,4.64275031673568e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRP2,Neuropilin-2,40332,-0.0226584095490641,0.0027874287448615,-0.0281217698889926,-0.0171950492091355,4.65337872870805e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPL,Periplakin,37598,0.0257655957713148,0.00317343464661309,0.0195456638639531,0.0319855276786765,5.11026576744893e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.0380125573251965,0.00468449569850046,0.0288309457561356,0.0471941688942574,5.23703713529383e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.0154396516243423,0.00190633191678591,-0.0191760621812427,-0.011703241067442,5.93450117067901e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.0304957103219472,0.00376613566834558,0.0231140844119899,0.0378773362319046,6.10897380266461e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL9,C-X-C motif chemokine 9,40422,0.0525436002275524,0.00649408669348554,0.0398151903083207,0.065272010146784,6.34046099601272e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0177269937289022,0.00219402103412796,0.0134267125020114,0.022027274955793,6.95098182599334e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHISA5,Protein shisa-5,37998,0.0193087413448089,0.00239089012244763,0.0146225967048116,0.0239948859848063,7.25681196044815e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD276,CD276 antigen,40357,-0.0278565893319932,0.00345075819740717,-0.0346200753989112,-0.0210931032650751,7.37035172840634e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,40359,0.051392850702457,0.00636805033554896,0.038911472044781,0.063874229360133,7.50242617931161e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CX3CL1,Fractalkine,40228,-0.0263890506883079,0.00327751362364694,-0.0328129773906559,-0.0199651239859599,8.75471781869259e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0333328232759829,0.00414467810947962,0.0252092541814029,0.041456392370563,9.56617996186308e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAP,Prolyl endopeptidase FAP,40536,0.0208075711582738,0.00259253281338497,0.0157262068440392,0.0258889354725083,1.07638947256298e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PI3,Elafin,40074,0.0411810940386216,0.00513415934493905,0.031118141722541,0.0512440463547021,1.1227895368298e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,37901,0.0203184153970499,0.00253853169792175,0.0153428932691232,0.0252939375249765,1.30262128026471e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,40305,0.0274294835123343,0.00343901747138553,0.0206890092684187,0.03416995775625,1.61451798809383e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSC,Dipeptidyl peptidase 1,40349,0.0325713511881236,0.00408374995412171,0.024567201278045,0.0405755010982021,1.61580796899752e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,37998,0.0198709339398893,0.00249172509704429,0.0149871527496825,0.0247547151300961,1.64841579908367e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM4,Intercellular adhesion molecule 4,40341,-0.0402104059263184,0.00505932336417759,-0.0501266797201065,-0.0302941321325303,2.0254630625074e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0420965071019149,0.00529721362897851,0.031713968389117,0.0524790458147128,2.03816802741037e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,40457,0.0198934188658687,0.00250668202149826,0.0149803221037321,0.0248065156280052,2.22271704930512e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B2M,Beta-2-microglobulin,38013,0.02400886448174,0.00304854335331413,0.0180337195092444,0.0299840094542357,3.65014577976014e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGKZ,Diacylglycerol kinase zeta,40044,0.02638095036984,0.00336207304068157,0.0197912872101041,0.0329706135295759,4.54956302763223e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.0288331505752085,0.00368152472635799,0.0216173621115468,0.0360489390388702,5.10927031554348e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.0213166087053336,0.00273080218135581,-0.026668980980791,-0.0159642364298762,6.26943239197096e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.0256849562329691,0.00329132249164216,-0.0321359483165877,-0.0192339641493504,6.37619359150985e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0258218151504722,0.00332143323389675,0.0193118060120345,0.0323318242889098,8.05052594534001e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,37942,0.034442767303527,0.00443248486536857,0.0257550969674046,0.0431304376396494,8.37889092829061e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEP1B,Meprin A subunit beta,40359,0.0878974168104115,0.0113499640123042,0.0656514873462953,0.110143346274528,1.01882850623689e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.027908427178601,0.00360573517054207,0.0208411862443386,0.0349756681128635,1.05507844716941e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD209,CD209 antigen,40382,-0.0288265302747504,0.00372613603065597,-0.0361297568948361,-0.0215233036546647,1.08451338134987e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSM,Oncostatin-M,40268,0.0537326426593386,0.00695095062952954,0.0401087794254607,0.0673565058932165,1.13757656671074e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.0431848023484666,0.00559206897879706,0.0322243471500243,0.0541452575469088,1.20826590505195e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK7,Kallikrein-7,37352,0.0287634843128009,0.00372948981738395,0.0214536842707284,0.0360732843548735,1.32464601041951e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0857712954935367,0.0111279282394263,0.0639605561442611,0.107582034842812,1.35692647078667e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD93,Complement component C1q receptor,39725,-0.0233299164287008,0.00302839118232206,-0.029265563146052,-0.0173942697113495,1.40239464538213e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,40314,-0.020839290772238,0.00270908645701032,-0.0261491002279782,-0.0155294813164977,1.52892277357648e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM3,Myomesin-3,37671,-0.0666015624097164,0.00866669225086211,-0.0835882792214061,-0.0496148455980267,1.64049067960255e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.019084461464524,0.00249037126234985,-0.0239655891387297,-0.0142033337903183,1.93504482052517e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSR,Insulin receptor,37598,0.0124531839369869,0.00162503194393007,0.00926812132688393,0.0156382465470898,1.93818762825865e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR2,Complement factor H-related protein 2,37911,0.0420216013480806,0.00549397670136796,0.0312534070133994,0.0527897956827618,2.16827979888349e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0321064645109207,0.00420063665383808,0.0238732166693981,0.0403397123524433,2.24177622453318e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.0183742086963811,0.00240571380213529,-0.0230894077485663,-0.0136590096441959,2.36240002680356e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRG2,Bone marrow proteoglycan,37998,-0.0382677082594666,0.00501935120838668,-0.0481056366279045,-0.0284297798910287,2.62196026790497e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0373929385533549,0.00490901574246099,0.0277712676981313,0.0470146094085784,2.74153155206706e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFC1,Cryptic protein,39980,0.0336950809140149,0.00442942268663563,0.0250134124482091,0.0423767493798207,2.96338957666798e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.0584684900070176,0.00769653868002828,0.0433832741941622,0.0735537058198731,3.20996222211771e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0333837794019767,0.00439558792306165,0.0247684270727759,0.0419991317311775,3.29018651952169e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PVALB,Parvalbumin alpha,40417,0.0821759328250038,0.010837047996521,0.0609353187518226,0.103416546898185,3.56543041938537e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN5,CCN family member 5,40332,0.0285497778166945,0.00376525779207631,0.0211698725442249,0.035929683089164,3.57872939114561e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RSPO3,R-spondin-3,40489,0.0207186150312274,0.00274117884148836,0.0153459045019102,0.0260913255605446,4.30436619940624e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARF2,Scavenger receptor class F member 2,40471,-0.0215456045419459,0.00285084331881724,-0.0271332574468277,-0.0159579516370641,4.32648533617292e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.0373850058709484,0.00494912240520294,0.0276847259567507,0.0470852857851462,4.4601973484336e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,37628,0.0170663635029971,0.00226030486879278,0.0126361659601633,0.021496561045831,4.6218461824584e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN2,Calsyntenin-2,40516,-0.0282427388533569,0.00374390809045268,-0.0355807987106442,-0.0209046789960697,4.81398902579696e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.0259586508434374,0.00344047104253302,0.0192153276000727,0.0327019740868022,4.81751429148944e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC3B,Tetranectin,37681,0.0152302202992339,0.00202542554631485,0.0112603862284568,0.019200054370011,5.85171435439076e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YAP1,Transcriptional coactivator YAP1,37942,0.019226370600283,0.00256056983569321,0.0142076537223243,0.0242450874782417,6.34957964465974e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0562575737228048,0.00749423076040907,0.0415688814324031,0.0709462660132066,6.44861864700711e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.040125772111723,0.00535165272346653,0.0296365327737286,0.0506150114497174,6.90490970013228e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.026986593606148,0.0036038879966531,0.019922973132708,0.0340502140795881,7.41553011454602e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST5,Cystatin-D,40070,0.039613549584046,0.00529194203862264,0.0292413431883457,0.0499857559797464,7.49959779836048e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP3,"Fatty acid-binding protein, heart",37990,0.0341297116289777,0.00456869391640518,0.0251750715528235,0.0430843517051318,8.48804936262665e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAT,Catalase,37786,0.039106222165435,0.00523577633983494,0.0288441005393585,0.0493683437915115,8.57995399952559e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.0370249242021635,0.00495921295341695,0.0273048668134663,0.0467449815908607,8.71202100506184e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,40042,0.0401151580055181,0.0053743822665784,0.0295813687630245,0.0506489472480118,8.82680639856948e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0266148107751603,0.00356601093698664,0.0196254293386665,0.0336041922116542,8.86441701736515e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0256832832579741,0.00345626914942777,0.0189089957250957,0.0324575707908525,1.13324520744855e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0237384927711152,0.00319528279745356,0.0174757384881062,0.0300012470541242,1.15812795458935e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.0190976263262681,0.00257922927635892,0.0140423369446046,0.0241529157079315,1.38340381749055e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0286117742838981,0.00386939725884612,0.0210277556565597,0.0361957929112365,1.50412094294157e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0253426564513624,0.00343001959805368,0.0186198180391772,0.0320654948635476,1.57232224310296e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFIC,Nuclear factor 1 C-type,37959,0.0309937873858805,0.00419656533399437,0.0227685193312516,0.0392190554405095,1.60761782919512e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY75,Lymphocyte antigen 75,40341,0.0275397001834879,0.00373119389721991,0.0202265601449368,0.0348528402220389,1.64957819470674e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0239097263565718,0.00324288810083004,0.0175536656789449,0.0302657870341986,1.750063550202e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0292253133563609,0.00396407474224307,0.0214557268615645,0.0369948998511574,1.77459354523957e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0485524881434263,0.00659713446901368,0.0356221045841595,0.0614828717026931,1.9534063365054e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.0316560865490649,0.00430160792528469,0.0232249350155069,0.0400872380826229,1.9610241644718e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSF,Cathepsin F,40411,0.028209439189868,0.00383616445742494,0.0206905568533152,0.0357283215264209,2.02371071368213e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.0342339700498222,0.0046624568505591,-0.043372385476918,-0.0250955546227263,2.19845794825289e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC16A1,Monocarboxylate transporter 1,39961,0.0423001263026859,0.00576379029684759,0.0310030973208646,0.0535971552845072,2.25957998460431e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD101,Immunoglobulin superfamily member 2,37901,0.0300045105611112,0.0040885153643697,0.0219910204469465,0.0380180006752758,2.27994308980824e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.0201219391829299,0.00274910517468041,0.0147336930405563,0.0255101853253035,2.6341501683341e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0307339009772761,0.0042011096826839,0.0224997259992156,0.0389680759553366,2.68676742061659e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANSC1,MANSC domain-containing protein 1,40411,-0.0192071765068909,0.00262925047114532,-0.0243605074303357,-0.014053845583446,2.8995618169344e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300LF,CMRF35-like molecule 1,40489,0.0424181989581629,0.00582512768013155,0.031000948705105,0.0538354492112207,3.44341490909386e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6L2,Seizure 6-like protein 2,40305,-0.0165567783684636,0.00227747722634942,-0.0210206337321085,-0.0120929230048188,3.76848313504457e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,37987,-0.0180883383051474,0.00248938997454537,-0.0229675426552563,-0.0132091339550385,3.90054823064365e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDF2,Growth/differentiation factor 2,40359,0.0248812441764799,0.00342582196926111,0.0181666331167281,0.0315958552362317,3.9656155703508e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.016814280699597,0.00231519126685769,0.0122765058165559,0.0213520555826381,3.97369370291902e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP1,"Fatty acid-binding protein, liver",40357,0.064710006014338,0.00891399441183642,0.0472385769671386,0.0821814350615374,4.06869624965971e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.0225520075008323,0.00311281614947486,0.0164508878478616,0.028653127153803,4.52476383283103e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.0190114302757481,0.00262905097891763,0.0138584903570695,0.0241643701944266,5.00114506946097e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AZU1,Azurocidin,39809,0.0539297477110968,0.00746818904964632,0.03929209717379,0.0685673982484036,5.39239210196651e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGA,Fibrinogen alpha chain,37698,0.02127805295645,0.00295863031777232,0.0154791375336162,0.0270769683792837,6.73461068240802e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP2,Retinol-binding protein 2,40305,-0.0523887660994235,0.00729799043910409,-0.0666928273600675,-0.0380847048387795,7.35957485117179e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.037633300708635,0.00524700708810776,0.0273491668159438,0.0479174346013263,7.76819071586308e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCAM1,Vascular cell adhesion protein 1,40372,-0.0185319754201729,0.00259277834140326,-0.0236138209693233,-0.0134501298710225,9.21841000600788e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGT,Angiotensinogen,37987,0.0166347835894443,0.00232877205141542,0.0120703903686701,0.0211991768102185,9.58721252781224e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GM2A,Ganglioside GM2 activator,37714,0.0264106240375313,0.00370110690473871,0.0191564545042434,0.0336647935708192,1.01172834609907e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,37969,-0.033252670907298,0.00466301499873931,-0.0423921803048271,-0.024113161509769,1.04590306394274e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.0181173944977041,0.00254239338307745,0.0131343034668723,0.0231004855285359,1.07655591386819e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.0178373818038933,0.00250303138287683,0.0129314402934547,0.0227433233143319,1.08346200760645e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SBSN,Suprabasin,37977,-0.0228936797104228,0.00323155805087126,-0.0292275334901305,-0.0165598259307151,1.4654608714183e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRLB,Fc receptor-like B,39980,0.04141796008029,0.00585937911500363,0.0299335770148829,0.0529023431456971,1.6309823732656e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1B,Interleukin-1 beta,39946,0.0382096767988321,0.00540951390208316,0.0276070295507491,0.0488123240469151,1.69364647104712e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR5,Complement factor H-related protein 5,37785,0.0283704489850481,0.00401847841240473,0.0204942312967349,0.0362466666733614,1.74747741477862e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.0178730382766153,0.0025329213472511,-0.0228375641172275,-0.0129085124360032,1.78081555127624e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0386176598724735,0.00547528680969961,0.0278860977254622,0.0493492220194847,1.82226808674362e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.0278006824956569,0.00394285029079053,0.0200726959257074,0.0355286690656063,1.86428908676805e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,40403,0.0308442160265372,0.00438303267755643,0.0222534719785266,0.0394349600745478,2.04144815255821e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.0249697367273597,0.003553695270827,0.0180044939965387,0.0319349794581806,2.22109470663572e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QA,Complement C1q subcomponent subunit A,40442,-0.0153034550109765,0.00218034823717243,-0.0195769375558345,-0.0110299724661186,2.32752301189568e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFB,Vascular endothelial growth factor B,37598,0.0192548166776941,0.00274614120467895,0.0138723799165233,0.0246372534388649,2.47136017391745e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RALY,RNA-binding protein Raly,37900,0.0325392323481093,0.00464300571756143,0.0234389411416889,0.0416395235545297,2.52858211967454e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE1,Ribonuclease pancreatic,37987,0.0162750265894487,0.00232272298483649,0.0117224895391692,0.0208275636397282,2.55227689442672e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP4,Guanylate-binding protein 4,39961,0.0331259372110683,0.00473075537863319,0.0238536566689472,0.0423982177531893,2.62223446779555e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENSA,Alpha-endosulfine,37900,0.0355004162965742,0.0050776920059184,0.0255481399649742,0.0454526926281743,2.84902772563781e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.0498871676928237,0.00713606579432461,0.0359004787359474,0.0638738566496999,2.8629813219344e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CENPF,Centromere protein F,37714,0.0366990680124626,0.00525612512261317,0.0263970627721408,0.0470010732527844,3.04530372437593e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,40136,0.0197777134702528,0.00283630025661367,0.01421856496729,0.0253368619732156,3.22482303589774e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPARCL1,SPARC-like protein 1,40346,-0.0184459343948841,0.00264790215603464,-0.023635822620712,-0.0132560461690562,3.38281981943053e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCP1,Plastin-2,37998,0.0315146066049224,0.00452960934977736,0.0226365722793587,0.040392640930486,3.62359032079422e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSLN,Mesothelin,40271,0.0361447057715702,0.00519653912638326,0.025959489083859,0.0463299224592814,3.64988145085033e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VGF,Neurosecretory protein VGF,37959,0.0203638999140468,0.00293238516298969,0.014616424994587,0.0261113748335066,3.97216582282636e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.051470802938561,0.00741500115155223,-0.0660042051956034,-0.0369374006815187,4.03113935318382e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.0405145977814858,0.00583638428428821,0.0290752845842809,0.0519539109786907,4.05508128133087e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0256882290217585,0.0037019229515281,0.0184324600367634,0.0329439980067536,4.12979704423839e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTX2,Neuronal pentraxin-2,37998,-0.0217995845924178,0.00314265715539065,-0.0279591926169834,-0.0156399765678521,4.19661856840227e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH1,Cadherin-1,39806,0.0266907412263791,0.00385026963282488,0.0191442127460423,0.0342372697067158,4.30932381855868e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAM,Integrin alpha-M,40332,-0.0210724906582224,0.0030411267792275,-0.0270330991455083,-0.0151118821709365,4.395809469888e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.0195323305948233,0.00282311129656767,0.0139990324535507,0.0250656287360959,4.7298511039132e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPE,Carboxypeptidase E,40360,-0.0253495894705516,0.00366909484804175,-0.0325410153727134,-0.0181581635683897,5.06772785729024e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.0279480835909628,0.00404850081822795,0.020013021987236,0.0358831451946895,5.3080451924324e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL3,Fc receptor-like protein 3,40044,0.0362486901736825,0.00525397784626694,0.0259508935949993,0.0465464867523657,5.42765172736068e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.0285241711926363,0.00413592789301145,-0.0366305898629388,-0.0204177525223339,5.52398850563324e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCAN,Versican core protein,40471,-0.0198715894890365,0.00288437864813532,-0.0255249716393817,-0.0142182073386912,5.81210937142751e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LBP,Lipopolysaccharide-binding protein,40403,-0.0383507691455805,0.00558611199583542,-0.0492995486574179,-0.0274019896337431,6.87609450177883e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,37942,0.15746938377253,0.0229582603407022,0.112471193504754,0.202467574040306,7.2394673978856e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAS2,Growth arrest-specific protein 2,37714,0.0353268668488463,0.0051509481562872,0.0252310084625234,0.0454227252351692,7.27611819370164e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR15L,Protein GPR15L,37901,0.039759747346427,0.00579818360456998,0.0283953074814698,0.0511241872113841,7.3250185246163e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0311698471130662,0.00456258248709006,0.0222271854383697,0.0401125087877627,8.70786323079879e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GC,Vitamin D-binding protein,38013,0.0170672872303873,0.00249872111133787,0.0121697938521651,0.0219647806086095,8.82815997974868e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2,Apoptosis regulator Bcl-2,37901,0.0354611463295907,0.0051997186128699,0.0252696978483657,0.0456525948108157,9.50482131142789e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYZL2,Lysozyme-like protein 2,37482,0.0235238496920788,0.00345293506680461,0.0167560969611418,0.0302916024230158,9.99839019391253e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.0475442741127545,0.00698833802679165,0.0338471315802429,0.0612414166452661,1.06501788340728e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.035962786395278,0.00528890518565148,0.0255965322314011,0.0463290405591549,1.09288900625395e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALPP,"Alkaline phosphatase, placental type",40305,0.0671467583523208,0.00988189823986071,0.0477782378021938,0.0865152789024478,1.12228119012761e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRH,Corticoliberin,39947,0.0564543298589571,0.00834137797176746,0.0401052290342929,0.0728034306836213,1.35272325226515e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.0212930294069267,0.00314651886181111,-0.0274602063760765,-0.0151258524377769,1.35926575370866e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN10,Ataxin-10,39961,0.0469544368882962,0.0069496323473225,0.0333331574875441,0.0605757162890483,1.46507125228445e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMIGO2,Amphoterin-induced protein 2,40305,0.0145803649480621,0.0021622945464874,0.0103422676369468,0.0188184622591774,1.60501734977136e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.0169244281428743,0.00251000382095136,-0.021844035631939,-0.0120048206538096,1.61850248921733e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.0566882255922276,0.00841748497064955,0.0401899550497544,0.0731864961347007,1.70052573910695e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0431531320238009,0.00641131436145947,0.0305869558753404,0.0557193081722615,1.75822595295504e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA5,Protein disulfide-isomerase A5,37482,0.0396868513885699,0.00591118504605237,0.0281009286983073,0.0512727740788326,1.97400829902474e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,40335,0.0289253219999281,0.00430991668234474,0.0204778853025324,0.0373727586973238,1.99368361726311e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0386625197689986,0.00577313326710409,0.0273471785654746,0.0499778609725227,2.20084448935233e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.0467688296650827,0.00698544991259215,0.0330773478364021,0.0604603114937634,2.24175719513766e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA1,Annexin A1,37608,0.0267113341406094,0.00399067481336503,0.0188896115064139,0.0345330567748048,2.26824827596219e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOC,Brother of CDO,40042,-0.0151607239974952,0.00226621338950497,-0.0196025022409249,-0.0107189457540654,2.30937926695876e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RCOR1,REST corepressor 1,40042,0.028702176390026,0.00429956075121401,0.0202750373176465,0.0371293154624054,2.54522743396774e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN4,Contactin-4,40332,-0.0155588761383817,0.00233396914160708,-0.0201334556559316,-0.0109842966208318,2.71025210424493e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAM,Basal cell adhesion molecule,40332,-0.0151378173500364,0.0022744724373533,-0.0195957833272489,-0.0106798513728239,2.9152382223102e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAM1,Neural cell adhesion molecule 1,40403,-0.0176098361878452,0.00265144839559493,-0.0228066750432112,-0.0124129973324791,3.20343675920342e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIMAP7,GTPase IMAP family member 7,37671,-0.0207239748960253,0.00312123331075754,-0.02684159218511,-0.0146063576069405,3.26657200397234e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LACRT,Extracellular glycoprotein lacritin,37863,0.0339735775313943,0.0051224979043907,0.0239334816387885,0.0440136734240001,3.43328675129355e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRC1,Macrophage mannose receptor 1,37987,0.0179971974345069,0.00271789581011668,0.0126701216466782,0.0233242732223356,3.68391197906935e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MST1,Hepatocyte growth factor-like protein,37787,0.039117565919247,0.00592228389474844,0.0275098894855401,0.050725242352954,4.12179387311569e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,40311,0.0256430265460114,0.00388883450338428,0.0180209109193782,0.0332651421726446,4.41618158473031e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGA4,Pepsin A-4,37987,0.0431014417080774,0.00654140905926362,0.0302802799519207,0.0559226034642341,4.59133650731687e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSH,Pro-cathepsin H,40013,0.0457654760064534,0.00694814541688088,0.0321471109893668,0.0593838410235399,4.64072937831478e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD7,T-cell antigen CD7,37567,0.0270502024509054,0.00413230520501524,0.0189508842490756,0.0351495206527353,6.12848319061225e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CABP2,Calcium-binding protein 2,37572,0.0411521709506227,0.00629558182067489,0.0288128305820999,0.0534915113191454,6.52283746299832e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.0190134762071889,0.00290955265612535,-0.0247161994131946,-0.0133107530011832,6.60446355240613e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFAP1,Actin filament-associated protein 1,37671,0.053240280613367,0.00814921501849195,0.0372678191771228,0.0692127420496112,6.67466952870433e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST7,Cystatin-F,40376,0.0576253098647033,0.00883110852679861,0.040316337152178,0.0749342825772285,6.99308364581434e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0373699943425036,0.00572690189937842,0.0261452666197219,0.0485947220652853,7.03398439286133e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGBL1,Integrin beta-like protein 1,37998,0.0219119303549959,0.00335951227175203,0.015327286302362,0.0284965744076299,7.16690368917426e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17D,Interleukin-17D,40044,0.0214431272759364,0.00328904442472598,0.0149966002034735,0.0278896543483993,7.26797811004981e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC1,Sialoadhesin,40422,0.0270729105979644,0.00415651634297114,0.018926138565741,0.0352196826301879,7.56807764244591e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSBP1,Heat shock factor-binding protein 1,37628,0.0598645450385567,0.00919471848838827,0.0418428968013157,0.0778861932757977,7.74856084211546e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.0196730815896931,0.00302213204090798,0.0137497027895134,0.0255964603898727,7.80511538323173e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF8,SLAM family member 8,39980,0.033392168228814,0.00513970823286152,0.0233183400924054,0.0434659963652226,8.44872037514884e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0633431486698349,0.00975825167404253,0.0442169753887115,0.0824693219509582,8.81983242080515e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0240006071402008,0.00371102248075569,0.0167270030779197,0.031274211202482,1.03242388049621e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN1,Tetraspanin-1,40042,0.0189445278040843,0.00293057292189231,0.0132006048771754,0.0246884507309932,1.04692029338697e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A13,Protein S100-A13,37598,0.0216753280605093,0.00335477412402409,0.0150999707774221,0.0282506853435965,1.07651332059512e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.0260783748018394,0.00404164731270163,0.0181567460689443,0.0340000035347346,1.13270278658424e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN8,Septin-8,37921,0.0196781291505527,0.00306378209452524,0.0136731162452832,0.0256831420558222,1.38263345405084e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNXB,Tenascin-X,40332,-0.015684558771523,0.00244650170658106,-0.0204797021164219,-0.0108894154266241,1.48633300510444e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.0126195406700259,0.001973306603786,-0.0164872216134464,-0.00875185972660529,1.65832925393223e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMH,Granzyme H,40042,0.0457478892368756,0.00716247069925464,0.0317094466663365,0.0597863318074147,1.73775506710813e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L15,Bcl-2-like protein 15,37598,0.0346374339755191,0.00543867356748935,0.02397763378324,0.0452972341677982,1.96946890317761e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.0358999173469378,0.00563860366390475,0.0248482541656845,0.0469515805281912,1.98399102655447e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.026120864050316,0.00410470039895082,0.0180756512683724,0.0341660768322596,2.02376974024312e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0222968979633134,0.00351946302078219,0.0153987504425803,0.0291950454840465,2.4456490512353e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNC,Tenascin,40403,-0.0287282395865655,0.00453604193286412,-0.0376188817749792,-0.0198375973981519,2.46351969172455e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN2,Prefoldin subunit 2,39961,0.0341055178941096,0.00539064703244083,0.0235398497105256,0.0446711860776937,2.57171284111654e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGCR6,Protein DGCR6,37541,0.027692425859927,0.00437905308349102,0.0191094818162846,0.0362753699035694,2.6343880618249e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0291644624336171,0.00461610631952384,0.0201168940473504,0.0382120308198838,2.73357199392145e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JAM2,Junctional adhesion molecule B,40471,0.0158094591913598,0.00250503310861401,0.0108995942984763,0.0207193240842432,2.84382244236277e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0268221482411339,0.00425152518104683,-0.0351551375959856,-0.0184891588862821,2.88564959767262e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBA,Lysosomal acid glucosylceramidase,37572,0.0320711888414722,0.00508751643378717,0.0220996566312493,0.042042721051695,2.99546541540121e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF1C,Kinesin-like protein KIF1C,37562,0.0228284756481337,0.00362243955990053,0.0157284941107287,0.0299284571855387,3.03310956009279e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDF15,Growth/differentiation factor 15,40536,0.0259692080595158,0.00412690225955655,0.0178804796307849,0.0340579364882466,3.20139329144012e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.0164117671813559,0.00260942839211381,0.0112972875328129,0.021526246829899,3.26912522821359e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK6,Kallikrein-6,40387,0.0183532672685866,0.00292036990049915,0.0126293422636082,0.0240771922735649,3.37308082359512e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYTL1,Cytokine-like protein 1,37998,0.0139055471411112,0.00221268320837105,0.00956868805270392,0.0182424062295184,3.39045309683005e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.0243425551457113,0.00388400722130078,0.0167299009919618,0.0319552092994609,3.78378338318189e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,40305,0.0328736784167276,0.00524648772693114,0.0225905624719426,0.0431567943615127,3.80383243840654e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A14,Protein S100-A14,37959,0.0323451554188553,0.00517626518704021,0.0221996756522565,0.0424906351854541,4.26194510094545e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTB,Lymphotoxin-beta,37900,0.0212688047763682,0.00341181769832228,0.0145816420876565,0.0279559674650799,4.68670658951581e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PREB,Prolactin regulatory element-binding protein,40044,0.0177419025265046,0.00284699633543897,0.0121617897090443,0.023322015343965,4.72964780736369e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.0200829085338515,0.003222765011479,0.0137662891113527,0.0263995279563503,4.7340282938345e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLIN3,Perilipin-3,40359,0.0253655143107995,0.00407132612568515,0.0173857151044566,0.0333453135171424,4.77306684217326e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN4B,Sodium channel subunit beta-4,37628,0.0250307701807774,0.00403682066103181,0.017118601685155,0.0329429386763997,5.79230750111468e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD14,Monocyte differentiation antigen CD14,40048,0.0247145789064795,0.00398862820283467,0.0168968676289236,0.0325322901840355,5.92727015887584e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO2,Roundabout homolog 2,40471,0.0137522798916678,0.00223434566020982,0.00937296239765657,0.0181315973856791,7.6890601680746e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.0240102920483477,0.00390139689477856,0.0163635541345817,0.0316570299621137,7.72712328730316e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB1A1,Uteroglobin,40384,0.0334690537221348,0.00544545176218048,0.0227959682682611,0.0441421391760086,8.12301057223587e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.023284965778297,0.00378962953033222,0.0158572918988458,0.0307126396577481,8.25217662659356e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.0178769324784507,0.00291204912059013,-0.0235845487548073,-0.012169316202094,8.5079205639777e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF3,Granulocyte colony-stimulating factor,40044,0.0287680906393438,0.00468926037320449,0.019577140307863,0.0379590409708246,8.72773123947585e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN3,CCN family member 3,40522,0.0198584358362555,0.00323943374116654,0.0135091457035691,0.026207725968942,8.98085929353603e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMOD1,Leiomodin-1,37959,-0.0213545292319611,0.00348884534176381,-0.0281926661018182,-0.014516392362104,9.56827579766011e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OLFM4,Olfactomedin-4,37177,0.0725035329936524,0.0118579020119283,0.0492620450502729,0.0957450209370318,9.97807517561809e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.025854617830909,0.00423653031491586,0.017551018413674,0.0341582172481441,1.06631625651902e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCT,Secretin,37572,0.0268353611872036,0.00442444421286194,0.0181634505299942,0.035507271844413,1.353707353403e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.0122958021394185,0.00202846187818639,0.00832001685817316,0.0162715874206638,1.37794595150879e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP1,Caspase-1,39961,0.0391338465474709,0.00645591675622536,0.0264802497052692,0.0517874433896726,1.37808071999089e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0251021468703217,0.0041446987608732,0.0169785372990102,0.0332257564416332,1.42924357415304e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDM1,Nuclear protein MDM1,37572,0.0182292829330281,0.00301174999606295,0.0123262529407447,0.0241323129253114,1.46303174182995e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA7,Carbonic anhydrase 7,37714,-0.0205099680715145,0.00338901597966763,-0.027152439391663,-0.0138674967513659,1.47011500955552e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.019438278562303,0.0032122371823616,0.0131422936848743,0.0257342634397318,1.47454809719685e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0490450947483718,0.00814553849400689,0.0330798393001183,0.0650103501966253,1.7786784732362e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,39980,0.0270716538659015,0.00449714718115855,0.0182572453908308,0.0358860623409723,1.78630705668046e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF3,Trefoil factor 3,40309,0.030868800084192,0.0051281446365238,0.0208176365966053,0.0409199635717786,1.78826248959533e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.0139784403016683,0.00232322158520237,-0.0185319546086649,-0.00942492599467166,1.81717230060322e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00892941312382962,0.00148932547971489,0.00601033518358844,0.0118484910640708,2.07059516361675e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.0208953422331009,0.00348655627205402,0.014061691939875,0.0277289925263268,2.11243805974285e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNG,Interferon gamma,40044,0.0653571227315376,0.0109128136650525,0.0439680079480347,0.0867462375150405,2.15739643503315e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PADI4,Protein-arginine deiminase type-4,39934,0.0399206433494889,0.00666827435855496,0.0268508256067212,0.0529904610922566,2.1893584930499e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.0207697709411717,0.00346995344794171,0.013968662183206,0.0275708796991375,2.20312786384341e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D17,TBC1 domain family member 17,39961,0.0263289943432528,0.0044153239249781,0.0176749594502957,0.0349830292362099,2.52879588106735e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA1,Carbonic anhydrase 1,40003,0.0356897923234945,0.00600441982830169,0.0239211294600232,0.0474584551869658,2.84235745211616e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0505147635554412,0.00851140329020142,0.0338324131066465,0.067197114004236,3.00025482908151e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,40182,0.0163483154780431,0.00275779105646314,0.0109430450073753,0.0217535859487108,3.12970601941986e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIF,Leukemia inhibitory factor,39961,0.0298238565790633,0.00505451822806635,0.0199170008520533,0.0397307123060733,3.70096611875641e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.0121911877047855,0.00206704265821278,0.00813978409468845,0.0162425913148825,3.77023512882363e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRLF1,Cytokine receptor-like factor 1,40422,0.0147975378978863,0.00252322216442577,0.00985202245561177,0.0197430533401608,4.59272003988494e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA2,Ephrin type-A receptor 2,39759,0.0173479950551127,0.00295866546414563,0.0115490107453872,0.0231469793648381,4.6267587749965e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.0243811911604174,0.00416304344971548,0.0162216259989751,0.0325407563218597,4.81833334767336e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEK,Angiopoietin-1 receptor,40411,0.0120877606686673,0.00206522125834527,0.00803992700231054,0.016135594335024,4.92220691518517e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RETN,Resistin,40283,0.0232779486854772,0.00397805505233966,0.0154809607828915,0.0310749365880629,4.96509998758572e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA12,Serpin A12,39903,0.0640444719281806,0.0109690270588788,0.0425451788927782,0.085543764963583,5.36765726896081e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0216906501799335,0.00371484038384346,0.0144095630276003,0.0289717373322667,5.37517503725972e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH3,Cadherin-3,40471,0.0198550022695457,0.00340189244263315,0.0131872930819847,0.0265227114571066,5.43522505841974e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSHB,Follitropin subunit beta,37628,0.039240457123488,0.00672741062585349,0.0260547322968152,0.0524261819501609,5.57435983874535e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTPN,Myotrophin,40042,0.0185058276306285,0.00318210597710137,0.0122688999155098,0.0247427553457472,6.16027412887106e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPHS1,Nephrin,37598,0.0194318065542214,0.00334137608335037,0.0128827094308547,0.0259809036775882,6.18546980528968e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,39980,0.0293524941873366,0.00504975069058166,0.0194549828337965,0.0392500055408767,6.26932571092417e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,37942,0.0162280464492812,0.00280479266095288,0.0107306528338136,0.0217254400647489,7.37581541541069e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.0141713840160603,0.00245050404906995,0.00936839607988317,0.0189743719522374,7.47469689297633e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNLY,Granulysin,40332,0.0281340418738895,0.00487585164101313,0.0185773726575038,0.0376907110902753,8.07114258360943e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.0232771952172622,0.00403736829178833,0.0153639533653571,0.0311904370691673,8.29871300093972e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.0146236968400408,0.00254173787057442,0.00964189061371493,0.0196055030663666,8.90646441807494e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPS10,40S ribosomal protein S10,37562,-0.0234451314679884,0.00407864640844007,-0.031439278428531,-0.0154509845074459,9.21732569871821e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F3,Tissue factor,40393,-0.0154702322671033,0.00269612528740983,-0.0207546378304265,-0.01018582670378,9.75694918805821e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CILP,Cartilage intermediate layer protein 1,37998,0.0294942293680574,0.00518110256277396,0.0193392683450204,0.0396491903910943,1.2767346184091e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB44,Ras-related protein Rab-44,37900,0.0218179238569557,0.00383691828215831,0.0142975640239254,0.029338283689986,1.32510880755467e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC16,Mucin-16,40305,0.101945372189707,0.0179808396643122,0.066702926447655,0.137187817931759,1.45568246459606e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA12,Carbonic anhydrase 12,40305,-0.0175701331349229,0.00309931141101569,-0.0236447835005137,-0.0114954827693322,1.4609725492785e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECE1,Endothelin-converting enzyme 1,39961,0.0191792923101539,0.00338503035774822,0.0125446328089674,0.0258139518113404,1.4884074944506e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0301506509958205,0.00532489188100603,0.0197138629090487,0.0405874390825923,1.52070949065086e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XG,Glycoprotein Xg,40458,0.0162611193562001,0.00287372093110407,0.0106286263312362,0.0218936123811641,1.55263182924511e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MBL2,Mannose-binding protein C,37810,-0.0579988916135063,0.0102588945339,-0.0781063248999503,-0.0378914583270624,1.60411118578048e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROCR,Endothelial protein C receptor,37562,-0.0199701587294471,0.00356432169616383,-0.0269562292539282,-0.012984088204966,2.15172818485339e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD48,CD48 antigen,40396,0.0157675202898978,0.00281643954249476,0.0102472987866081,0.0212877417931875,2.19921463396439e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLU,Clusterin,38013,0.0178159047124746,0.00318401360578305,0.0115752380451398,0.0240565713798094,2.24346106743557e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMB,Granzyme B,40341,0.0337046481291632,0.00603969138234792,0.0218668530197613,0.0455424432385651,2.43711643767098e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPOCK1,Testican-1,40228,0.0134339677349836,0.0024146894813907,0.00870117635145788,0.0181667591185094,2.68816570004783e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.0178334518875865,0.00320705946275389,0.0115476153405889,0.0241192884345841,2.73034939348808e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0141908425748152,0.00255353157637677,0.00918592068511673,0.0191957644645137,2.78315855594508e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.0191982574740092,0.00345795424386331,0.0124206671560371,0.0259758477919813,2.87096694898254e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAEP,Glycodelin,40228,-0.069937077213043,0.0126244920235113,-0.0946810815791251,-0.0451930728469609,3.07671418847246e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP2,Guanylate-binding protein 2,40044,0.0316608628105448,0.00571571445754488,0.0204580624737568,0.0428636631473327,3.08655138825269e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.0164519890329622,0.00297242343880349,0.0106260390929074,0.0222779389730171,3.16391322388668e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB37,Ras-related protein Rab-37,40044,0.0442417260551345,0.00800474657774547,0.0285524227627533,0.0599310293475156,3.31096227738724e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1A,Protein phosphatase 1A,39980,0.0164769406273292,0.00298222699476183,0.010631775717596,0.0223221055370624,3.34696544847736e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.0220329718313111,0.00398997781719185,0.014212615309615,0.0298533283530071,3.40387972481421e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD160,CD160 antigen,40516,0.0240309947171485,0.00438521834561031,0.0154359667597522,0.0326260226745447,4.31728480876043e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0229685674213108,0.00419354964634316,0.0147492101144782,0.0311879247281434,4.38999476602984e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK11,Kallikrein-11,40260,0.0156263035539188,0.00285361596337529,0.0100332162657032,0.0212193908421344,4.41768462288475e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0327721822718495,0.00599632401325172,0.0210193872058761,0.0445249773378228,4.70122009020593e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL28,C-C motif chemokine 28,40278,0.0312514345252363,0.00572379302459311,0.0200328001970338,0.0424700688534388,4.83532012850703e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,37900,0.0317143868760471,0.00583655410548257,0.0202747408293013,0.043154032922793,5.61422455346305e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.0138169721842073,0.00254545087569288,-0.0188060559005654,-0.00882788846784926,5.79755920184495e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.0196916907707784,0.00362822166977474,0.01258037629802,0.0268030052435369,5.80556437758777e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0175762633107817,0.00324317853672181,0.0112196333788069,0.0239328932427564,6.06467039027402e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG3,Desmoglein-3,40419,0.0174042545411256,0.00321392984411214,0.0111049520466658,0.0237035570355854,6.20856708815318e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0186243932667041,0.0034405938750028,0.0118808292716986,0.0253679572617096,6.30215473145701e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG4,Desmoglein-4,40250,0.0263453855126047,0.0048842213193832,0.0167723117266137,0.0359184592985958,6.99060706782977e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR1,Folate receptor alpha,40299,0.0146829506498048,0.00272362946054519,0.00934463690713623,0.0200212643924734,7.10893008428092e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSAB1,Tryptase alpha/beta-1,40498,0.0272763111669529,0.00506055898535279,0.0173576155556614,0.0371950067782443,7.14609033942506e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.0156567468860372,0.00290945015408714,0.00995422458402645,0.021359269188048,7.50064435507408e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0264076215032183,0.00491003916243602,0.0167839447448437,0.0360312982615929,7.64540095000754e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OBP2B,Odorant-binding protein 2b,40184,-0.0341493898504421,0.0063590529057669,-0.0466131335457452,-0.0216856461551389,7.97662048131229e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.0234078847876641,0.00436151973264125,0.0148593061116872,0.0319564634636409,8.14259392617886e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN2,Ataxin-2,37541,0.0595867437017929,0.0111044170389403,0.0378220863054699,0.0813514010981159,8.18556701767825e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.013580541012523,0.00253562193541448,0.00861072201911065,0.0185503600059354,8.63096732182427e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHB6,Ephrin type-B receptor 6,40192,0.0160430842254927,0.00299732484877384,0.010168327521896,0.0219178409290895,8.79787721729583e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLVRB,Flavin reductase,40332,0.0340954192084588,0.00637230841915256,0.0216056947069198,0.0465851437099978,8.88986693021111e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.053430296045652,0.0100037354408242,0.0338229745816365,0.0730376175096674,9.39603741461397e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPC1,Glypican-1,40489,0.0150422423037583,0.00281845652714424,0.00951806751055558,0.020566417096961,9.57559925191278e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,40341,0.02402232283163,0.00451558640460895,0.0151717734785965,0.0328728721846635,1.0525034523393e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPM3,Tropomyosin alpha-3 chain,37562,-0.0217728428892061,0.00409503240176674,-0.0297991063966689,-0.0137465793817433,1.07287447985508e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.0140773084153707,0.00265077292729239,0.00888179347787757,0.0192728233528637,1.10746295139293e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.0274120065536096,0.00516851748469093,0.0172817122836154,0.0375423008236039,1.15066085225321e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.0179619614536607,0.00338885126751395,0.0113198129693333,0.024604109937988,1.17475676827724e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD27,CD27 antigen,40411,0.0206755194554337,0.00390504574290038,0.013021629799349,0.0283294091115184,1.20880361259217e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.0114963417426287,0.00217540417197881,0.00723254956555024,0.0157601339197072,1.27591557414315e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSHB,Thyrotropin subunit beta,40359,0.042508405227296,0.0080496766634473,0.0267310389669393,0.0582857714876527,1.30342224564693e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEDD9,Enhancer of filamentation 1,37598,0.0167841210209592,0.0031851295388037,0.0105412671249039,0.0230269749170144,1.38938923680542e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HYAL1,Hyaluronidase-1,40214,0.0116161906088999,0.00220752981785586,0.00728943216590243,0.0159429490518974,1.44303007078751e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.029578547285247,0.00563774689904376,0.0185285633631212,0.0406285312073728,1.57036861301669e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.019025299850431,0.00362873562000691,-0.0261376216656446,-0.0119129780352175,1.60478565231256e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,37562,0.0239694624408562,0.00457408304647313,0.0150042596697688,0.0329346652119435,1.62822552638375e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD1,Bromodomain-containing protein 1,37714,-0.0156635727986528,0.00298980952967655,-0.0215235994768188,-0.00980354612048674,1.63933599923437e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN5,Contactin-5,40367,-0.0185951038180027,0.00355771472622967,-0.0255682246814129,-0.0116219829545926,1.74743338020768e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,39961,0.0424470135617975,0.00814502724350418,0.0264827601645293,0.0584112669590657,1.89821225982834e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.0133367865359677,0.00256401220442274,0.0083113226152991,0.0183622504566362,2.00121341064813e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.034524973684154,0.00665454986074574,-0.0475678914112157,-0.0214820559570924,2.15452078626937e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.0286112350394087,0.00551671522986864,0.0177984731888662,0.0394239968899512,2.17166352187142e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.0163869301921254,0.00316867848580076,-0.0225975400242949,-0.0101763203599559,2.3551340680886e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.0165628670396491,0.0032086845294519,-0.0228518887173748,-0.0102738453619234,2.48054428771106e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR2,Folate receptor beta,40471,-0.0145300041853283,0.00282751612548746,-0.0200719357912838,-0.00898807257937291,2.79766451606157e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.027174725631999,0.00529225742008231,-0.0375475501753604,-0.0168019010886377,2.85768377126348e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNPEP,Aspartyl aminopeptidase,37942,0.0293598063899309,0.0057217121322692,0.0181452506106832,0.0405743621691785,2.91748102774547e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.0143526880505976,0.00280212800914633,-0.0198448589485244,-0.00886051715267083,3.06443810975655e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO1,Alpha-enolase,40299,0.0389171404167998,0.0076106649484452,0.0240002371178472,0.0538340437157524,3.19928094054067e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRUNE2,Protein prune homolog 2,37714,0.0145590746934111,0.00284907046339405,0.0089748965851587,0.0201432528016634,3.26440697843401e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0320357970472097,0.00627039389592963,0.0197458250111877,0.0443257690832318,3.27521958528248e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFLAM,Pikachurin,37901,0.0151028939372922,0.00296238003710582,0.00929662906456475,0.0209091588100196,3.47502060553012e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL1A1,Collagen alpha-1(I) chain,40536,-0.0126977520854513,0.00249381490918674,-0.0175856293074573,-0.00780987486344531,3.58878683375839e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSN,Gelsolin,37928,-0.00931974456804863,0.00183041836135098,-0.0129073645562966,-0.0057321245798007,3.5985789672483e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB6,Integrin beta-6,40044,0.0147443009297211,0.00289810947629743,0.0090640063561781,0.020424595503264,3.66915311962957e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0695385100239386,0.0136725604706484,0.0427402915014678,0.0963367285464095,3.69977832420421e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINI1,Neuroserpin,37642,0.0156220288788704,0.00307204881269381,0.00960081320599051,0.0216432445517503,3.722464328041e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,37562,0.0222557407716993,0.0043825298433929,0.0136659822786492,0.0308454992647494,3.86082853597375e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCN,Decorin,40042,-0.0110854294865969,0.00219021019359832,-0.0153782414660497,-0.00679261750714422,4.21028576000504e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIT,Vitrin,37990,0.017936490088477,0.00354785576623303,0.0109826927866602,0.0248902873902937,4.34675623004072e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LUZP2,Leucine zipper protein 2,37900,0.0217034343352436,0.00430277655199021,0.0132699922933427,0.0301368763771444,4.6171264650226e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.0234719709912848,0.00467919192816364,-0.0326431871704856,-0.0143007548120841,5.33770309019106e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPA,Apolipoprotein(a),37735,-0.0847932585031672,0.0169055538264687,-0.117928144003046,-0.0516583730032885,5.35217687073633e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.0235884187675428,0.00471214227601313,0.0143526199065571,0.0328242176285286,5.63293598947698e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNPY2,Protein canopy homolog 2,40042,0.029350620311486,0.00587198928035232,0.0178415213219955,0.0408597193009766,5.84313919449814e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD109,CD109 antigen,40332,-0.0160059368653584,0.00321068844458736,-0.0222988862167497,-0.0097129875139672,6.25487686997251e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,0.0173575584720449,0.00348708557816627,0.010522870738839,0.0241922462052508,6.50287591177524e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C8B,Complement component C8 beta chain,38013,0.0146308737256097,0.00293936525668094,0.00886971782251504,0.0203920296287043,6.51805308543638e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK8,Kallikrein-8,39801,0.0169682412963026,0.00341226792204564,0.0102801961690932,0.0236562864235121,6.67341251466478e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0195396678675407,0.0039341768838769,0.011828681175142,0.0272506545599395,6.8845010485854e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CR2,Complement receptor type 2,40403,0.0221424544176516,0.00446402692000175,0.0133929616544482,0.0308919471808551,7.11461802361441e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,40228,-0.0170833124665317,0.00346327017009268,-0.0238713219999134,-0.0102953029331501,8.19216538035729e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP10,Bone morphogenetic protein 10,37671,-0.0136062233698129,0.00276435825020798,-0.0190243655402205,-0.00818808119940523,8.66889562106071e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0186060753881078,0.00379388697636073,0.0111700569144408,0.0260420938617749,9.48931739287316e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.017142704284784,0.00350356025657809,0.010275726181891,0.0240096823876771,1.00304240755179e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH6,Cadherin-6,40359,-0.0177773077369881,0.00364091678336854,-0.0249135046323904,-0.0106411108415857,1.05687787870815e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",40310,0.0317895821217533,0.00652688649551457,0.0189968845905447,0.0445822796529619,1.12356577398487e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,40332,0.0161028309233917,0.0033063744533831,0.00962233699476085,0.0225833248520226,1.12537108822251e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMBS,Porphobilinogen deaminase,40489,0.0212472033646001,0.00436484402392566,0.0126921090777058,0.0298022976514944,1.13919223985673e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICOSLG,ICOS ligand,40305,0.00888744431812364,0.00183492663760821,0.00529098810841155,0.0124839005278357,1.28784358353784e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMPD3,AMP deaminase 3,37942,0.0336434512378441,0.00698170220435247,0.0199593149173132,0.0473275875583749,1.45993905384012e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGA,Glycoprotein hormones alpha chain,40332,0.0414383825108509,0.00860751660064175,0.0245676499735931,0.0583091150481088,1.49144987070556e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MATN3,Matrilin-3,40203,-0.0144428484231675,0.00300241971618984,-0.0203275910668996,-0.00855810577943547,1.52020483339729e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UROS,Uroporphyrinogen-III synthase,37572,0.0325313429680277,0.00676328599804112,0.0192753024118671,0.0457873835241883,1.5261508193907e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD3,Extracellular superoxide dismutase,37987,-0.0273773930982151,0.00569288355798187,-0.0385354448718596,-0.0162193413245706,1.53277612259729e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,37875,-0.012502315151874,0.00260035636770041,-0.0175990136325668,-0.00740561667118118,1.54159949499502e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LHB,Lutropin subunit beta,39980,0.039204211566813,0.00815767160770459,0.0232151752157121,0.055193247917914,1.55568725606606e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH15,Cadherin-15,40435,0.0203909114143157,0.00425399790047658,0.0120530755293816,0.0287287472992498,1.65492627558153e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBS4,Thrombospondin-4,40355,0.020650378742712,0.00433043026473732,0.0121627354238268,0.0291380220615971,1.87092865015445e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,40357,0.0181860317096334,0.00382297432029592,0.0106930020418534,0.0256790613774134,1.98179531248753e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOC1,Apolipoprotein C-I,37981,0.0165487477044608,0.00348326495087212,0.00972154840075145,0.0233759470081702,2.04564057169647e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0313850926170932,0.00661328061580035,0.0184230626101245,0.0443471226240619,2.09885715542197e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0394775976737504,0.0083233641469936,-0.0557913914018578,-0.0231638039456429,2.1248265016698e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLL4,Delta-like protein 4,37628,0.0385536130266444,0.00812837488109349,0.0226219982597011,0.0544852277935876,2.1268981790939e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOSB,Protein fosB,39961,0.0177824310733963,0.00375621820087918,0.0104202433996731,0.0251446187471195,2.21939361564843e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6,Seizure protein 6 homolog,37572,-0.0142608568225691,0.00301477662502636,-0.0201698190076208,-0.00835189463751747,2.26502871595048e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP4,Dipeptidyl peptidase 4,40068,0.0135577646320884,0.00287017860365228,0.00793221456892993,0.0191833146952469,2.33646735592621e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0298005598828784,0.00631972262196181,-0.0421872162219236,-0.0174139035438333,2.43549545915953e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLPS,Colipase,40311,0.0310164626808203,0.00658832625027878,0.0181033432302738,0.0439295821313667,2.52533868629383e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.015496030252939,0.00329251902355991,0.00904269296676153,0.0219493675391164,2.54650342769046e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGMA,Repulsive guidance molecule A,40471,-0.0139767264293596,0.00297062163273441,-0.019799144829519,-0.00815430802920013,2.56007316214059e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA9,Carbonic anhydrase 9,40489,-0.0203109630256655,0.00432246857109949,-0.0287830014250205,-0.0118389246263106,2.63703998760509e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD200,OX-2 membrane glycoprotein,40341,-0.0116897169699756,0.00249689270874231,-0.0165836266791105,-0.00679580726084064,2.86848656370369e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0281758165083518,0.00602131232197281,0.0163740443572851,0.0399775886594185,2.90207717026546e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,40305,0.0118149169441208,0.00252531942195187,0.00686529087709516,0.0167645430111465,2.9125039296693e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EBI3_IL27,Interleukin-27,40453,-0.0140001762516104,0.00299452477001326,-0.0198694448008364,-0.0081309077023844,2.95980433317982e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD58,Lymphocyte function-associated antigen 3,40335,-0.00792185104552322,0.00169863275539021,-0.011251171246088,-0.00459253084495842,3.13159681186314e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSPN,Persephin,40341,0.0444010899312342,0.00954258933141705,0.0256976148416568,0.0631045650208116,3.29877211619249e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITM2A,Integral membrane protein 2A,40341,-0.0263863618894685,0.00567744646804721,-0.037514156966841,-0.0152585668120959,3.38557314352177e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF16,Fibroblast growth factor 16,37598,0.0220029836428115,0.00473902183411541,0.0127145008479452,0.0312914664376777,3.46814615308712e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1R1,Interleukin-1 receptor type 1,40303,-0.00994355784287794,0.00214537759635396,-0.0141484979317317,-0.00573861775402418,3.59998745357849e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALB1,Calbindin,40305,0.0188648642963301,0.00407089306752714,0.0108859138839769,0.0268438147086833,3.61374622550058e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPEP1,Dipeptidase 1,40192,-0.0226149733551371,0.00488042142523936,-0.0321805993486063,-0.013049347361668,3.6186516497748e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLASP1,CLIP-associating protein 1,37482,0.0318666919058778,0.00688624053045037,0.0183696604661951,0.0453637233455605,3.73514179139134e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECM1,Extracellular matrix protein 1,37655,0.0164793116640645,0.00356447010664745,0.00949295025503554,0.0234656730730936,3.8142001468932e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PADI2,Protein-arginine deiminase type-2,40044,0.0248443783397412,0.00539026827404808,0.014279452522607,0.0354093041568755,4.07589086613296e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.0179169285752642,0.00388900759999342,-0.0255393834712513,-0.0102944736792771,4.1223068354657e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELAVL4,ELAV-like protein 4,37541,0.0386721830723453,0.00840901828291575,0.0221905072378305,0.0551538589068602,4.28720493710361e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0153783663794729,0.00334909270236752,0.00881414468283255,0.0219425880761132,4.42771302191283e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD99,CD99 antigen,40332,-0.0085629733768834,0.00186612187588494,-0.0122205722536179,-0.00490537450014892,4.49543987290117e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0265558687301942,0.00578791048257286,0.0152115641843514,0.0379001732760371,4.50650876202228e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRAL,GDNF family receptor alpha-like,37477,-0.0274023422794009,0.00597322733154122,-0.0391098678492217,-0.0156948167095801,4.52711362300416e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,40437,0.0356664359269988,0.00779396818559464,0.0203902582832333,0.0509426135707643,4.77154494574506e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM5,Intercellular adhesion molecule 5,40359,0.0193771338577657,0.00423655092459461,0.0110734940455602,0.0276807736699711,4.82572821851821e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA7A,Semaphorin-7A,40490,0.0117414677963655,0.00258255696151384,0.0066796561517984,0.0168032794409327,5.49571811897768e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRDL1,Chordin-like protein 1,40396,0.0133195279286471,0.00293027331058449,0.00757619223990152,0.0190628636173927,5.52105041102574e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.0131548918910195,0.00290331406261427,0.00746439632829547,0.0188453874537434,5.91452029752829e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EP300,Histone acetyltransferase p300,37598,0.0130335854943051,0.00287674276052301,0.00739516968367996,0.0186720013049302,5.93136055545167e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PODXL,Podocalyxin,40305,0.00660466903878444,0.00145903122321331,0.00374496784128635,0.00946437023628252,6.0333715342736e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0452153143181058,0.0100347075111839,0.0255472875961854,0.0648833410400263,6.65693468101546e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.0109228449899906,0.00243065362487911,0.0061587638852276,0.0156869260947537,7.04562678642399e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0268367804531561,0.00597234765639598,0.01513097904662,0.0385425818596923,7.06606309472245e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.0190137969387349,0.00424764814089676,0.0106884065825772,0.0273391872948925,7.65767385219389e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST6,Cystatin-M,39992,0.0205481743399245,0.00459648356859431,0.0115390665454797,0.0295572821343694,7.86215303234088e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,40516,0.0251389876827414,0.00562506987225117,0.0141138507331291,0.0361641246323537,7.90872060912155e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.00893330019328906,0.00200774767036379,-0.0128684856272021,-0.00499811475937603,8.67014068972915e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL19,Interleukin-19,39924,0.029008216212892,0.00652630026536597,0.0162166676927747,0.0417997647330093,8.85778998724498e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3D,Protein FAM3D,37901,0.0350954548988918,0.00792273422417491,0.019566895819509,0.0506240139782747,9.51028585740387e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.021197141455037,0.00479474640893941,0.0117994384935158,0.0305948444165583,9.90509576434412e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPA2,Replication protein A 32 kDa subunit,37598,0.0138661978897783,0.00314679430362298,0.00769848105467728,0.0200339147248794,1.05909657416216e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MILR1,Allergin-1,40044,-0.0211243050705244,0.00479790185771935,-0.0305281927116543,-0.0117204174293944,1.07562906482911e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDC1,Syndecan-1,40359,0.0169083592773126,0.00384249455208717,0.00937706995522174,0.0244396485994035,1.08774563775035e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00623196295027246,0.00141871277316726,0.00345128591486464,0.00901263998568028,1.12810159726546e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,39961,0.0162286135514889,0.00370557469042934,0.00896568715824741,0.0234915399447304,1.19724149499017e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR4,Complement factor H-related protein 4,37973,0.0309359085741325,0.00706380266592071,0.0170908553489279,0.044780961799337,1.19847551499177e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB2A2,Mammaglobin-A,37562,-0.0135341262197344,0.00309419602351302,-0.0195987504258199,-0.00746950201364885,1.22911462083383e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.0302702784789632,0.00693297627013964,0.0166816449894895,0.0438589119684369,1.27259974897617e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.0188459450684662,0.00431737883076168,0.0103838825601733,0.0273080075767591,1.27848040858463e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0208145879973259,0.00476876123861421,0.011467815969642,0.0301613600250097,1.28225007912007e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX18,Sorting nexin-18,37901,0.0190381013064088,0.00437923510155956,0.0104548005073521,0.0276214021054656,1.38800109017402e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0220463324009893,0.00510198063041407,0.0120464503653777,0.0320462144366009,1.56345547423509e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0168324719614899,0.00390307474145563,0.00918244546823683,0.0244824984547429,1.62513769196286e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL3,Myosin light chain 3,37628,-0.0284020026155116,0.00658906347765254,-0.0413165670317106,-0.0154874381993126,1.64086179108153e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.0247027566052012,0.00573500436852066,0.0134621480429007,0.0359433651675017,1.66420785802487e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD6,Programmed cell death protein 6,40359,-0.028861604205945,0.00670292449734361,-0.0419993362207385,-0.0157238721911516,1.67362410935472e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.0257093729422211,0.0059719685744115,0.0140043145363746,0.0374144313480677,1.68186339895807e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.023511599150144,0.00547289949125801,0.0127847161472784,0.0342384821530097,1.74961751144625e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.013308317185445,0.00309804715307508,0.00723614476541787,0.0193804896054722,1.75179774634864e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.0200750847272474,0.00467753777484536,0.0109071106885505,0.0292430587659443,1.78460444536482e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,0.0231875752578998,0.00541414457831778,0.012575851884397,0.0337992986314026,1.85889239836841e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0241280857807341,0.00567445645690782,0.0130061511251948,0.0352500204362734,2.13240414315927e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.0145166601174897,0.00342358283135671,0.00780643776803051,0.0212268824669488,2.2461184021561e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCG3,Secretogranin-3,40379,-0.0135644356783902,0.00320473128731713,-0.0198457090015318,-0.0072831623552486,2.32269994047736e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNR,Tenascin-R,40228,-0.0172441405014251,0.00407608060966341,-0.0252332584963654,-0.00925502250648483,2.34416558154927e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOB,Apolipoprotein B-100,37987,0.00906695044551019,0.00215006745503643,0.00485281823363878,0.0132810826573816,2.4912393173536e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSTL1,Follistatin-related protein 1,37628,-0.00913255767553681,0.0021675765725348,-0.013381007757705,-0.00488410759336861,2.53389497769393e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM2,Myomesin-2,37562,-0.0190982919245208,0.00453372031545624,-0.027984383742815,-0.0102122001062266,2.54249270336831e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO4,Roundabout homolog 4,37628,-0.00725497188429922,0.00172321390603903,-0.0106324711401357,-0.00387747262846272,2.56906312524484e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIL1,Nucleotide exchange factor SIL1,37628,0.0129819929034695,0.00308492626092205,0.00693553743206225,0.0190284483748767,2.59116168269285e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYMP,Thymidine phosphorylase,40257,0.0268486956392875,0.00640027426912608,0.0143041580718004,0.0393932332067747,2.74446177750803e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0238725445638296,0.00570601872653652,0.012688747859818,0.0350563412678412,2.8858791050937e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDN1,Endothelin-1,37628,0.0117238181614287,0.00280412251166865,0.00622773803855813,0.0172198982842993,2.92205614614951e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NME1,Nucleoside diphosphate kinase A,37598,-0.00885344175856135,0.00211884174802512,-0.0130063715846906,-0.00470051193243211,2.95419452793988e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.012602647922596,0.00302622295457273,0.00667125093163342,0.0185340449135585,3.13709752560497e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.007838865963692,0.00188424242077023,-0.0115319811084016,-0.00414575081898236,3.19898037478414e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SATB1,DNA-binding protein SATB1,37959,0.0120576074606683,0.00290233574561343,0.00636902939926594,0.0177461855220706,3.28078093862345e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AOC3,Membrane primary amine oxidase,40403,-0.0121177466640531,0.00291986037642503,-0.0178406730018461,-0.00639482032626003,3.34037264799758e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX5,Syntaxin-5,37598,0.0167552790077326,0.00404003540881065,0.00883680960646374,0.0246737484090015,3.38517760328005e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAP,Cartilage-associated protein,37572,0.0193583572893537,0.00466988500913247,0.0102053826714541,0.0285113319072534,3.41411075635307e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDHB15,Protocadherin beta-15,37900,-0.0160738238850372,0.0038831932148737,-0.0236848825861896,-0.00846276518388471,3.50442580428483e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0151997491541014,0.00367984352934724,0.00798725583658078,0.0224122424716219,3.64093752247119e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,37482,0.0164197226344566,0.00398259490413711,0.00861383662234788,0.0242256086465653,3.76498993801567e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEFL,Neurofilament light polypeptide,39903,0.016861678669396,0.00410215006833317,0.00882146453546301,0.0249018928033291,3.96929872019863e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB39B,Ras-related protein Rab-39B,37562,0.0352923903865798,0.00859741973113008,0.0184414477135648,0.0521433330595947,4.06767821559452e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP9,Fatty acid-binding protein 9,40341,0.0220197177325302,0.00536589590626854,0.0115025617562438,0.0325368737088165,4.08725525884291e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.017272724567509,0.00421068551823078,0.00901978095177666,0.0255256681832413,4.11787786714994e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMS1,PMS1 protein homolog 1,37572,0.0205650168901279,0.00501464074193645,0.0107363210359324,0.0303937127443233,4.13858343911139e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERC2,ERC protein 2,37572,0.0302985820590839,0.00741925368410457,0.0157568448382389,0.0448403192799289,4.45724247115858e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.0151382610089845,0.00370857815216274,-0.0224070741872235,-0.00786944783074554,4.49230628796984e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC13A1,Solute carrier family 13 member 1,37900,0.0244098806488068,0.00598560187713841,0.0126781009696155,0.0361416603279981,4.56668320308245e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PI16,Peptidase inhibitor 16,37987,-0.00966801390386213,0.0023721449421998,-0.0143174179905737,-0.00501860981715052,4.61495320715753e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH1,Protocadherin-1,40475,0.00851711489793517,0.0020916162582467,0.00441754703177164,0.0126166827640987,4.6830007590642e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOC,Myocilin,40332,-0.0179039934378262,0.00440604686594699,-0.0265398452950823,-0.00926814158057008,4.85738107810641e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.0212084675216502,0.00522093103197216,0.0109754426989848,0.0314414923443156,4.88873425060917e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMMD9,COMM domain-containing protein 9,37900,0.0153277543325444,0.00378309363796727,0.00791289080212857,0.0227426178629603,5.11444531719278e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JUN,Transcription factor AP-1,40044,0.0201707256558222,0.00498332638289094,0.010403405945356,0.0299380453662885,5.19857158190962e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL34,Interleukin-34,39934,0.0139550982204472,0.00344817694782277,0.00719667140271453,0.0207135250381798,5.21092494421715e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0159498212975211,0.003948604794175,-0.0236890866941041,-0.00821055590093805,5.38505827318212e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0138726510094525,0.00343423765809899,0.00714154519957851,0.0206037568193266,5.38596300838049e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.0139828076256879,0.00347108241554635,0.0071794860912171,0.0207861291601588,5.64777672779419e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INHBB,Inhibin beta B chain,37671,0.0199547119304421,0.00496399662265101,0.0102252785500462,0.0296841453108381,5.854878907649e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0152967340573869,0.00380646768248762,0.00783605739971118,0.0227574107150626,5.88172729702698e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGFAC,Hepatocyte growth factor activator,37849,0.0111733413771705,0.00278785581966276,0.00570914397063149,0.0166375387837095,6.16025300695965e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,37998,-0.00813910346036808,0.00204024290382544,-0.012137979551866,-0.00414022736887021,6.66222603697283e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.0122328959392338,0.00307150205677252,-0.018253039970508,-0.0062127519079597,6.85024058945874e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP9,Matrix metalloproteinase-9,40312,0.0233616620785828,0.00587504164919994,0.011846580446151,0.0348767437110147,7.02694155399366e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.0185649626724467,0.00467220908238287,0.00940743287097624,0.0277224924739171,7.11484100387177e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFD,Complement factor D,38013,0.00728257520072271,0.00183322914464328,0.00368944607722188,0.0108757043242235,7.1478103126798e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0296342821480882,0.00746004138200986,0.0150126010393488,0.0442559632568275,7.15344058419409e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF2,Trefoil factor 2,40396,0.021704484793217,0.00547517323992992,0.0109731452429543,0.0324358243434796,7.39748285841988e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0199186385419479,0.00502810320696468,-0.0297737208275987,-0.0100635562562971,7.48865467170186e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDI2,Protein DDI1 homolog 2,37671,0.0297522886625459,0.00753340656779997,0.014986811789658,0.0445177655354338,7.87602392819997e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0206197669664238,0.00524173182341355,-0.0308935613403143,-0.0103459725925332,8.40554792505349e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.012463626113909,0.00317294475216017,-0.0186825978281429,-0.00624465439967502,8.59792286553327e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPH1,Neurexophilin-1,39961,0.0141995784493278,0.00362242978254771,0.0070996160755343,0.0212995408231213,8.89647704479972e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.016518673086391,0.0042171891976924,0.00825298225891387,0.0247843639138681,9.01161811016651e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL6,Fc receptor-like protein 6,40341,0.0253774751740942,0.00648475815364417,0.0126673491929516,0.0380876011552368,9.13835971239347e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP8,Neutrophil collagenase,40442,0.0274916864899437,0.00703084704501715,0.0137112262817101,0.0412721466981773,9.26185664703211e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMI,N-myc-interactor,37857,0.026919875336511,0.00689686458436262,0.0134020207511603,0.0404377299218617,9.53917921161323e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.0269483911056757,0.00691970828296028,0.0133857628710736,0.0405110193402779,9.89084105156659e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAA4,Serum amyloid A-4 protein,38013,0.0122244628573732,0.0031440098631773,0.00606220352554567,0.0183867221892007,0.000101481938695782
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNU13,NHP2-like protein 1,37562,0.023381478791343,0.00601832823829103,0.0115855554442925,0.0351774021383934,0.000102813708452013
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTN2,Alpha-actinin-2,37562,-0.020487547622311,0.00527566404846587,-0.0308278491573041,-0.0101472460873179,0.000103508748770702
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.0146458543741598,0.00378375881844143,-0.022062021658305,-0.00722968709001459,0.000109041993935605
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FMR1,Synaptic functional regulator FMR1,39980,0.013007510247131,0.00337726944555736,0.00638806213383854,0.0196269583604234,0.000117874083948308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCB,Calcitonin gene-related peptide 2,37942,0.0147991548127984,0.00384410719409196,0.00726470471237816,0.0223336049132186,0.000118745968130255
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM1,Myomesin-1,37541,0.0173857656811954,0.00452083932620065,0.00852492060184212,0.0262466107605487,0.000120781175933256
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMG4,Proteasome assembly chaperone 4,37598,0.0208557774810164,0.00544087801387758,0.0101916565738164,0.0315198983882165,0.000127095062156073
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKAP12,A-kinase anchor protein 12,37671,-0.00803646232170862,0.00210126384425394,-0.0121549394564464,-0.00391798518697089,0.00013159441690103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,37482,-0.0160747592837597,0.00420955680372494,-0.0243254906190606,-0.00782402794845886,0.000134814256672591
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAN,Brevican core protein,40228,-0.0122761502037776,0.00321985565655358,-0.0185870672906226,-0.00596523311693263,0.000138013370151389
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHNAK2,Protein AHNAK2,37628,0.010514966187481,0.0027594796059863,0.00510638615974789,0.0159235462152142,0.000139322805216689
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.0550236268875747,0.0144466266754604,0.0267082386036723,0.083339015171477,0.00014019511915839
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",37541,0.0225300111485628,0.00594279183793679,0.0108821391462066,0.0341778831509189,0.000150624973551931
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,37714,0.0168499320491565,0.00447504207252995,0.00807884958699783,0.0256210145113153,0.000167059150595073
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.010583743928786,0.00281671561099811,0.00506298133122969,0.0161045065263423,0.000172383634235086
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,40411,-0.0153175575269872,0.00407912545467992,-0.0233126434181599,-0.00732247163581456,0.000173881859634049
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUP50,Nuclear pore complex protein Nup50,37562,-0.0128617948764991,0.00343086591635519,-0.0195862920725553,-0.00613729768044292,0.00017841199897935
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.0186671163186115,0.00498495482841954,0.00889660485490915,0.0284376277823138,0.000181369172305553
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.00949492366529633,0.00255032727429461,0.0044962822076789,0.0144935651229138,0.000197650631848133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIFR,Leukemia inhibitory factor receptor,40341,-0.00874788043960452,0.00235152728148163,-0.0133568739113085,-0.00413888696790053,0.000199841754727163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.0138650135058912,0.00374313543572279,0.00652846805187452,0.0212015589599078,0.000212998443549788
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0175729154355638,0.00475757171474599,0.00824807487466171,0.026897755996466,0.00022179688507466
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0195922265737336,0.0053119025389926,0.00918089759730812,0.0300035555501591,0.000226472138749393
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RLN2,Prorelaxin H2,37643,0.0501040546500041,0.0135886408583865,0.0234703185675665,0.0767377907324417,0.000227643633640533
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.0156113779893002,0.00424487412944452,0.00729142469558893,0.0239313312830115,0.000236262783470314
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G1B,Phospholipase A2,40514,-0.0147874289293484,0.00402598095853682,-0.0226783516080805,-0.00689650625061619,0.000240497581539794
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN1,Nectin-1,37598,0.0113001572507986,0.00308023569842358,0.0052628952818884,0.0173374192197088,0.000244844221583011
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.0136731879710241,0.00373270964681307,-0.0209892988787778,-0.00635707706327052,0.000250157343150074
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH23,Cadherin-23,37942,-0.00931989619780879,0.00254721982436116,-0.0143124470535567,-0.00432734534206093,0.0002543146844394
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00808901975514926,0.00221226991758908,0.00375297071667467,0.0124250687936238,0.000256566415373301
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00938970148998175,0.00257181078694328,-0.0144304506323906,-0.00434895234757292,0.000262224238400208
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK4,Kallikrein-4,40489,-0.0212575549263227,0.00584358263796249,-0.0327109768967292,-0.00980413295591621,0.000275881349003519
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARG1,Arginase-1,40227,0.0184692935305755,0.00507709173399983,0.00851819373193587,0.0284203933292152,0.000275885352885151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRDL2,Chordin-like protein 2,40359,0.0198450570430104,0.00546850828551176,0.00912678080340735,0.0305633332826135,0.000285444988789679
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00776825730928619,0.00214710674947294,0.00355992808031923,0.0119765865382532,0.0002977966854831
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TK1,"Thymidine kinase, cytosolic",37714,0.0155901729716665,0.00431383948987209,0.00713504757151723,0.0240452983718158,0.000302636617855961
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.0187618125536382,0.00519280258451114,0.00858391948799633,0.02893970561928,0.00030375703947003
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG1B,Lithostathine-1-beta,40536,0.0193824595964028,0.0053670132018132,0.00886311372084895,0.0299018054719567,0.000305469069452013
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.024151141778792,0.00669197577799492,0.011034869253922,0.0372674143036621,0.000308366130579037
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.00933553431881767,0.00259064354292021,0.00425787297469405,0.0144131956629413,0.000315019005041891
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARTN,Artemin,40044,0.0154268494972665,0.00428151497405563,0.00703508014811747,0.0238186188464155,0.000315388254950416
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RCC1,Regulator of chromosome condensation,37900,0.017686779350458,0.00492483336978928,0.008034105945671,0.027339452755245,0.000330147645717857
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",37562,0.0198729693547985,0.00555689396290004,0.00898145718751444,0.0307644815220826,0.000349782433464399
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,0.0133835560891539,0.00374857853037831,0.00603634216961242,0.0207307700086954,0.000357624771314011
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.0140754782882928,0.00394335859815624,-0.021804461140679,-0.00634649543590653,0.000359059741409131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF1,Trefoil factor 1,40261,0.0266509771207014,0.00747185931290728,0.0120061328674031,0.0412958213739996,0.000362370382808812
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS5,Transmembrane protease serine 5,40159,-0.0129404182408837,0.00362915246554161,-0.0200535570733453,-0.00582727940842217,0.000363983782999455
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRELP,Prolargin,40357,0.00793161726429698,0.00222907224256459,0.0035626356688704,0.0123005988597236,0.000374407296198714
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.0117645041076744,0.00330767099853288,-0.0182475392647988,-0.00528146895054993,0.00037682119283559
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DRAXIN,Draxin,40228,0.0147893378041615,0.0041611637630306,0.00663345682862151,0.0229452187797015,0.000380332652496875
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LXN,Latexin,40183,-0.02258265527029,0.00637155530691508,-0.0350709036718436,-0.0100944068687364,0.000394810104460113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.0100864932434024,0.00284746509452137,0.00450546165814048,0.0156675248286643,0.000397833110982172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX1,Peroxiredoxin-1,39953,-0.0303238384110782,0.00856840006570254,-0.0471179025398552,-0.0135297742823012,0.000402773323809137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM26,Tripartite motif-containing protein 26,37482,0.0187828131856106,0.00530878677267211,0.00837759111117321,0.0291880352600479,0.000404478824501294
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.00925674915102145,0.00262948568380696,0.00410295721075981,0.0144105410912831,0.000432379099725956
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.00868300508788547,0.0024756534346728,0.00383072435592679,0.0135352858198441,0.000453826570299956
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,L1CAM,Neural cell adhesion molecule L1,40411,-0.00950020645276659,0.00271803862795472,-0.0148275621635579,-0.00417285074197534,0.000474915052778959
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN2B,Sodium channel subunit beta-2,37572,-0.00999304522724012,0.00286217832991018,-0.0156029147538641,-0.00438317570061617,0.000482053687810946
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EXTL1,Exostosin-like 1,37562,0.0160764519045678,0.00460769526937376,0.00704536917659526,0.0251075346325404,0.000486342341150133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAFB2,Scaffold attachment factor B2,37959,0.0092653203918334,0.00266846126328524,0.00403513631579434,0.0144955044678725,0.00051790676397336
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,37714,0.0237067910409162,0.00683961052696053,0.0103011544080735,0.0371124276737588,0.000529733713363606
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00949606811717071,0.00274036504681333,0.00412495262541659,0.0148671836089248,0.000531378054689024
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0196510319661176,0.0056863486874758,0.00850578853866499,0.0307962753935701,0.000550059308187141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,37598,0.00682037612928412,0.00197442105816795,0.00295051085527493,0.0106902414032933,0.000553324498501392
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0593875571165164,0.0172633596676647,0.0255513721678936,0.0932237420651393,0.000583014050396986
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.010948603206613,0.00319275321018617,-0.0172063994985779,-0.00469080691464812,0.000606884387208315
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.0191584386830007,0.00560393048614069,0.00817473493016491,0.0301421424358364,0.000630685083723103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0126472691781746,0.00370289988130698,0.00538958541081294,0.0199049529455363,0.000638263752164747
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYB5A,Cytochrome b5,37482,0.0241789646915767,0.00708477596853873,0.0102928037932408,0.0380651255899126,0.000644933002901722
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0226894249692741,0.00665728263599488,-0.0357376989358241,-0.00964115100272413,0.000655528864770366
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0198497499999875,0.00582751039900621,0.0084278296179353,0.0312716703820397,0.000660346822149003
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD2,T-cell surface antigen CD2,37562,0.0125438007502671,0.00368804152634503,0.00531523935863084,0.0197723621419034,0.000672887184441832
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX3,Syntaxin-3,37942,0.0126660741943294,0.00372877576466858,0.00535767369557894,0.0199744746930798,0.000683643026292096
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,37959,0.0101291007700177,0.00298537278354821,0.0042777701142632,0.0159804314257722,0.000693529232662389
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENG,Endoglin,40536,-0.00552166992687711,0.00163719438801665,-0.00873057092738974,-0.00231276892636447,0.000746263054245667
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA4,Carboxypeptidase A4,37410,0.0142224939359646,0.00423526673663042,0.00592137113216894,0.0225236167397602,0.000787032444767062
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWF,von Willebrand factor,40536,-0.0230414400162678,0.00686616717496524,-0.0364991276791997,-0.00958375235333598,0.000793207277516988
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKCQ,Protein kinase C theta type,40044,0.0143040318137433,0.00426658630991084,0.00594152264631803,0.0226665409811685,0.000802552626547155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00804784735272867,0.00240471319692351,-0.0127610852186987,-0.0033346094867586,0.000820030442460924
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST1,Cystatin-SN,36179,0.0336381544251287,0.0100637843414406,0.0139131371159051,0.0533631717343524,0.000832884131488626
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDK2,Protein sidekick-2,37671,0.0122898081232069,0.00367722913685589,0.00508243901496938,0.0194971772314445,0.000833662381995853
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TERF1,Telomeric repeat-binding factor 1,37598,-0.00957314001161206,0.00286805773794099,-0.0151945331779764,-0.00395174684524772,0.000846643696583189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHAD,Chondroadherin,37671,0.0172652880173066,0.00518063423971758,0.00711124490746014,0.0274193311271531,0.000862563549334933
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDK1,Cyclin-dependent kinase 1,37482,0.0117294180141316,0.00353240215408644,0.00480590979212217,0.018652926236141,0.000900961938239477
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.0118271639817742,0.00356307890569462,0.0048435293266127,0.0188107986369356,0.000904250736423664
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.0280831669541165,0.00846934514935051,0.0114832504613895,0.0446830834468435,0.000916088907016967
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0100129992593348,0.0030216617579961,-0.0159354563050072,-0.00409054221366247,0.000923046871847534
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM171B,Protein FAM171B,37900,0.00878086742196457,0.00266975566672414,0.00354814631518525,0.0140135885287439,0.00100796838993476
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM19,Probable RNA-binding protein 19,37562,-0.0152014227060394,0.00462268401657681,-0.0242618833785299,-0.00614096203354882,0.00101009311096513
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.0142433162430901,0.00435191130112298,-0.0227730623932911,-0.00571357009288903,0.00106680002183943
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTF4,Neurotrophin-4,39980,0.0128263238356156,0.00392580208414174,0.00513175175069783,0.0205208959205335,0.00108858247710934
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPO,Erythropoietin,40341,0.024537146788071,0.00751818693575099,0.00980150039399904,0.0392727931821429,0.00110197825834736
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.0209302713825147,0.00641989284569146,0.00834728140495943,0.0335132613600699,0.00111606065468186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.0109537559135948,0.00336414293726002,0.00436003575656513,0.0175474760706244,0.00113222353919059
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,37598,0.0203037653938371,0.00623667913624389,0.00807987428679906,0.0325276565008751,0.0011346291795032
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF7,SLAM family member 7,40341,-0.0179932759720199,0.0055424818836803,-0.0288565404640332,-0.00713001148000648,0.00117104573545086
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANSC4,MANSC domain-containing protein 4,37562,0.0205759906705247,0.0063456233157234,0.00813856897170685,0.0330134123693426,0.00118762039271444
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0118943944848652,0.00367111898050033,0.00469900128308451,0.0190897876866458,0.00119778849608691
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAT1,Diamine acetyltransferase 1,37562,-0.0163397008566652,0.00504544462443636,-0.0262287723205605,-0.00645062939276996,0.00120456705868017
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKD1,Polycystin-1,37990,0.00800563655731712,0.00249143222150446,0.00312242940316838,0.0128888437114659,0.00131541587507681
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.00973393353805145,0.00302957203240615,0.00379597235453541,0.0156718947215675,0.00131685252987945
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPS,Calcyphosin,37942,0.0293312470089498,0.009145186093876,0.0114066822649528,0.0472558117529467,0.00134305416265338
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.0184785669846172,0.00578701212718177,-0.0298211107538935,-0.00713602321534097,0.00141081786502011
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.00937846045640889,0.00293714141093077,0.00362166329098459,0.0151352576218332,0.00141106724943454
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0189403813622165,0.00593385612024737,-0.0305707393579013,-0.00731002336653162,0.00141665492347887
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",37562,0.0193590310183431,0.00607001951814156,0.00746179276278568,0.0312562692739006,0.00142959942177431
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACRV1,Acrosomal protein SP-10,37598,0.0108431819805371,0.00340141877017583,0.00417640119099252,0.0175099627700818,0.00143675033522096
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.0129971714511811,0.00407833082304911,0.00500364303800482,0.0209906998643573,0.00144149567982
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA3G,Semaphorin-3G,37671,0.0132490076715051,0.00416638249746279,0.00508289797647803,0.0214151173665322,0.00147625764327221
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.0154040049997605,0.00485399432105562,0.00589017613049152,0.0249178338690296,0.00150967622485239
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,37562,0.0123796023903786,0.00393581225019732,0.00466541037999188,0.0200937944007654,0.0016624524148095
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MKI67,Proliferation marker protein Ki-67,37598,0.011435081256134,0.00364306307881763,0.00429467762165144,0.0185754848906165,0.00169979036665613
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH17,Cadherin-17,40359,-0.020372844291531,0.00650524372471711,-0.0331231219919765,-0.00762256659108545,0.00174078454068669
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYT1,Synaptotagmin-1,37942,0.0118048362920565,0.00377047571738248,0.00441470388598683,0.0191949686981262,0.0017466668356217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QL2,Complement C1q-like protein 2,37598,0.0129597977440737,0.00414364790992864,0.00483824784061356,0.0210813476475338,0.001766065340178
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.00880645022293519,0.00281959529010841,0.00328004345432271,0.0143328569915477,0.00179151015318739
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QSOX1,Sulfhydryl oxidase 1,37761,0.0134919382724333,0.0043220809664192,0.00502065957825167,0.0219632169666149,0.00180237814210651
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLIC5,Chloride intracellular channel protein 5,37572,-0.00971343657930186,0.00311342830269459,-0.0158157560525833,-0.00361111710602047,0.00181333898614607
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNN,Tenascin-N,37998,0.0130677270060827,0.00421814868590809,0.0048001555817028,0.0213352984304625,0.00195245240785555
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD5,Sushi domain-containing protein 5,37604,-0.0102038756673246,0.00330005959909164,-0.0166719924815443,-0.00373575885310502,0.00199210220856901
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSAP,Gamma-secretase-activating protein,39980,0.0265573225240592,0.00859566446981532,0.0097098201632212,0.0434048248848973,0.00200767954653438
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL11,Interleukin-11,40044,0.0189691392397212,0.00614137283093858,0.00693204849108162,0.0310062299883608,0.00201356693225588
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.0185685638805655,0.00603434210462464,-0.0303958744056298,-0.00674125335550123,0.00209421271735345
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAL,Galanin peptides,40422,-0.0183852714471548,0.00599843422387876,-0.0301422025259572,-0.00662834036835244,0.00218024561320655
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.00832612976353303,0.00272102886615687,-0.0136593463412005,-0.00299291318586556,0.00221767989798706
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD5L,CD5 antigen-like,37934,0.0136811208768977,0.00448904884045803,0.00488258514960001,0.0224796566041955,0.00231072635406824
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL5A1,Collagen alpha-1(V) chain,37671,0.0116226650363766,0.00383091332560652,0.00411407491818784,0.0191312551545654,0.00241871268736823
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.0161220346229511,0.00532544906679309,0.00568415445203664,0.0265599147938656,0.00247169685110151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN7,Septin-7,37714,0.0153015872448748,0.00506720168255847,0.00536987194706014,0.0252333025426894,0.00253480437436274
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,40305,-0.0182301280382679,0.00604336207842184,-0.0300751177119747,-0.00638513836456107,0.0025607101362975
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.0105974764131047,0.00352499179124468,0.00368849250226516,0.0175064603239443,0.00264875810147846
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTTG1,Securin,37714,0.0119834432750213,0.00399045599898032,0.00416214951701991,0.0198047370330228,0.00267807942500962
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.0140520302719076,0.00468285355507329,-0.0232304232398512,-0.00487363730396393,0.00269830162892687
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCN1,Transcobalamin-1,37766,0.0095429424666297,0.0031859513645153,0.00329847779217972,0.0157874071410797,0.00274661845315052
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,39961,0.0115532481393477,0.0038580970473313,0.00399137792657838,0.0191151183521171,0.0027528749968744
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00751493607045881,0.00251301277762032,-0.0124404411145946,-0.00258943102632299,0.0027910698133391
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,40208,0.0115758297858298,0.00387361876520543,0.0039835370060271,0.0191681225656324,0.00280896496274738
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.0188235496641376,0.00630078899611667,-0.0311730960965263,-0.00647400323174899,0.00281799081400912
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.0152894422598285,0.00512080182118287,0.00525267069031012,0.025326213829347,0.00283398746071697
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.0174015910554617,0.00583289521319841,0.00596911643759281,0.0288340656733306,0.00285632643859485
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMOD4,Tropomodulin-4,37482,-0.0120373726798507,0.00404319844933464,-0.0199620416405466,-0.00411270371915482,0.00291437934256486
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,39934,0.015326170580728,0.0051498452453316,0.00523247389987806,0.0254198672615779,0.00292443324578837
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.0132230802868165,0.00444820304513789,0.0045046023183462,0.0219415582552867,0.00295663997526217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA2,GDNF family receptor alpha-2,40305,0.00605517391306737,0.00203917039563515,0.00205839993762248,0.0100519478885122,0.0029879929582806
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00937619168490993,0.00318942941661942,0.00312491002833586,0.015627473341484,0.00329012109789879
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSB,Lupus La protein,39961,0.017039830905781,0.00580793529601005,0.00565627772560131,0.0284233840859607,0.00335235330563985
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.0100887319388563,0.00344345415750362,0.00333956179014919,0.0168379020875634,0.00339714361692226
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0183062222492501,0.00626647035688691,0.00602394034975174,0.0305885041487484,0.0034908638965394
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CENPJ,Centromere protein J,37714,0.0206696319877012,0.00707572503732194,0.00680121091455023,0.0345380530608523,0.00349269950207837
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NINJ1,Ninjurin-1,39980,0.0157889429807584,0.00541758593167199,0.00517047455468131,0.0264074114068355,0.003568963795515
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTG,Protogenin,40489,0.00704624377402211,0.00241843090824821,0.00230611919385562,0.0117863683541886,0.00357826482385183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK14,Kallikrein-14,40489,-0.0128588086098697,0.00441458167799326,-0.0215113886987365,-0.00420622852100291,0.00358694171988833
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEF,Thyrotroph embryonic factor,37562,0.0121045549945453,0.0041592922780695,0.00395234212952906,0.0202567678595615,0.00361754359533969
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,37598,-0.00904458801272823,0.00310950640161992,-0.0151392205599033,-0.00294995546555319,0.00363555097359369
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDRG1,Protein NDRG1,39961,0.0192274038308357,0.0066111051976364,0.00626963764346838,0.0321851700182031,0.00363857579084774
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAG,S-arrestin,37541,-0.0149711233520337,0.00515913375378571,-0.0250830255094537,-0.00485922119461367,0.00371563752911928
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRXN3,Neurexin-3,37572,0.00970105269191907,0.00336322443669404,0.00310913279599876,0.0162929725878394,0.00392736189064952
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3GL3,Endophilin-A3,37643,0.0230105007499321,0.00800285392082491,0.00732490706511528,0.0386960944347489,0.00404306513262401
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL15,Interleukin-15,40341,0.00905254831993464,0.00314884281847313,0.00288081639572731,0.015224280244142,0.00404716465470135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH7B,Myosin-7B,37482,-0.0126779436354255,0.00441261673536398,-0.0213266724367389,-0.00402921483411211,0.00407106186299316
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD33,Myeloid cell surface antigen CD33,40411,0.0218555481139645,0.00762427277259222,0.00691197347968374,0.0367991227482452,0.00415482887898112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACE,Angiotensin-converting enzyme,37987,-0.00705106929583042,0.00246083230498349,-0.0118743006135981,-0.00222783797806278,0.00417231043091605
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR101,Probable G-protein coupled receptor 101,37541,-0.0178100296719361,0.00623997627743604,-0.0300403831757107,-0.00557967616816146,0.00432155181903031
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMBN,Ameloblastin,40044,-0.00814222677135842,0.00285477351656217,-0.0137375828638203,-0.00254687067889657,0.00434824353435254
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0103949473040933,0.00364592413122737,-0.017540958601299,-0.0032489360068877,0.00436323048885813
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRCAM,Neuronal cell adhesion molecule,40359,0.00765108010166414,0.00268765493065118,0.00238327643758782,0.0129188837657404,0.00442246410566021
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,40272,0.006326022331519,0.00222388820288501,0.00196720145386439,0.0106848432091736,0.00445274354017207
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSC1,Hamartin,37598,0.0209334765780949,0.00736103278759917,0.00650585231440049,0.0353611008417892,0.00446445382532788
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP290,Centrosomal protein of 290 kDa,37714,0.0145923759344298,0.00514510156481168,0.00450797686739886,0.0246767750014606,0.00457274776992043
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA3,GDNF family receptor alpha-3,40194,-0.00776770432485783,0.00274299703413417,-0.0131439785117608,-0.00239143013795485,0.00463410140793972
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.018657710879272,0.0065944191370112,0.00573264937073004,0.031582772387814,0.00467163440077673
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA4,Apolipoprotein A-IV,38013,0.0100207330836068,0.0035445052056175,0.00307350288059648,0.0169679632866171,0.00470378445629712
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00686659247996424,0.00244003763867654,0.00208411870815822,0.0116490662517703,0.00489822855495242
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0241500616354365,0.0085886471751124,0.00731631317221621,0.0409838100986568,0.00493297529040989
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.00875111334890402,0.00311987904719241,-0.0148660762814011,-0.00263615041640691,0.00503864963852944
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0240297341330455,0.00860660017426206,0.0071607977914919,0.0408986704745992,0.00524577999596724
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,40332,-0.0084351223214452,0.00302361959744177,-0.0143614167324311,-0.00250882791045934,0.00528127143695469
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGN,Mimecan,40332,0.0109174982058453,0.00391453103722974,0.00324501737287497,0.0185899790388156,0.00529393844402787
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,37598,0.0289741731256482,0.0103920553543428,0.00860574463113633,0.0493426016201601,0.00530930168927107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSPN,Claspin,39925,0.00910694638242134,0.00328186805186387,0.00267448500076815,0.0155394077640745,0.00552802314916013
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.010234884692506,0.00368922364351609,-0.0174657630337976,-0.0030040063512145,0.00554048364009868
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.010726647071657,0.00386867164685603,0.00314405064381915,0.0183092434994948,0.00556726711117966
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,37671,0.0142906256504931,0.0051565628927498,0.00418376238070355,0.0243974889202827,0.00559029162160188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,40489,0.0154216723914659,0.00556628051652585,0.00451176257907523,0.0263315822038566,0.00560256869079112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.0114712760093306,0.00414399559738137,0.00334904463846308,0.0195935073801981,0.00564392718006703
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYO6,Unconventional myosin-VI,37959,0.00998137557991552,0.00361097764085715,0.0029038594038355,0.0170588917559955,0.00571441968275503
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMNB1,Lamin-B1,37874,0.0150692898196787,0.00548785152736167,0.00431310082604985,0.0258254788133076,0.00604188656438717
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR1,Cadherin-related family member 1,39961,0.0115842837863907,0.00422581057463946,0.00330169506009735,0.019866872512684,0.00612636523537933
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0163568253940669,0.00596723851502358,0.00466103790462066,0.0280526128835131,0.00613157324376121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIM,Vimentin,40042,0.031183315275951,0.0113840030943682,0.00887066921098934,0.0534959613409126,0.00616547045705843
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.0250492123256015,0.00914926900347283,0.00711664507879472,0.0429817795724082,0.00619259504972746
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD86,T-lymphocyte activation antigen CD86,37901,0.00770737437426225,0.00281633163091676,0.00218736437766541,0.0132273843708591,0.00621457374101707
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH4,Myosin-4,37562,-0.0124842113726424,0.00459642815948028,-0.0214932105652238,-0.00347521218006111,0.00661489542847992
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC12A2,Solute carrier family 12 member 2,37562,-0.0074303473435685,0.00276195006927024,-0.0128437694793382,-0.00201692520779883,0.00714880900694604
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TUBB3,Tubulin beta-3 chain,37541,-0.00721876092224251,0.00268698845146602,-0.0124852582871159,-0.00195226355736912,0.00722827098175649
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTNNA1,Catenin alpha-1,37541,-0.00939153879817381,0.00350592731316307,-0.0162631563319734,-0.00251992126437419,0.00739876116374978
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0749750779198977,0.0281173404020422,0.019865090731895,0.1300850651079,0.0076721593661035
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPTC,Opticin,40305,-0.0115282952386293,0.00432837282617372,-0.0200119059779298,-0.00304468449932878,0.00774278862126827
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.00822958959852462,0.00310011860278147,-0.0143058220599763,-0.00215335713707295,0.00794972035667085
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCP2,Non-specific lipid-transfer protein,39980,0.0198987256977088,0.00750433584767263,0.00519022743627044,0.0346072239591471,0.00801855044084766
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA3,Carbonic anhydrase 3,40500,0.0155259790464768,0.0058636440799034,0.00403323664986612,0.0270187214430875,0.0081087553208888
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00758067122485725,0.00286668980572117,0.00196195920564376,0.0131993832440707,0.00819160404187753
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MELTF,Melanotransferrin,37990,0.00741922168136542,0.00281311405197363,0.00190551813949709,0.0129329252232337,0.00836471946287115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAV,Integrin alpha-V,40489,-0.00413224551328226,0.00157280249666784,-0.00721493840675123,-0.00104955261981328,0.0086143846292042
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHB4,Ephrin type-B receptor 4,40536,-0.00615200104777988,0.00236556084919839,-0.0107885003122087,-0.00151550178335103,0.00931318556862994
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK1,Kallikrein-1,40209,-0.0318255446060908,0.012259476032074,-0.0558541176289557,-0.00779697158322576,0.00944048176627703
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA4,Ephrin type-A receptor 4,37671,0.00703227516010235,0.00271666867203868,0.00170760456290654,0.0123569457572982,0.00964820988898564
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD3,Bromodomain-containing protein 3,37562,0.012073963842505,0.0046748757745457,0.00291120732439544,0.0212367203606146,0.00981280167092729
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBLN2,Fibulin-2,37998,-0.00765492886642874,0.00297269174148297,-0.0134814046797354,-0.00182845305312212,0.0100321051930727
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL14,C-X-C motif chemokine 14,40044,0.0152162147463738,0.00590912776397809,0.00363432432897671,0.0267981051637708,0.0100321067527629
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRR4,Proline-rich protein 4,37577,-0.0171044313268368,0.00664589113117323,-0.0301303779439364,-0.00407848470973731,0.010073049883597
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,-0.00659022464691106,0.00256960424240808,-0.0116266489620309,-0.00155380033179123,0.0103376674649334
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.0136155048359263,0.00532139356911354,-0.0240454362313889,-0.00318557344046381,0.0105195445962085
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLI2,Zinc finger protein GLI2,37598,-0.00829846446901807,0.00325051954802527,-0.0146694827831476,-0.00192744615488854,0.0106922004364542
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.0126225945331225,0.00494699409847758,0.00292648610010645,0.0223187029661386,0.0107334195997289
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL33,Interleukin-33,40044,0.00949181796971694,0.00372020057176827,0.00220022484905112,0.0167834110903828,0.0107377578002852
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0101287697408367,0.00397625082133264,-0.0179222213506487,-0.00233531813102477,0.0108668092295263
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP6,Guanylate-binding protein 6,37562,-0.0116791335132811,0.00458605248521859,-0.0206677963843095,-0.00269047064225266,0.0108871485288242
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.0161082063161105,0.00636093871534315,-0.0285756461981831,-0.00364076643403796,0.0113412223784669
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17RA,Interleukin-17 receptor A,40332,0.0106757523987041,0.00421774646493964,0.00240896932742241,0.0189425354699858,0.0113784638618748
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00617068517238859,0.00246059384656747,0.00134792123311636,0.0109934491116608,0.012158358580978
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.0119903994989104,0.00478290409688135,0.00261590746902295,0.0213648915287979,0.0121886720144416
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEG1,Protein LEG1 homolog,37231,-0.0168346018979632,0.00671948844685812,-0.0300047992538051,-0.00366440454212127,0.0122457193957505
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH22,Cadherin-22,37714,-0.00712912560930771,0.00284670099754289,-0.0127086595644918,-0.00154959165412365,0.0122796900518786
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNL1,Thioredoxin-like protein 1,37525,0.0230745609043467,0.00921403607451349,0.00501505019830025,0.0411340716103931,0.0122820382727616
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUK1,Guanylate kinase,37562,-0.00968945055504761,0.00387938641028663,-0.0172930479192094,-0.00208585319088581,0.012513195928692
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.0138527341594266,0.00555604341108059,-0.0247425792451445,-0.00296288907370861,0.0126672660817242
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RALB,Ras-related protein Ral-B,37598,0.00712637160642614,0.00285854517749042,0.00152362305854492,0.0127291201543074,0.0126788591461004
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKKL1,Dickkopf-like protein 1,40305,-0.0210404707320419,0.00844712103147535,-0.0375968279537335,-0.00448411351035017,0.0127541150457385
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17A,Interleukin-17A,40028,0.0102121072529635,0.00410328009764871,0.00216967826157206,0.018254536244355,0.0128290638084216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.0088396604826906,0.00356466909476599,0.00185290905694927,0.0158264119084319,0.013158102352007
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00643413712246107,0.00260497802211917,0.0013283801991075,0.0115398940458146,0.0135242303577352
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFHD1,EF-hand domain-containing protein D1,37959,0.00825704858379544,0.0033451757630528,0.00170050408821195,0.0148135930793789,0.0135862254857828
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP164,Centrosomal protein of 164 kDa,40044,0.0151532336078708,0.00615221688834166,0.00309488850672118,0.0272115787090205,0.0137866960793531
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFAP,Glial fibrillary acidic protein,39959,0.0110584916107695,0.00450504212155233,0.00222860905252693,0.0198883741690121,0.0141114336940449
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNGR1,Interferon gamma receptor 1,40422,0.00481359592727477,0.00196812253782654,0.000956075753134745,0.00867111610141479,0.0144646097496016
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,37628,0.0136430567862262,0.00559249360823264,0.0026817693140902,0.0246043442583621,0.0147194740227275
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRC,Chymotrypsin-C,40360,0.0146789116923956,0.00602707399233249,0.00286584666742395,0.0264919767173673,0.0148823158634263
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,37714,0.012742338760959,0.00524480362383623,0.00246252365823995,0.023022153863678,0.0151321492419997
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX1B,Syntaxin-1B,37572,0.0100660629229005,0.00414684523031222,0.00193824627148853,0.0181938795743124,0.0152207360683735
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.0161359679541022,0.00665989448327015,0.00308257476689274,0.0291893611413117,0.0154120736626564
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNW1,Interferon omega-1,37562,-0.00859353299674277,0.00355552702459032,-0.0155623659649398,-0.00162470002854573,0.0156647036681417
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CADPS,Calcium-dependent secretion activator 1,37572,-0.0104993079241736,0.00434811581559267,-0.0190216149227353,-0.00197700092561201,0.0157626328920851
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAD1,Glutamate decarboxylase 1,37482,-0.00602269033889754,0.00249700152679113,-0.0109168133314081,-0.00112856734638693,0.0158803612834154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TJP3,Tight junction protein ZO-3,37541,-0.0102396242469174,0.00424724456595035,-0.0185642235961801,-0.00191502489765468,0.0159274924536022
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00987659257827471,0.00411170409679126,-0.0179355326079856,-0.00181765254856383,0.0163165250676174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00886758786334431,0.00369632762255807,-0.0161123900035581,-0.00162278572313048,0.0164526017726143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.00796387402472772,0.0033253269052777,0.00144623329038343,0.014481514759072,0.0166356654724324
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOP56,Nucleolar protein 56,37562,0.025503030090465,0.0106885238219194,0.00455352339950296,0.0464525367814271,0.0170459372415731
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,-0.00655226872035,0.00275700151921882,-0.0119559916980189,-0.00114854574268112,0.0174876824018515
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.0058646325667959,0.00246923870018459,0.00102492471443411,0.0107043404191577,0.0175591300476808
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.00793448892491782,0.00334492128339349,0.00137844320946659,0.0144905346403691,0.0176989846492756
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,-0.0101679918735879,0.00430681914187926,-0.0186093573916712,-0.00172662635550453,0.0182423411226814
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.00788204333557129,0.00334948663267208,0.001317049535534,0.0144470371356086,0.0186243126632591
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGF,Beta-nerve growth factor,40228,0.00274869997155756,0.001171969239667,0.000451640261810237,0.00504575968130487,0.0190205928234533
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,37714,-0.0103101839559127,0.00439721792656625,-0.0189287310919825,-0.00169163681984283,0.0190567480144287
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC4A1,Band 3 anion transport protein,37998,-0.0104225934850851,0.00445296188568801,-0.0191503987810336,-0.00169478818913661,0.0192673181613992
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.0099759399511472,0.00426374483327138,-0.0183328798243591,-0.0016190000779353,0.0193134813599607
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA10,Annexin A10,39961,0.0185553520255683,0.00793584682902026,0.00300109224068861,0.034109611810448,0.0193911172446421
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,-0.00455912554727839,0.00195090328318687,-0.00838289598232466,-0.000735355112232119,0.019457769909078
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPP1,Osteopontin,40497,-0.0106635435378988,0.004574666781353,-0.0196298904293507,-0.00169719664644692,0.0197657365769788
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.010715876614878,0.0046141833424145,0.0016720772637456,0.0197596759660105,0.020227457143071
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPON1,Spondin-1,40379,0.00733621136614535,0.0031613889252728,0.00113988907261066,0.01353253365968,0.0203228499970852
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CORO6,Coronin-6,37541,-0.00816922628435862,0.00352132571557776,-0.015071024686891,-0.0012674278818262,0.0203600110539903
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.0205152430703367,0.00884773019264889,0.00317369189274484,0.0378567942479285,0.0204263649084458
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00675095571741902,0.00291570836221571,-0.0124657441073618,-0.00103616732747623,0.0206079189431518
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBQ1,Hemoglobin subunit theta-1,40489,-0.0131185182189578,0.00567759596303192,-0.0242466063065003,-0.0019904301314152,0.0208688988059379
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCN2,Transcobalamin-2,40497,0.00661992309261366,0.00286838799523099,0.000997882621960916,0.0122419635632664,0.0210179298616256
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,37901,-0.0112190614280932,0.00487568050259569,-0.0207753952131808,-0.00166272764300569,0.0214054526412142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.0108727096004516,0.00473171914250756,-0.0201468791197664,-0.00159854008113675,0.0215868426926832
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNG,Uracil-DNA glycosylase,37900,0.00750513444246871,0.00326833780690497,0.00109919234093497,0.0139110765440024,0.0216731561440855
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,0.00605852960193391,0.00263871796008746,0.000886642400162477,0.0112304168037053,0.0216881606822403
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.00640332034996701,0.00280225711756304,0.000910896399543453,0.0118957443003906,0.0223252729767887
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.00887143880653821,0.00389211076415841,0.00124290170878774,0.0164999759042887,0.0226628024177702
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.0114797287095857,0.00503895346293411,-0.0213560774969366,-0.00160337992223488,0.0227308472651059
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.0064743871084774,0.00284662823867397,0.00089499576067641,0.0120537784562784,0.0229576849204888
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.00906906631500506,0.00398907069059657,-0.0168876448685743,-0.00125048776143578,0.0230134885877121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.00905098194475419,0.0039893102107804,0.00123193393162461,0.0168700299578838,0.0232931484255562
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,40359,0.0038049234671154,0.00167887056198164,0.000514337165631378,0.00709550976859942,0.0234427822344002
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFR,Epidermal growth factor receptor,40536,0.00356125922329576,0.00157195539511577,0.000480226648868854,0.00664229179772267,0.0234954750994584
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,37900,0.00843836955651165,0.003725037247354,0.00113729655169782,0.0157394425613255,0.0235094095349066
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN8,Tetraspanin-8,37901,0.022599178092285,0.0100110623889633,0.00297749580991687,0.0422208603746531,0.0239977783668375
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.0108754668788838,0.00484703494662604,-0.0203756553742709,-0.0013752783834968,0.0248660416335277
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP4,Bone morphogenetic protein 4,40203,-0.00979097784012222,0.00436413648059746,-0.0183446853420933,-0.0012372703381512,0.0248778736040572
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00723963798942791,0.00323845212754805,-0.0135870041594221,-0.000892271819433734,0.0253997242704108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDS,Iduronate 2-sulfatase,40516,0.00185162888167803,0.000830645147095144,0.000223564393371552,0.00347969336998452,0.0258180008137223
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAMDC2,MAM domain-containing protein 2,37990,-0.00728515012795102,0.00327268801582277,-0.0136996186389636,-0.000870681616938391,0.0260275783709372
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLMP,CXADR-like membrane protein,40489,0.00435976153311746,0.00195931867397968,0.000519496932117297,0.00820002613411763,0.0260855872231795
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,37598,0.0260554880017367,0.0117117531155218,0.003100451895314,0.0490105241081593,0.0261162811688212
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD55,Complement decay-accelerating factor,39802,0.00560772656899475,0.00252616683149159,0.00065643957927124,0.0105590135587183,0.0264430984658982
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.00600522013109141,0.00271299567189898,0.000687748614169417,0.0113226916480134,0.0268772211944685
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AREG,Amphiregulin,40305,0.0105208350564119,0.00475467050647337,0.00120168086372414,0.0198399892490997,0.0269299811912396
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B4,Protein ATP1B4,37482,-0.00901485636023418,0.00408383972636807,-0.0170191822239156,-0.00101053049655275,0.0273002654462965
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADA2,Adenosine deaminase 2,40258,0.00888359948339216,0.00402577133003319,0.000993087676527105,0.0167741112902572,0.0273505659059315
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGS8,Regulator of G-protein signaling 8,40044,0.0141099092900127,0.00639469360878677,0.00157630981679065,0.0266435087632348,0.0273633374307088
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPN1,Epsin-1,37714,0.0093914303693856,0.004270481408104,0.00102128680950177,0.0177615739292694,0.0278844380432338
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,0.00974676323737945,0.00443220962527498,0.00105963237184049,0.0184338941029184,0.0278868002134845
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0152749519816568,0.0069511344371231,-0.0288991754784181,-0.00165072848489553,0.0280038873413265
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.0144377080024532,0.00659270893687841,0.00151599848617155,0.0273594175187349,0.0285453164719784
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSLNL,Mesothelin-like protein,37572,-0.00791920857786381,0.00362994271466864,-0.0150338962986143,-0.000804520857113282,0.0291541980714684
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS53,Serine protease 53,37942,0.00771429360891776,0.00353882209267966,0.00077820230726562,0.0146503849105699,0.0292817833807285
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUMF1,Formylglycine-generating enzyme,37598,0.014063627529503,0.00647936632267464,0.00136406953706075,0.0267631855219453,0.0299849256110835
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTX1,Neuronal pentraxin-1,40332,0.00821462320130924,0.00379261012495891,0.000781107356389778,0.0156481390462287,0.0303294511677717
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.0108894499682423,0.0050281728308893,0.00103423121969926,0.0207446687167853,0.0303530621055782
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100G,Protein S100-G,37959,-0.00925863075694245,0.00428821475180044,-0.0176635316704713,-0.000853729843413595,0.0308609321015204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNL1,Interferon lambda-1,39961,0.00938237997874026,0.00435797222949305,0.000840754408933874,0.0179240055485466,0.0313400794165528
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX2,Peroxiredoxin-2,37763,0.0129848016095412,0.00604389566962069,0.00113876609708467,0.0248308371219978,0.0316987161032983
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAN,Neurocan core protein,40471,-0.00767204500255791,0.00358100360431219,-0.0146908120670098,-0.00065327793810601,0.0321740253713514
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,37628,0.00805858625070633,0.00377095658309792,0.000667511347834402,0.0154496611535782,0.0326152290533917
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUCA2A,Guanylin,40276,-0.00688039599911829,0.00321970846508714,-0.0131910245906891,-0.000569767407547506,0.0326163360903741
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,39957,0.00579709826492373,0.00271550017517836,0.00047471792157414,0.0111194786082733,0.0327915236699149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.0115769264710072,0.00542465830874113,0.00094459618587461,0.0222092567561398,0.0328504221846685
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.0118264744765176,0.00555912657605493,-0.0227223625655853,-0.000930586387449932,0.0334057581573902
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLL1,Delta-like protein 1,40411,0.00595710702477077,0.00281251842643922,0.000444570908949902,0.0114696431405916,0.0341846714402501
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERVV_1,,37562,-0.00988291837203658,0.00467043777779831,-0.0190369764165213,-0.000728860327551895,0.0343586519496386
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA11,Carbonic anhydrase-related protein 11,39980,0.00672540624727082,0.00318368252423082,0.000485388499778419,0.0129654239947632,0.0346628188272474
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.0101068838106872,0.00479163835734944,-0.0194984949910921,-0.000715272630282308,0.0349364243135779
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00661509871783255,0.00315939536192866,0.000422683808452376,0.0128075136272127,0.0362980843645581
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSMB,Beta-microseminoprotein,40236,0.013921859950941,0.00665333774047158,0.000881317979616731,0.0269624019222653,0.0364130905960483
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLNS1A,Methylosome subunit pICln,37572,0.00678534086419703,0.00324377222411079,0.000427547304939886,0.0131431344234542,0.0364750864744216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00515161829723727,0.00246696755712066,-0.00998687470919376,-0.000316361885280779,0.0367956311533917
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.0115046803293289,0.00551604572542962,0.000693230707486822,0.0223161299511709,0.0370242633828396
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00979559266336911,0.00473488436407624,-0.0190759660169585,-0.000515219309779692,0.0385831470395339
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.0238231718875904,0.0115531762242657,0.00117894648802963,0.0464673972871511,0.0392199615259234
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCLRE1C,Protein artemis,37482,-0.0063175570532847,0.00306735983694214,-0.0123295823336913,-0.000305531772878102,0.039455907056366
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL25,Interleukin-25,37429,0.00694603337862574,0.00337251319194782,0.000335907522408022,0.0135561592348435,0.0394565494279161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.0166167481945481,0.00807250405330886,0.000794640250062782,0.0324388561390335,0.0395678199476815
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELENOP,Selenoprotein P,38013,-0.00445600338715172,0.00217667947191025,-0.00872229515209581,-0.000189711622207641,0.0406619567572268
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP152,Centrosomal protein of 152 kDa,37482,0.00820884654235754,0.00401121045030501,0.000346874059759717,0.0160708190249554,0.0407295696137795
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POF1B,Protein POF1B,37598,0.00916139097472355,0.0044784265307088,0.000383674974534291,0.0179391069749128,0.0408085286746768
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAPPA,Pappalysin-1,40044,0.00922305733560707,0.00452269615982093,0.000358572862358056,0.0180875418088561,0.0414386179542402
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP7,Retinoid-binding protein 7,37901,0.0114518488683493,0.00562914956997993,0.000418715711188677,0.02248498202551,0.0419325253334459
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRTN,Neurturin,40044,0.00966400433110305,0.00476163023317482,0.000331209074080399,0.0189967995881257,0.0424184450677217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOM,Apolipoprotein M,40372,0.00521067752692764,0.00256759596001496,0.000178189445298317,0.010243165608557,0.0424342345327459
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.00601616126502503,0.00297658224316226,-0.0118502624616231,-0.000182060068427005,0.043279901608391
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF5,Fibroblast growth factor 5,40044,-0.00623376902038109,0.00310167267209402,-0.0123130474576854,-0.000154490583076809,0.0444686239488081
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCC,Netrin receptor DCC,37572,0.0045187053241064,0.00225432287550522,0.000100232488116173,0.00893717816009664,0.0450410684482621
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.00724754247030549,0.00361710527643213,0.00015801612849852,0.0143370688121125,0.0451236890328398
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0133922535656786,0.00674026294720122,0.000181338189164246,0.026603168942193,0.0469500035622712
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,37900,0.0110013810158912,0.00554783384062273,0.000127626688270668,0.0218751353435118,0.0473872062861946
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA1,Alpha-1-antitrypsin,37779,-0.00154989688346165,0.000782639194290278,-0.00308386970427059,-1.59240626527021e-05,0.0476851251678373
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB116,Beta-defensin 116,37541,-0.0151311854528211,0.00764580753007028,-0.0301169682117589,-0.000145402693883381,0.047834980886309
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MN1,Transcriptional activator MN1,37572,-0.0113801983847124,0.00576052159727161,-0.0226708207153647,-8.95760540599918e-05,0.0482266898107672
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00945207984483021,0.00478608535611197,7.13525468507351e-05,0.0188328071428097,0.0482994989653138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.0172451134323954,0.00875128755570269,9.25898232180949e-05,0.0343976370415726,0.0487930564528511
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RSPO1,R-spondin-1,40228,0.0066876419964502,0.00340281774696103,1.8119212406585e-05,0.0133571647804938,0.0493941776591556
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZPR1,Zinc finger protein ZPR1,37541,0.0184225850702075,0.00939520077404137,7.99155308640193e-06,0.0368371785873286,0.049917627407707
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXDC2,Plexin domain-containing protein 2,37942,-0.005036371016264,0.002575211186248,-0.0100837849413101,1.10429087820819e-05,0.0505197206964736
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WNT9A,Protein Wnt-9a,40044,0.00539149477937679,0.00275750163487103,-1.32084249704302e-05,0.010796197983724,0.0505761271816004
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.00818327367314536,0.00419100625260876,-3.10985819678179e-05,0.0163976459282585,0.0508901358409003
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASA1,Ras GTPase-activating protein 1,39961,0.00609492658417215,0.0031326070332603,-4.49832010180401e-05,0.0122348363693623,0.0517160007773877
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,40359,0.0059262415167173,0.0030475086752046,-4.6875486683709e-05,0.0118993585201183,0.0518385218247979
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTO1,Protein LTO1 homolog,40044,0.00763935868376692,0.00395932775722568,-0.000120923720395421,0.0153996410879293,0.0536920873246442
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.00935449340337953,0.00484952451831982,-0.000150574652527314,0.0188595614592864,0.0537549076022171
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,40405,0.00943013556995044,0.00490185996827393,-0.000177509967866453,0.0190377811077673,0.0543990317912368
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NLGN2,Neuroligin-2,37541,-0.00896182950817696,0.00466840935518081,-0.0181119118443313,0.00018825282797743,0.0549206556071402
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0106123887574597,0.00552989823615966,-0.000226211785413207,0.0214509893003327,0.054994290698114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00600395698217017,0.00314337991445036,-0.0121649816144929,0.000157067650152535,0.0561509938904478
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.00615067929847498,0.00322755380391807,-0.0124766847541544,0.000175326157204441,0.0567101415160069
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTN3,Myeloblastin,39897,0.00860092937352403,0.00452264900514091,-0.000263462676552161,0.0174653214236002,0.0572229651995315
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLC,Galectin-10,40333,-0.0120093726397877,0.00632010982943374,-0.0243967879054778,0.000378042625902476,0.0574270484801099
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.0162482454956601,0.0085682310622544,-0.00054548738635847,0.0330419783776788,0.0579375853265818
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.00497950259573113,0.00263652171327727,-0.000188079962292323,0.0101470851537546,0.0589548953315573
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY6D,Lymphocyte antigen 6D,40268,0.00677806059329334,0.00359200504395295,-0.00026226929285445,0.0138183904794411,0.059180604947465
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBX2,Chromobox protein homolog 2,37562,-0.00741123011618838,0.00397339735840744,-0.015199088938667,0.000376628706290193,0.0621739569924565
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTN4,Alpha-actinin-4,40044,0.00581632528037345,0.0031251029012436,-0.000308876406064015,0.0119415269668109,0.0627399955421635
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSLP,Thymic stromal lymphopoietin,40042,0.0108580150615832,0.00585932894804112,-0.000626269676577411,0.0223422997997438,0.0638846444417707
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF75D,Zinc finger protein 75D,37714,0.0106053602725709,0.00574525885043661,-0.000655347074284886,0.0218660676194266,0.0649242729272832
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00471025135534799,0.00255860318744503,-0.000304610892044264,0.00972511360274024,0.0656521331131278
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTN,Titin,37562,-0.0116549677809075,0.00634165518598421,-0.0240846119454365,0.000774676383621576,0.066108129947825
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP1,Methionine aminopeptidase 1,39961,0.00540870402173468,0.00295397011903672,-0.000381077411577291,0.0111984854550467,0.0671204894424093
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHIT1,Chitotriosidase-1,40398,0.026172528473051,0.0143402000686144,-0.00193426366143313,0.0542793206075352,0.0680022250762599
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOH,Beta-2-glycoprotein 1,40332,0.00620233036752411,0.00341094450432526,-0.000483120860953393,0.0128877815960016,0.0690277195172317
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM25,Transmembrane protein 25,37959,-0.00764538674540251,0.00422445459797106,-0.0159253177574258,0.000634544266620769,0.0703501705044546
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0198624100903526,0.0109821196232448,-0.00166254437120708,0.0413873645519124,0.0705332937801576
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTF3,Neurotrophin-3,40341,0.00606907012923564,0.00335720216622102,-0.000511046116557556,0.0126491863750288,0.0706602436710188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,37541,0.018896646729315,0.010455301587846,-0.00159574438286321,0.0393890378414933,0.0707268380237372
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KEL,Kell blood group glycoprotein,39961,0.00618188623939072,0.00342398887198784,-0.000529131949705455,0.0128929044284869,0.071021597364019
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,37714,0.0135291072288838,0.00750395567267838,-0.00117864588956579,0.0282368603473334,0.0714218906426033
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.0127375897715919,0.00706631808846513,-0.00111239368179974,0.0265875732249836,0.0714767405494717
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,40422,0.00489048044306504,0.00271484680495333,-0.000430619294643489,0.0102115801807736,0.0716612979292744
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY96,Lymphocyte antigen 96,40228,0.00600212563613607,0.00333464863844054,-0.000533785695207381,0.0125380369674795,0.0718911915273534
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COPE,Coatomer subunit epsilon,39961,0.00835232896218591,0.00464786737382353,-0.000757491090508216,0.01746214901488,0.0723512671110572
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1B,Protein phosphatase 1B,37598,0.0109954484696935,0.00612498392229953,-0.00100952001801358,0.0230004169574006,0.0726479912609929
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BEX3,Protein BEX3,37482,-0.00827027366055524,0.00461406909233735,-0.0173138490815364,0.000773301760425969,0.0730915423302611
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,37541,0.0206399770245588,0.0115480292478552,-0.0019941603012375,0.043274114350355,0.073909565594163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00507439236252778,0.00283943235644298,-0.010639679781156,0.000490895056100454,0.0739419235476544
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMA1,Laminin subunit alpha-1,37562,-0.00967246879389403,0.00542365514624842,-0.0203028328805409,0.000957895292752874,0.0745466735438193
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF20B,Kinesin-like protein KIF20B,37541,0.0134631376438372,0.0075512476088678,-0.00133730766954365,0.0282635829572181,0.0746253572145803
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN4,Prefoldin subunit 4,37482,0.00929821929818133,0.00524995051407204,-0.000991683709399871,0.0195881223057625,0.0765664344945482
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.0050191440404311,0.0028396291455388,-0.0105848171656872,0.000546529084824951,0.0771612393200549
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,37942,0.0120715145545641,0.00686755460405581,-0.00138889246938525,0.0255319215785135,0.078810987685512
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RYR1,Ryanodine receptor 1,37562,-0.00580370334326725,0.00333879952112147,-0.0123477504046653,0.000740343718130823,0.0821884002794969
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRING1,SREBP regulating gene protein,37482,0.00965806137587913,0.00556363691688274,-0.00124666698121105,0.0205627897329693,0.08260057773375
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOX9,Transcription factor SOX-9,37572,0.0045390394217386,0.00262003469300296,-0.000596228576547205,0.0096743074200244,0.0832196672351366
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARB1,Scavenger receptor class B member 1,39961,0.00986140483094642,0.00570116804122568,-0.00131288452985592,0.0210356941917488,0.0837008226856834
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOE,Apolipoprotein E,38013,0.0124788663524603,0.00721972023193293,-0.00167178530212823,0.0266295180070489,0.0839318061587581
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTP1,Glutathione S-transferase P,39871,-0.0115809209854363,0.00671369429547295,-0.0247397618045632,0.00157791983369071,0.0845529250409531
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL4,Early placenta insulin-like peptide,37900,-0.0089520943237549,0.00522140375719215,-0.0191860456878515,0.00128185704034171,0.0864600627081574
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH12,Protocadherin-12,37959,0.00423100113178851,0.00246894023757558,-0.000608121733859635,0.00907012399743665,0.0866084007599974
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCL2,Phosducin-like protein 2,37482,0.00891580241007675,0.00520961197860745,-0.00129503706799387,0.0191266418881474,0.0870285297789327
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.00931291546931551,0.00544289558398905,-0.00135515987530303,0.019980990813934,0.0870999943431495
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,0.0195784486923584,0.0114542668943832,-0.00287191442063267,0.0420288118053494,0.0874202609042804
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOX2,Transcription factor SOX-2,37937,0.00381614058844993,0.00224938449555607,-0.000592653022839974,0.00822493419973983,0.0898092800059182
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACAN,Aggrecan core protein,40224,0.00462034506666957,0.00272591921324321,-0.000722456591287121,0.00996314672462626,0.0901012849489636
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00527635126849735,0.00312415251755391,-0.011399690202903,0.000846987665908316,0.0912600633072286
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.0101639268707654,0.00604991247553113,-0.0220217553228064,0.00169390158127562,0.0929787643276832
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00610465784987855,0.00363915427705702,-0.00102808453315321,0.0132374002329103,0.0934695730570897
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00631832222049319,0.00377286669396942,-0.00107649649968687,0.0137131409406732,0.094022038535576
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,40411,0.00437089255856991,0.00261078905813503,-0.000746253995374739,0.00948803911251456,0.0941177039348766
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00811527743567358,0.00485061722707116,-0.00139193232938591,0.0176224872007331,0.0943443709556694
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10,Interleukin-10,40044,0.0137877107877635,0.00827358708745551,-0.00242851990364933,0.0300039414791763,0.0956392963076465
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEPD,Xaa-Pro dipeptidase,37987,0.0041317573665695,0.00248666282528479,-0.000742101770988693,0.0090056165041277,0.0966227450644095
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNLZ,DNL-type zinc finger protein,37541,-0.0152498088078258,0.00919547940252775,-0.0332729484367801,0.00277333082112863,0.0972601525100414
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BSND,Barttin,37482,-0.00545240464390836,0.0033127277898895,-0.0119453511120918,0.00104054182427506,0.0998093388505665
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.00992180112019135,0.00608100015176112,-0.00199695917726045,0.0218405614176432,0.102786366140069
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEO1,Neogenin,37959,0.00334335032094314,0.00205642558018721,-0.000687243816223789,0.00737394445811007,0.104014129012063
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00461168211040834,0.00284159365072827,-0.00095784144501907,0.0101812056658357,0.104630264072061
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM3,Intercellular adhesion molecule 3,40536,-0.00392838607478654,0.00242483264112782,-0.00868105805139707,0.000824285901823995,0.10523795610357
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.0101111838328197,0.00626755254495833,-0.00217321915529867,0.022395586820938,0.106711772992813
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C9orf40,Uncharacterized protein C9orf40,37901,0.0128016493995007,0.00794100503314329,-0.00276272046546014,0.0283660192644616,0.106964872897314
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00866260876540293,0.00537960377779517,-0.0018814146390756,0.0192066321698815,0.107359512347877
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMP,Cartilage oligomeric matrix protein,40198,0.00522921313533403,0.0032503722862471,-0.00114151654571028,0.0115999428163784,0.10767917276756
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REST,RE1-silencing transcription factor,37482,-0.00554235538028123,0.00346328373982498,-0.0123303915103382,0.00124568074977573,0.109552294473708
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,40380,0.00730753951809865,0.00456763314657555,-0.00164502144918943,0.0162601004853867,0.10965113194542
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.0109424276570461,0.00685909177562913,-0.0243862475372792,0.00250139222318703,0.110665445509211
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00361539817098401,0.00227887865369067,-0.00808200033221772,0.000851203990249709,0.112653598926976
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA5,Annexin A5,39896,0.00463289213361755,0.00294032819591806,-0.00113015113038184,0.0103959353976169,0.115129791159928
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.0121246179425624,0.00770579216858375,-0.00297873470786172,0.0272279705929866,0.115636773471992
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP13,Collagenase 3,39961,-0.00498246416326728,0.00316976225174686,-0.0111951981766911,0.00123026985015658,0.116000372678823
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00832688115335537,0.00530166406005117,-0.00206438040434493,0.0187181427110557,0.116295922067158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRP15,RRP15-like protein,37541,-0.0137903331021681,0.00881149406709379,-0.0310608614736719,0.00348019526933577,0.11759790679509
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.0258813413065507,0.0167197214448947,-0.0586519953385443,0.00688931272544292,0.121657166136133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.014252381603657,0.00921702820620285,-0.0323177568878146,0.00381299368050055,0.122054037189258
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.00779571672439679,0.00504369928685059,-0.0176813673266239,0.00208993387783036,0.122216948757496
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.00470087807034063,0.00305857473100442,-0.0106956845431093,0.00129392840242804,0.124329594408451
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.0121692033364452,0.00793094735364007,-0.00337545347668935,0.0277138601495797,0.124956867536757
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL36G,Interleukin-36 gamma,37551,0.0101803557198467,0.00666021535606218,-0.0028736663780352,0.0232343778177285,0.126404523267486
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.00994691952295805,0.00650994541432734,-0.00281257348912353,0.0227064125350396,0.12654349890906
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.0093265197720653,0.00610869160224481,-0.00264651576833452,0.0212995553124651,0.126840426654494
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCUN1D1,DCN1-like protein 1,37541,-0.0110310704989422,0.00722785060197655,-0.0251976576788162,0.00313551668093187,0.12698681194367
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,37978,0.00355738448574462,0.00234018437802416,-0.00102937689518273,0.00814414586667197,0.128501679389718
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,0.00676741844847728,0.00446182363358474,-0.00197775587334881,0.0155125927703034,0.129353171253605
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM2,Intercellular adhesion molecule 2,40536,0.00453353683827315,0.00299392426607149,-0.00133455472322697,0.0104016283997733,0.129983193650143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00688563271523688,0.0045631418262861,-0.00205812526428387,0.0158293906947576,0.131330429841332
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL24,Interleukin-24,40044,0.00711487297038198,0.00474547895610407,-0.002186265783582,0.016416011724346,0.133817359482491
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,40296,0.00691003463130766,0.0046098512450818,-0.00212527380905266,0.015945343071668,0.133901005681103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JCHAIN,Immunoglobulin J chain,40044,-0.00889547307197604,0.00594016378631097,-0.0205381940931455,0.00274724794919345,0.134280042764549
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.00833285746177,0.0055686004203744,-0.0192473142857038,0.00258159936216383,0.134573383185455
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,-0.00452864626384275,0.00302864515186178,-0.0104647907614918,0.00140749823380635,0.134863481809134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN1,Calsyntenin-1,39961,0.00755679854984483,0.00505449794904623,-0.00235001743028579,0.0174636145299754,0.134918053833646
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB118,Beta-defensin 118,37541,0.00840283000036241,0.00563240276829793,-0.00263667942550154,0.0194423394262264,0.135756524237104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RELB,Transcription factor RelB,37598,0.00742545346122182,0.00497950138330916,-0.00233436925006415,0.0171852761725078,0.135931880836825
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.0106196393210273,0.00712312464684913,-0.0245809636288516,0.00334168498679697,0.136019910818906
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00551697827438661,0.00370329879044076,-0.00174148735487727,0.0127754439036505,0.136314826839741
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.0075414907902358,0.00510014456888741,-0.0175377741452551,0.00245479256478352,0.139249412410504
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00650869673076083,0.00441332710491078,-0.0021414243948643,0.015158817856386,0.140295092462968
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00515939335981789,0.00350477767332586,-0.0017099708799008,0.0120287575995366,0.141017032521229
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00516914131723229,0.00351708406421173,-0.0120626260830873,0.00172434344862271,0.141660782541648
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSTN,Osteocrin,37572,-0.00608400337205526,0.0041552901965044,-0.0142283721572039,0.00206036541309336,0.143174610983461
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.00315871577451499,0.0021605489734241,-0.00107596021339625,0.00739339176242622,0.143765979016203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.00568609821010183,0.00389460336241275,-0.0133195208004308,0.00194732438022715,0.144315637466749
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR4,Toll-like receptor 4,37598,0.00399800747040338,0.00274465123301481,-0.00138150894630565,0.00937752388711241,0.145235769342353
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHH,Sonic hedgehog protein,37598,-0.00611069602617471,0.00419690099715782,-0.014336621980604,0.00211522992825462,0.145415961945441
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.0118960297757506,0.0081854889692194,-0.00414752860391941,0.0279395881554206,0.146158237866861
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,37990,-0.00537523858283917,0.00373607911711869,-0.0126979536523918,0.00194747648671347,0.150247917729561
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBQLN3,Ubiquilin-3,37562,-0.00624085126780186,0.00436030777679338,-0.0147870545103169,0.00230535197471317,0.152371852486015
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,37572,0.0140214946399234,0.00980319679516055,-0.00519277107859131,0.033235760358438,0.15265526773875
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBN2,Fibrillin-2,37572,0.00835739222702142,0.00588290620439451,-0.00317310393359182,0.0198878883876347,0.15545013433524
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR2,Toll-like receptor 2,37714,0.00314759041537123,0.00221969431654646,-0.00120301044505984,0.00749819127580229,0.156205859349833
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM171A2,Protein FAM171A2,37959,0.0219948899221806,0.0155125846067347,-0.00840977590701951,0.0523995557513806,0.156250632018414
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTLA,B- and T-lymphocyte attenuator,37482,0.0121165073692813,0.008582626982841,-0.00470544151708703,0.0289384562556497,0.158048022836789
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00608714321229737,0.00431226584339821,-0.0145391842653579,0.00236489784076313,0.158095151973824
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTA2,"Actin, aortic smooth muscle",40042,-0.00592581064339406,0.00419873026160451,-0.0141553219561389,0.00230370066935079,0.158166118850081
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00443135800861628,0.00314485225494776,-0.00173255241108133,0.0105952684283139,0.158834368045553
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHGA,Chromogranin-A,37998,-0.0122474849794578,0.00870216318835329,-0.0293037248286303,0.00480875486971464,0.159329695610978
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SULT1A1,Sulfotransferase 1A1,40471,-0.0173623923982327,0.0123544163556941,-0.0415770484553932,0.0068522636589277,0.159933892558485
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.00892124342122252,0.00635825147003966,-0.0213834163025002,0.00354092946005521,0.160611398838016
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DENND2B,DENN domain-containing protein 2B,37562,-0.0071090902702886,0.00507109339607868,-0.0170484333266028,0.0028302527860256,0.160973235821869
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM3,Paralemmin-3,37562,0.00981899015045565,0.00700463576652932,-0.00391009595194182,0.0235480762528531,0.161003269903732
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.00690979955480886,0.00492991871309627,-0.0165724402324776,0.00275284112285984,0.161056855784327
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL36A,Interleukin-36 alpha,37598,-0.00799581096456952,0.00571042420652489,-0.0191882424093583,0.00319662048021927,0.161473104585421
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,40044,0.00425978021685598,0.00306407589087845,-0.00174580852926579,0.0102653689629777,0.164477901142767
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.00923170945233366,0.00666438780607722,-0.0038304906475777,0.022293909552245,0.166002094410281
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESPL1,Separin,37482,-0.00765854456449082,0.00553755067714466,-0.0185121438916944,0.00319505476271272,0.166682363547277
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,0.00977047315760607,0.00706721220365613,-0.00408126276155994,0.0236222090767721,0.166835278360665
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF12,Fibroblast growth factor 12,37598,0.0064309128972079,0.00465616251169534,-0.00269516562571496,0.0155569914201308,0.167252752749519
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,37562,-0.00952664911281153,0.00692181113066873,-0.0230933989289222,0.00404010070329918,0.168745106031012
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHPK,Sedoheptulokinase,37714,-0.0056835443027254,0.00413933485220014,-0.0137966406130377,0.00242955200758689,0.169757720877668
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00591465770292938,0.00436386891393888,-0.00263852536839082,0.0144678407742496,0.175322415267206
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.0066456450005022,0.00491142572330276,-0.0162720394181756,0.00298074941717121,0.176047334422206
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KDM3A,Lysine-specific demethylase 3A,37598,-0.0120983444949845,0.008946089208066,-0.0296326793427939,0.00543599035282482,0.176283037364708
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0111067158375279,0.00822361437144356,-0.0272250000055573,0.00501156833050145,0.176850135697841
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00596082110991423,0.00443206512517515,-0.0146476687552575,0.00272602653542907,0.178670768750911
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTKN2,Rhotekin-2,37562,-0.00681924728882504,0.00509045832810581,-0.0167965456119124,0.00315805103426235,0.1803942155795
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WIF1,Wnt inhibitory factor 1,40489,-0.00440270321009372,0.00328932484555541,-0.0108497799073823,0.00204437348719488,0.180758228887386
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVPL,Envoplakin,37714,-0.00444234990599863,0.00333270512945575,-0.0109744519597319,0.00208975214773465,0.182569081707691
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHP1,Calcineurin B homologous protein 1,37541,0.00938874430500498,0.00705673107502744,-0.00444244860204879,0.0232199372120588,0.183387795078403
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,37959,0.00428801597508242,0.00326266103661736,-0.00210679965668761,0.0106828316068524,0.188777836345444
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP29,Dual specificity phosphatase 29,37572,-0.00836933938810758,0.00643578113555101,-0.0209834704137876,0.00424479163757241,0.193473466948212
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FZD10,Frizzled-10,37572,0.00763370717707952,0.00588173955634487,-0.00389450235335643,0.0191619167075155,0.194356354450893
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN2,Contactin-2,40489,0.00559069657014782,0.00430893711440743,-0.00285482017409073,0.0140362133143864,0.194489785461153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDSN,Corneodesmosin,40456,-0.0053615381757653,0.00414754150682299,-0.0134907195291384,0.00276764317760776,0.196132559682249
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GJA8,Gap junction alpha-8 protein,37482,0.00777060421552434,0.00601687217546117,-0.00402246524837955,0.0195636736794282,0.196563987912558
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAP1,Antigen peptide transporter 1,37714,-0.00764795262963575,0.00595511739147822,-0.0193199827169331,0.00402407745766156,0.199071459914524
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRNN,Cornulin,39857,0.00819555274696814,0.00638608527977448,-0.00432117440138983,0.0207122798953261,0.199390421604183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TG,Thyroglobulin,37900,-0.0145052496761953,0.0113265774424614,-0.0367053414634197,0.00769484211102907,0.200342802293237
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00435692574943969,0.00341397598256848,-0.00233446717639452,0.0110483186752739,0.201906425588667
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,37901,0.00636260455761947,0.00498948163956754,-0.0034167794559329,0.0161419885711718,0.202259242763491
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00712039988777583,0.00559543447494661,-0.00384665168311952,0.0180874514586712,0.203204935363888
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,40341,0.00555608076294256,0.00438593319531535,-0.00304034829987554,0.0141525098257606,0.205246963506579
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIP1,Huntingtin-interacting protein 1,37562,0.00414845328609256,0.00328885540052762,-0.00229770329894158,0.0105946098711267,0.207199137788224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPEP2,Dipeptidase 2,40305,-0.00346655183474225,0.0027552497066148,-0.00886684125970725,0.00193373759022275,0.208351527199421
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN15,Tetraspanin-15,37562,-0.00620078316270069,0.00493293600842031,-0.0158693377392045,0.00346777141380311,0.208769966333584
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00880083370682954,0.00702170397425194,-0.00496170608270427,0.0225633734963633,0.210091315927422
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00476359564141302,0.00384537049807964,-0.00277333053482308,0.0123005218176491,0.215445880255293
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR158,Probable G-protein coupled receptor 158,37959,0.00440380234314202,0.00355735264080336,-0.00256860883283256,0.0113762135191166,0.21575844879546
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00501338119603221,0.00408069868154106,-0.0130115506118527,0.00298478821978827,0.219259038697479
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.00462085964796241,0.00376239826954384,-0.0119951602562683,0.00275344096034352,0.219405708633997
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISM2,Isthmin-2,37998,-0.00527771060061783,0.0042993838321752,-0.0137045029116812,0.00314908171044556,0.219637099847343
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB6A,Ras-related protein Rab-6A,40341,0.00562747441152664,0.00458700805716089,-0.0033630613805087,0.014618010203562,0.219905054932317
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.00427424300478727,0.00349660161630819,-0.0111275821727513,0.00257909616317678,0.22157867913925
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP112,Centrosomal protein of 112 kDa,37562,0.00550657092592425,0.00456032921635119,-0.00343167433812409,0.0144448161899726,0.227263674061065
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA6C,Semaphorin-6C,37598,0.00309512556704817,0.00257029147939424,-0.00194264573256453,0.00813289686666088,0.228536888146375
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM132A,Transmembrane protein 132A,37628,0.00728326198004917,0.0060646247104315,-0.00460340245239656,0.0191699264124949,0.229795324094059
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDAN1,Codanin-1,37942,0.00268266178675246,0.0022388266590243,-0.00170543846493518,0.00707076203844009,0.230842886924771
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RLN1,Prorelaxin H1,37959,-0.00949604369565821,0.00795919552752429,-0.0250960669296058,0.00610397953828939,0.232854734583996
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR1,TGF-beta receptor type-1,37598,0.00247883898573655,0.00207987272643126,-0.00159771155806873,0.00655538952954182,0.233352390203058
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00528232741418365,0.0044372458085684,-0.0139793291989777,0.00341467437061042,0.23389044000991
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PYDC1,Pyrin domain-containing protein 1,37628,-0.00490326208310109,0.00411975990388358,-0.0129779914947129,0.00317146732851073,0.233996500567913
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.0137324110608539,0.0115456216288794,-0.00889700733174977,0.0363618294534576,0.234302182835474
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.00687805746689145,0.00578301968144926,-0.00445666110874911,0.018212776042532,0.234318248385469
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GKN1,Gastrokine-1,39602,0.00319468477707938,0.00268741863332788,-0.00207265574424326,0.00846202529840201,0.234554365986432
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.00925369139457092,0.00779355869038149,-0.00602168363857681,0.0245290664277186,0.235107298751847
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,0.00647769126522026,0.00548140872564074,-0.0042658698370356,0.0172212523674761,0.237319918809806
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPH3,Neurexophilin-3,37598,0.00345140274801079,0.00292491653262195,-0.00228143365592823,0.00918423915194981,0.238021398318528
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,0.00391308126817375,0.00333586730412178,-0.00262521864790494,0.0104513811842524,0.24080021996044
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS1,"Nitric oxide synthase, brain",39961,0.0056103851286926,0.00479520024601896,-0.00378820735350457,0.0150089776108898,0.242018877399852
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00281658903180336,0.00240850374441943,-0.00753725637086543,0.00190407830725872,0.242248915819543
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00425075865096763,0.00365599494628028,-0.011416508745677,0.00291499144374172,0.244979806955227
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",37942,-0.00678161198848363,0.00584845315455608,-0.0182445801714135,0.00468135619444628,0.246249935334695
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP1,DNA topoisomerase 1,37901,0.0119313998872134,0.01029307180502,-0.00824302085062574,0.0321058206250525,0.24640827560006
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,37671,0.00298018940808516,0.00257510898534709,-0.00206702420319513,0.00802740301936545,0.247168222144765
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,-0.00413823104833098,0.00359033808808358,-0.0111752937009748,0.00289883160431284,0.249091820103265
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC2,Mucin-2,37998,0.0100597788657732,0.00874202509806831,-0.00707459032644072,0.0271941480579871,0.249860426709248
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GH2,Growth hormone variant,39980,0.0184753673518983,0.0162413253222936,-0.0133576302797972,0.0503083649835937,0.25532475946486
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YY1,Transcriptional repressor protein YY1,37598,0.00307311358447126,0.00271218244200197,-0.00224276400185261,0.00838899117079512,0.257202267586398
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLHL41,Kelch-like protein 41,37959,0.00517830378210172,0.00457997918009081,-0.00379845541087627,0.0141550629750797,0.258227076550677
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,40424,-0.00226708587695143,0.00201808611698701,-0.00622253466624598,0.00168836291234311,0.261291280091904
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,37628,0.00406210068340439,0.00362724709330817,-0.00304730361947963,0.0111715049862884,0.262783058254551
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL22,Interleukin-22,37900,0.00703455828457632,0.00629186505940595,-0.00529749723185935,0.019366613801012,0.263569781904126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53BP1,TP53-binding protein 1,37598,0.00955988207552947,0.00858599795305023,-0.00726867391244898,0.0263884380635079,0.265545435519336
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00689121564597046,0.00619897069992696,-0.0190411982178273,0.00525876692588639,0.266300165519736
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,40408,-0.00256078674646478,0.0023306806744125,-0.00712892086831328,0.00200734737538372,0.271902811499629
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00494228308449527,0.00453860203339953,-0.0138379430699583,0.0039533769009678,0.276198756733174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,40489,-0.00641048034672019,0.00588854446608144,-0.0179520275002398,0.00513106680679944,0.276330879950722
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPHS2,Podocin,37598,-0.0110112765209264,0.0101326825031924,-0.0308713342271834,0.00884878118533065,0.277185392889424
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A16,Protein S100-A16,39934,0.00649275761526049,0.00597829974197198,-0.00522470987900459,0.0182102251095256,0.277471917752166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.00734971848262245,0.00681929542073915,-0.0207155375072712,0.00601610054202628,0.2811505820795
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASN,Vasorin,40116,-0.00283283604237346,0.00263865882029444,-0.00800460733015057,0.00233893524540365,0.283023305261526
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00196129949013071,0.0018308214103368,-0.00162711047412943,0.00554970945439084,0.284068229799745
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTF,Ciliary neurotrophic factor,37541,-0.0035027149045674,0.00327391817826224,-0.00991959453396139,0.0029141647248266,0.284690948255649
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,40305,0.00461144087807771,0.00431358670877554,-0.00384318907112234,0.0130660708272778,0.285063312115292
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00585208036796323,0.00548077133253803,-0.0048902314438113,0.0165943921797378,0.285654078578437
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1A,Interleukin-1 alpha,40044,0.00546871883531134,0.00518230455934179,-0.00468859810099858,0.0156260357716212,0.291319240419204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPE4,NXPE family member 4,37562,-0.0036987794093098,0.00351428157456907,-0.0105867712954652,0.00318921247684558,0.292589863053297
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NENF,Neudesin,37900,0.010850697642905,0.0104426832802977,-0.0096169615864785,0.0313183568722885,0.298790029369151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUOX2,Dual oxidase 2,40042,0.00722802562732165,0.00697437729665624,-0.00644175387412457,0.0208978051287679,0.300046288335872
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA6,Corticosteroid-binding globulin,38013,0.00177604071578926,0.00172125208334917,-0.00159761336757512,0.00514969479915364,0.302169843275336
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.005966061622124,0.00579523130883088,-0.00539259174318452,0.0173247149874325,0.303274227750372
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRN1,Neuritin,37959,-0.00363707500672424,0.00353301736279826,-0.0105617890378088,0.00328763902436035,0.303285330521859
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKLR,Pyruvate kinase PKLR,40374,0.00656365305699742,0.00639399701048567,-0.00596858108355449,0.0190958871975493,0.304655707795223
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.00484084928916302,0.00471583128460142,-0.00440218002865577,0.0140838786069818,0.30467062230724
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTOA,Otoancorin,37541,-0.00541375645725877,0.00529771296137938,-0.0157972738615624,0.00496976094704482,0.306845012028461
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBH,Dopamine beta-hydroxylase,37967,-0.0103832216829756,0.0101722528092611,-0.0303208371891273,0.00955439382317614,0.307396078816017
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00343590321300664,0.00336873513758381,-0.00316681765665764,0.0100386240826709,0.307775781342258
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0135456859798633,0.0132812729896427,-0.0395769810395629,0.0124856090798363,0.30778997364851
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDNRB,Endothelin receptor type B,37598,0.00466717386443491,0.00457733775716172,-0.00430440813960206,0.0136387558684719,0.307924500638006
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,-0.0033957207778243,0.0033351737566437,-0.00993266134084596,0.00314121978519735,0.308623640639815
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAGLN3,Transgelin-3,37482,-0.00598117373438279,0.00589334565369338,-0.0175321312156218,0.00556978374685623,0.310170948949321
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA8,Carbonic anhydrase-related protein,37598,-0.00271867542056395,0.00268672988959077,-0.00798466600416186,0.00254731516303396,0.311609219095026
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPA33,Cell surface A33 antigen,40305,-0.0132239540961352,0.0130861758888336,-0.038872858838249,0.0124249506459786,0.312257560312123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00391201879260403,0.00389563319181283,-0.00372342226334912,0.0115474598485572,0.315294434549784
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP1,Retinol-binding protein 1,37572,0.00667666260289419,0.00665281295761144,-0.00636285079402424,0.0197161759998126,0.315597246109656
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCNE1,G1/S-specific cyclin-E1,37598,0.0090505939086971,0.0090469126386132,-0.00868135486298479,0.026782542680379,0.317132041353371
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEX33,Testis-expressed protein 33,37714,-0.00379894161605426,0.00381363363236486,-0.0112736635354894,0.00367578030338086,0.319196657282825
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STC2,Stanniocalcin-2,40309,0.00258939948158642,0.00261094448261792,-0.00252805170434469,0.00770685066751754,0.321335506674484
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STEAP4,Metalloreductase STEAP4,37541,-0.00717525184860899,0.00728187868804554,-0.0214477340771783,0.00709723037996027,0.324466841655229
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCIN,Adseverin,37541,0.00695296115227027,0.00709771401580031,-0.00695855831869833,0.0208644806232389,0.32729889253338
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASPN,Asporin,37990,0.00257325182287111,0.00262792858300974,-0.00257748819982797,0.00772399184557019,0.327501644844343
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,-0.00749812054793062,0.00766141834107834,-0.0225145004964442,0.00751825940058292,0.327753346828635
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP15,Matrix metalloproteinase-15,37990,0.00468885040034087,0.00480848072313387,-0.00473577181700151,0.0141134726176833,0.329517679579009
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00652494774049609,0.00670778680511108,-0.00662231439752164,0.0196722098785138,0.330699154106735
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC44A4,Choline transporter-like protein 4,37572,-0.00656686273974244,0.00676564231290365,-0.0198275216730336,0.00669379619354872,0.331755804110579
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVI2B,Protein EVI2B,37482,0.00393157362238369,0.00407074876652316,-0.0040470939600017,0.0119102412047691,0.334156726560787
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00470260066572441,0.00488675021058459,-0.0048754297470214,0.0142806310784702,0.335908469249757
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUCL3,Mucin-like protein 3,37482,-0.00416726496779096,0.00435433935407809,-0.012701770101784,0.00436724016620209,0.338566209029605
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN4,Nectin-4,40411,0.00279864867569951,0.00293650590867887,-0.00295690290531107,0.00855420025671009,0.340577150178306
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTXR,Neuronal pentraxin receptor,40359,0.0031056043295792,0.0032625232603016,-0.00328894126061194,0.00950014991977034,0.341160851014735
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAYN,Layilin,40192,0.00313096393147741,0.00330240028297775,-0.00334174062315898,0.00960366848611379,0.34309954326036
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL5,Fc receptor-like protein 5,40332,-0.00509472628410592,0.00538114267351603,-0.0156417659241973,0.00545231335598549,0.343768329928463
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00265541785121683,0.00281143482953372,-0.00285499441466925,0.00816583011710291,0.344925629763093
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNNI3,"Troponin I, cardiac muscle",40042,0.00767093470998137,0.00814569718646105,-0.00829463177548229,0.023636501195445,0.346352568760978
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD70,CD70 antigen,40341,-0.00375454867338381,0.00399454228795507,-0.0115838515577757,0.00407475421100812,0.347273080425902
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.00346830710254697,0.00370461897638475,-0.00379274609116715,0.0107293602962611,0.349181376398672
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPT,Microtubule-associated protein tau,39961,0.00474341392126984,0.00510974549052824,-0.00527168724016551,0.0147585150827052,0.353262647467303
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGN,Secretagogin,40044,-0.00389822077462665,0.00422031799310404,-0.0121700440411106,0.00437360249185728,0.355667556372757
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAX,Integrin alpha-X,37714,0.00491552422334186,0.00533514758070423,-0.00554136503483844,0.0153724134815222,0.356885853540805
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_A,,37959,0.0029016521827203,0.00315324661813846,-0.00327871118883108,0.00908201555427168,0.357478947796301
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEBP1,Heme-binding protein 1,40042,0.00481448324780765,0.00524125649998125,-0.0054583794921556,0.0150873459877709,0.358332517843224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.0056430211438149,0.00614933125259107,-0.0064096681112636,0.0176957103988934,0.358808573015241
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00240278625692175,0.00262643979940976,-0.00274503574992138,0.00755060826376489,0.360286589694218
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00370791438069015,0.00406001151030752,-0.00424970817951259,0.0116655369408929,0.361113366326771
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRG3,Proteoglycan 3,37998,-0.00440408100809101,0.00482926763322609,-0.0138694455692142,0.00506128355303212,0.361807955004627
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD82,CD82 antigen,37714,-0.00367824816548301,0.00404449981280268,-0.0116054677985763,0.00424897146761024,0.363132061201873
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00524670398164225,0.00587498987392932,-0.0167616841345437,0.00626827617125921,0.371842754140765
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBR1,T-box brain protein 1,37572,0.00419716264371773,0.00471071504145596,-0.00503583883753596,0.0134301641249714,0.372955127252272
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.0108482891944352,0.0121769014547163,-0.0130184376568087,0.034715016045679,0.373001572153835
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPO,Lactoperoxidase,39831,-0.00505600945519489,0.00569187958124925,-0.0162120934344434,0.00610007452405364,0.374401528686668
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.00309328906749244,0.00348556539453848,-0.00373841910580298,0.00992499724078786,0.374849053363936
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,40341,0.00308302160979849,0.00348674335473366,-0.00375099536547948,0.00991703858507646,0.37659496043494
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNL2,Interferon lambda-2,37541,0.00551788023952142,0.00625964677523236,-0.006751027439934,0.0177867879189768,0.378063301640272
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLGAP5,Disks large-associated protein 5,37959,-0.00455860758537415,0.00518415824956696,-0.0147195577545254,0.0056023425837771,0.379235747414312
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCUN1D2,DCN1-like protein 2,37482,0.00687124989458866,0.00781431995299198,-0.00844481721327561,0.0221873170024529,0.379246641160342
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABO,Histo-blood group ABO system transferase,37987,-0.0120971896106154,0.0139011409208539,-0.039343425815489,0.0151490465942583,0.384190167236201
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NME3,Nucleoside diphosphate kinase 3,40379,0.0020029366005924,0.00230264671128043,-0.00251025095351724,0.00651612415470205,0.384400391044675
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00230096562777776,0.00267704073983574,-0.00754796547785581,0.00294603422230028,0.390069813263435
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00299212376641274,0.00348129460411115,-0.00383121365764511,0.0098154611904706,0.390088177071519
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.0041385377914849,0.00481593789948975,-0.00530070049151502,0.0135777760744848,0.390167586746157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMMR,Hyaluronan mediated motility receptor,37460,-0.00401783850023013,0.0047058807779259,-0.0132413648249649,0.00520568782450464,0.393236542301103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00423572695700156,0.00496420712161955,-0.0139655729153759,0.00549411900137276,0.393534471307615
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.00319022568505371,0.00374612721075855,-0.0105326350181405,0.00415218364803305,0.394448162580404
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13,Interleukin-13,40044,0.00391241457990354,0.0046149987071404,-0.00513298288609165,0.0129578120458987,0.396584261562928
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00570239765635053,0.00676876157180381,-0.018969170337086,0.00756437502438495,0.39954696980336
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00702433802227646,0.00836629642065237,-0.00937360296220219,0.0234222790067551,0.401148296070502
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.00783457171502102,0.00933813423725934,-0.0261373148200493,0.0104681713900073,0.401491993166798
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRR5,Proline-rich protein 5,37598,0.00389338353635373,0.00465963312857342,-0.00523949739565017,0.0130262644683576,0.403420022624375
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.00265266878808706,0.00317943034569114,-0.00357901468946758,0.0088843522656417,0.404114260888988
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAP1A,Ras-related protein Rap-1A,37598,0.005592892872807,0.00673341808349397,-0.00760460657084119,0.0187903923164552,0.406204999703367
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACHE,Acetylcholinesterase,37671,-0.00253672510508045,0.00307915083136348,-0.00857186073455286,0.00349841052439196,0.410045803697243
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_DRA,,40288,-0.00285367052194188,0.00346470012789076,-0.00964448277260777,0.00393714172872402,0.410155739201237
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00302052692555677,0.00368687983204846,-0.00420575754525821,0.0102468113963718,0.412650851357507
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.00230901846367688,0.00283398754566596,-0.00324559712582841,0.00786363405318217,0.415222013049366
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAGE2A,G antigen 2A,37482,0.00490104408900449,0.00601676692845711,-0.00689181909077144,0.0166939072687804,0.415336587017832
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,H2AP,Huntingtin-interacting protein M,37482,-0.00409888287892085,0.00503427414229635,-0.0139660601978217,0.00576829443997999,0.415547895981549
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00504056469060373,0.00622780519085775,-0.00716593348347746,0.0172470628646849,0.418320012334074
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDAC8,Histone deacetylase 8,37598,0.00488361030624351,0.00604192147708888,-0.00695855578885069,0.0167257764013377,0.418939656321954
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PITHD1,PITH domain-containing protein 1,37457,-0.00640220610576101,0.0079311091691455,-0.0219471800772862,0.00914276786576416,0.419550428885785
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.0034944830730916,0.00434255323277885,-0.00501692126315495,0.0120058874093381,0.421003192749242
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20,Interleukin-20,40044,0.00394663537995131,0.00490800156117455,-0.0056730476799508,0.0135663184398534,0.421338385721017
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6L,Seizure 6-like protein,40411,-0.00211920306929676,0.00263744268094878,-0.00728859072395637,0.00305018458536286,0.421693848248944
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00260022977034333,0.00324513375534463,-0.00896069193081879,0.00376023239013214,0.422987308173269
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00382701825688539,0.0047839209440402,-0.0132035033072042,0.00554946679343341,0.423739732578309
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF9,Fibroblast growth factor 9,37457,0.00310185921486028,0.00392212548279088,-0.00458550673140985,0.0107892251611304,0.429039064514113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCND2,G1/S-specific cyclin-D2,37714,0.00277775081283947,0.0035429371671034,-0.00416640603468319,0.00972190766036213,0.433039526387325
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLN1,Cerebellin-1,37541,-0.00733422726899209,0.00948765098350254,-0.0259300231966571,0.0112615686586729,0.439519307287537
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMIGO1,Amphoterin-induced protein 1,37572,0.00372669830997639,0.00482314966436117,-0.0057266750321715,0.0131800716521243,0.43973220625478
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THY1,Thy-1 membrane glycoprotein,40471,0.00207020597548551,0.00269135885325402,-0.00320485737689237,0.00734526932786339,0.441783120615054
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH17,Protocadherin-17,40359,0.00254403379652654,0.00334876221175026,-0.00401954013850396,0.00910760773155704,0.447448910547794
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00535498107011589,0.00705931012410181,-0.00848126677312366,0.0191912289133554,0.448123466948122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB6B,Ras-related protein Rab-6B,39961,0.00354590205371461,0.00469125810663337,-0.00564896383528679,0.012740767942716,0.449748746616527
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFRC,Transferrin receptor protein 1,40391,-0.00285642990885068,0.00380053739428951,-0.0103054832016581,0.00459262338395676,0.452311287156642
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.00679954283983646,0.00905925173434542,-0.0109565905594806,0.0245556762391535,0.452928884654985
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00419578480500059,0.00560379903642097,-0.0151792309163857,0.0067876613063845,0.454027758666166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,37541,-0.00513476173664905,0.00686450693615834,-0.0185891953315194,0.0083196718582213,0.454463882947245
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,37541,0.0031371080568003,0.00419935050982368,-0.00509361894245411,0.0113678350560547,0.455049205308037
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRMD7,FERM domain-containing protein 7,37572,0.00239742694093188,0.00321354448355971,-0.00390112024684515,0.00869597412870892,0.45565770607503
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.00265348535845283,0.00355704568310424,-0.00431832418043148,0.00962529489733714,0.455692733743525
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00489092505327063,0.00656469662265284,-0.00797588032712893,0.0177577304336702,0.456264104457438
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGM2,Phosphoglucomutase-2,37572,0.00430671323959818,0.00579250486852221,-0.00704659630270536,0.0156600227819017,0.457193811437279
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,37901,0.00912917861490177,0.0124142918296026,-0.0152028333711194,0.0334611906009229,0.462123046374064
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,0.00520255061631729,0.00713715556158588,-0.00878627428439103,0.0191913755170256,0.466049762532012
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00390988414019551,0.00539224861887649,-0.00665892315280241,0.0144786914331934,0.468407724984591
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.00299869969273222,0.00414151640367329,-0.00511867245846743,0.0111160718439319,0.46904279976243
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,40044,0.00413146698905444,0.00572296561538348,-0.00708554561709718,0.0153484795952061,0.470360543828402
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTN,Neuroplastin,39980,0.00585921393998128,0.00813001888193325,-0.0100756230686079,0.0217940509485704,0.471111824535831
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTR,Methionine synthase,37562,0.00455244343211769,0.00632346902300308,-0.00784155585296835,0.0169464427172037,0.47158206168756
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARG2,"Arginase-2, mitochondrial",37900,0.00306851761748689,0.00428871526471427,-0.00533736430135308,0.0114743995363269,0.474320938543719
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.00387867701066543,0.00545388044337065,-0.00681092865834105,0.0145682826796719,0.476986985342902
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCN15,Lipocalin-15,37959,-0.00435812473219169,0.006153079198826,-0.0164181599618906,0.00770191049750727,0.478781417618821
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRND,Prion-like protein doppel,37942,-0.00366481862655985,0.00517626987888655,-0.0138103075891775,0.00648067033605779,0.478955144045148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,-0.00201202135481948,0.00284803577829261,-0.00759417148027299,0.00357012877063403,0.479914706966966
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.00322012425246122,0.00458551448978408,-0.00576748414751558,0.012207732652438,0.482542983508403
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00505936248783224,0.00721404198782729,-0.00908015980830925,0.0191988847839737,0.483114727253753
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,-0.00173609994304456,0.00247911815313045,-0.00659517152318025,0.00312297163709113,0.48375907272257
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.0027469717215035,0.00392570316566297,-0.0104413499262029,0.00494740648319591,0.484102014625597
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR1,Toll-like receptor 1,37598,0.00176046853605388,0.00252769991292578,-0.00319382329328064,0.00671476036538841,0.486146511304947
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00338161048451357,0.00487155239180009,-0.0129298531724417,0.0061666322034146,0.487597638181221
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,37900,-0.0028361380833057,0.00411813358634211,-0.0109076799125362,0.00523540374592483,0.491027092711277
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEB,Nebulin,37562,0.00241996027617415,0.00351877828993609,-0.00447684517210059,0.0093167657244489,0.491636623151382
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,-0.00326704223082549,0.00475421139454834,-0.0125852965641402,0.00605121210248926,0.491975730388604
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB5,Integrin beta-5,40411,-0.002436198127593,0.00355912126132452,-0.00941207579978906,0.00453967954460305,0.493673043127363
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK15,Kallikrein-15,37880,0.00338117087464946,0.00494107808017878,-0.00630334216250094,0.0130656839117999,0.493798687941884
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,37901,0.00322556567251687,0.00472351137333179,-0.00603251661921343,0.0124836479642472,0.494697883334593
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBS2,Thrombospondin-2,40332,0.0023362187344188,0.00344208343579479,-0.004410264799739,0.0090827022685766,0.497323734198898
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSV,Cathepsin L2,40444,-0.00276528980923575,0.00407904153587647,-0.0107602112195536,0.00522963160108213,0.497828189250111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.00272635217734283,0.00407841384183306,-0.00526733895264997,0.0107200433073356,0.50383646283532
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGN,Cingulin,37572,0.00270393874866275,0.00405300268602303,-0.00523994651594238,0.0106478240132679,0.5046915237943
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,37541,0.00582323240393888,0.00880196000971723,-0.0114286092151069,0.0230750740229847,0.508249765764939
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,0.00468995701905853,0.00713649617962975,-0.00929757549301579,0.0186774895311328,0.511077238222536
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG1A,Lithostathine-1-alpha,40274,0.00308184789432751,0.00469009932811649,-0.0061107467887808,0.0122744425774358,0.511128421437454
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00425230410241309,0.00648411768701241,-0.00845656656413123,0.0169611747689574,0.511962358648354
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00399363507565271,0.0060941148792088,-0.00795083008759654,0.015938100238902,0.512268918635041
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCARE,Photoreceptor cilium actin regulator,37541,0.00545408712043802,0.00832732394033953,-0.0108674678026275,0.0217756420435035,0.512503236734982
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB7,Integrin beta-7,40489,0.00286399693563009,0.00437462930969409,-0.00571027651137032,0.0114382703826305,0.512681041787517
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDAC9,Histone deacetylase 9,37541,-0.00397623670938168,0.00613047413079762,-0.015991966005745,0.00803949258698166,0.516607154299294
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK12,Kallikrein-12,39980,-0.00893214419716772,0.0137778883336027,-0.0359368053310291,0.0180725169366937,0.516803374256165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL21R,Interleukin-21 receptor,37598,0.00350061439774729,0.00541012627161756,-0.00710323309462312,0.0141044618901177,0.517611815283038
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAU,Urokinase-type plasminogen activator,40332,-0.00182640949462082,0.00282372371495825,-0.00736090797593898,0.00370808898669735,0.517765011062475
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,37942,0.00176114616023348,0.00272489024182977,-0.00357963871375286,0.00710193103421982,0.518084297544349
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,-0.00257585898840653,0.0039876761486691,-0.010391704239798,0.00523998626298492,0.518317838395735
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN3B,Sodium channel subunit beta-3,37541,0.0028530866467773,0.00443761314080128,-0.00584463510919321,0.0115508084027478,0.520279025256974
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RUVBL1,RuvB-like 1,39980,0.00659282572211641,0.0103377876693389,-0.0136692381097879,0.0268548895540207,0.523652030458824
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",39530,0.00174284558097237,0.00274891895538515,-0.00364503557158253,0.00713072673352726,0.526083089129337
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC51B,Organic solute transporter subunit beta,37562,-0.00485871083764646,0.00768929514122807,-0.0199297293144535,0.0102123076391605,0.527476394173432
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,37572,0.00219631550186825,0.00347809885644495,-0.00462075825676385,0.00901338926050035,0.527744181825633
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSG1,Tryptase gamma,37598,-0.00165790670598116,0.00263643082500353,-0.00682531112298808,0.00350949771102575,0.529461372041476
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHODH,Dihydroorotate dehydrogenase,37562,0.00293706329914325,0.00467123828618453,-0.00621856374177843,0.0120926903400649,0.529520577304721
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00345175239014041,0.00559830679172648,-0.0075209289216435,0.0144244337019243,0.537528595455389
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17F,Interleukin-17F,40044,0.00468746667141009,0.00765320960284299,-0.0103128241501622,0.0196877574929823,0.540226664866547
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,37714,-0.0024143879631515,0.00394763192050692,-0.010151746527345,0.00532297060104206,0.540810192540095
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.00162149822632374,0.0026746874472798,-0.00362088917034466,0.00686388562299214,0.544365076710845
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.00191324855657209,0.00316759030231143,-0.0042952284359583,0.00812172554910248,0.545848746001702
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRR1B,Cornifin-B,37714,0.00493571291543836,0.00823163166213847,-0.011198285142353,0.0210697109732298,0.548780938886818
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00326586643562396,0.0054537178686497,-0.00742342058692944,0.0139551534581774,0.549294639237038
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,37598,-0.00255680957398587,0.00427672641171994,-0.010939193340957,0.00582557419298521,0.549955208742848
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM25,RNA-binding protein 25,37482,-0.00267563939766338,0.00447612694399003,-0.0114488482078838,0.00609756941255708,0.550011999775318
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF6,Fibroblast growth factor 6,37598,-0.00245753038587869,0.00415521098279112,-0.0106017439121493,0.0056866831403919,0.554240264276569
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HK2,Hexokinase-2,40042,-0.00155878368546414,0.00266139543618108,-0.00677511874037906,0.00365755136945077,0.558084506551948
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPESP1,Sperm equatorial segment protein 1,37990,0.00155656176125686,0.00265960389773205,-0.00365626187829797,0.00676938540081168,0.558382159576404
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF830,Zinc finger protein 830,37900,-0.00454975251255793,0.00779359838499637,-0.0198252053471508,0.010725700322035,0.559377639162065
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00329071250499329,0.00565744632922258,-0.00779788230028296,0.0143793073102695,0.560805422392975
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCP11,T-complex protein 11 homolog,37714,-0.00337276164630542,0.00587074422204247,-0.0148794203215087,0.00813389702889782,0.565637045112262
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,-0.00319976038801014,0.00558079178601314,-0.0141381122885959,0.00773859151257562,0.566415960008885
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,-0.00165873727086156,0.00289854647172122,-0.00733988835543514,0.00402241381371203,0.567152151725283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,-0.00175494012787873,0.00308415617827854,-0.00779988623730467,0.00429000598154721,0.569352177265921
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,37572,0.00272345279207853,0.00479227470804634,-0.0066694056356923,0.0121163112198494,0.569840569374171
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA4C,Semaphorin-4C,40305,-0.00153364701429205,0.0027209978007036,-0.00686680270367111,0.00379950867508701,0.573011180181929
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXDC1,Plexin domain-containing protein 1,39980,0.00179608638599746,0.003265829144171,-0.0046049387365777,0.00819711150857262,0.582352411311723
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASQ2,Calsequestrin-2,37562,-0.00266051476616869,0.00484568403913668,-0.0121580554828766,0.0068370259505392,0.582981628744129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPN3,Calpain-3,37900,0.00196324554117606,0.00358178068103006,-0.00505704459364285,0.00898353567599497,0.583618622961935
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHGB,Secretogranin-1,40406,-0.00211063844286448,0.00387489500572538,-0.00970543265408622,0.00548415576835727,0.585970472344023
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRAS,GTPase Hras,37697,-0.0051659753864138,0.00950789101988113,-0.0238014417853808,0.0134694910125532,0.586907921815221
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1,Integrin beta-1,40333,-0.0011356087426343,0.00210368814129875,-0.00525883749957985,0.00298762001431125,0.589330115435636
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00116987502269615,0.00216910764020366,-0.00308157595210304,0.00542132599749533,0.58966339384941
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF20,Fibroblast growth factor 20,37598,-0.00231157231184203,0.00431850462530511,-0.01077584137744,0.00615269675375597,0.592471207044864
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,37688,-0.00271081547486338,0.00506973201613737,-0.0126474902264926,0.00722585927676586,0.59286224261857
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,-0.00174068114680332,0.00327500258672768,-0.00815968621678959,0.00467832392318294,0.595077707291074
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAND5,DAN domain family member 5,37598,-0.00276276076017507,0.00525911605164533,-0.0130706282213999,0.00754510670104977,0.599364076543361
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSCA,Prostate stem cell antigen,37901,0.013062859171829,0.0250669979512101,-0.0360684568125427,0.0621941751562008,0.602293282184555
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF174,Zinc finger protein 174,37598,-0.0019458538144851,0.00374990703515564,-0.00929567160339015,0.00540396397441995,0.603834181275198
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSC2,Desmocollin-2,40177,-0.0016778969309949,0.00324091162526244,-0.00803008371650927,0.00467428985451948,0.604658305861868
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,-0.00143884262331259,0.00278255861209668,-0.00689265750302208,0.0040149722563969,0.605098088702607
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00429416219832032,0.00831545762095432,-0.0205924591353908,0.0120041347387501,0.605578800716487
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,40042,0.00246193569453615,0.0047898722598666,-0.00692621393480239,0.0118500853238747,0.607267836004327
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL31,Interleukin-31,37598,-0.00287832573563444,0.00562217779628356,-0.0138977942163502,0.00814114274508134,0.608688153390487
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA2,Protein disulfide-isomerase A2,37482,-0.00205122347111771,0.00401764003579958,-0.00992579794128489,0.00582335099904946,0.609671819122054
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL3A1,Collagen alpha-1(III) chain,37998,0.00112746747781044,0.00222803237177178,-0.00323947597086225,0.00549441092648314,0.612838702333671
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,37959,0.0037899441040745,0.00756462975363547,-0.011036730213051,0.0186166184212,0.61637327732051
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNPO1,Transportin-1,37714,-0.00171348719597429,0.00342691340153514,-0.00843023746298316,0.00500326307103458,0.617077107578515
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MERTK,Tyrosine-protein kinase Mer,40516,-0.00125498555477819,0.00251332277618191,-0.00618109819609474,0.00367112708653837,0.617551494226023
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALMS1,Alstrom syndrome protein 1,37714,0.00211357837475303,0.00435279929316031,-0.00641790823984117,0.0106450649893472,0.627281783277848
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENOPH1,Enolase-phosphatase E1,37900,0.00264025966621733,0.00553029177868609,-0.00819911222000742,0.0134796315524421,0.633072409118231
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.00142721354097394,0.00299030662352008,-0.00443378744112542,0.0072882145230733,0.633170483851881
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMCH,Pro-MCH,37562,-0.00391712692020325,0.00821050288829192,-0.0200097125812554,0.0121754587408489,0.633307887290405
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEX101,Testis-expressed protein 101,37572,0.00180875360352363,0.00379325815277708,-0.00562603237591944,0.0092435395829667,0.633488434758511
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.00305529966094906,0.00644063012935454,-0.00956833539258584,0.015678934714484,0.635237581228194
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.0063878994123007,0.013672277425091,-0.0204097643408777,0.0331855631654791,0.640353545062031
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,37482,0.0015147559790671,0.00324515184242115,-0.00484574163207836,0.00787525359021257,0.640668618026404
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC123,Cell division cycle protein 123 homolog,37482,0.00286753677474103,0.00619352902132773,-0.00927178010706133,0.0150068536565434,0.643379872074533
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MB,Myoglobin,40536,0.00218332619518187,0.0047201192313185,-0.00706810749820239,0.0114347598885661,0.643687889512595
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPT1,Translationally-controlled tumor protein,40044,0.0028260973177094,0.0063989049497054,-0.00971575638371319,0.015367951019132,0.658746252040259
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,37572,0.00332254839438475,0.00753933594463286,-0.0114545500570957,0.0180996468458652,0.659441006606457
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL12,Stromal cell-derived factor 1,40044,0.00171708066266034,0.0039057862705151,-0.00593826042754925,0.00937242175286993,0.660214940024048
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FZD8,Frizzled-8,37541,0.00190711352098903,0.00433964439952951,-0.00659858950208882,0.0104128165440669,0.660333278703283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17C,Interleukin-17C,40044,-0.00292091138560594,0.00674945336921767,-0.0161498399892726,0.0103080172180607,0.665193189405547
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXK,Tyrosine-protein kinase TXK,37714,0.00315202069009992,0.00732902627145055,-0.0112128708019431,0.017516912182143,0.667149093622994
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00398932798586481,0.00939132386146455,-0.0144176667826057,0.0223963227543353,0.670997707975775
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MLLT1,Protein ENL,37482,0.00293757773090363,0.00692150150930048,-0.0106285652273253,0.0165037206891326,0.671271384078965
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00234432363737097,0.00552399619322708,-0.00848270890135411,0.0131713561760961,0.671289061583376
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.0049429424103031,0.011656804938479,-0.0179043952691157,0.0277902800897219,0.671543088608522
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PXDNL,Peroxidasin-like protein,37900,0.00238286050898449,0.00565205907637219,-0.008695175280705,0.013460896298674,0.673329892618943
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TET2,Methylcytosine dioxygenase TET2,37697,0.00408767035529987,0.00972802615881014,-0.014979260915968,0.0231546016265677,0.674349642927999
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC25A,M-phase inducer phosphatase 1,37482,-0.00163099567785891,0.00395733943456166,-0.00938738096959976,0.00612538961388193,0.680240294460846
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00306268099488843,0.00750440343708052,-0.0177713117315662,0.0116459497417894,0.6831936533764
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCNA,Proliferating cell nuclear antigen,37482,0.00246488143391853,0.00604066824630855,-0.00937482832884622,0.0143045911966833,0.683245281283714
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00147066974350038,0.00360998733652418,-0.005604905436087,0.00854624492308777,0.68372777299475
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA11,Serpin A11,40536,-0.00156225709467062,0.00385916460865937,-0.00912621972764299,0.00600170553830175,0.685617099986288
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00249392296676625,0.00616252048624678,-0.0145724631198099,0.00958461718627744,0.685710423154185
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.00165786478867058,0.00411079459915289,-0.00639929262566907,0.00971502220301024,0.686737266680296
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANK2,Ankyrin-2,37562,0.00287733389127201,0.00717457254819535,-0.0111848283031909,0.0169394960857349,0.688392765334654
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNC5D,Netrin receptor UNC5D,37598,0.00103458308903577,0.0025819574936694,-0.00402605359855626,0.00609521977662781,0.688649598352294
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,-0.00209028912382441,0.00522531442695752,-0.0123319054006611,0.00815132715301232,0.689140008863852
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,40536,0.0023399510755026,0.005855620129718,-0.00913706437874468,0.0138169665297499,0.689450767294164
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOS,Proto-oncogene c-Fos,37457,0.00132239431748161,0.00339248352621645,-0.00532687339390264,0.00797166202886585,0.696689903039415
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD2,Bromodomain-containing protein 2,37541,-0.00129256444623813,0.00333911336339343,-0.00783722663848926,0.005252097746013,0.698689875962565
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00315139813674529,0.00819956948589414,-0.0192225543290978,0.0129197580556072,0.70073483210483
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPLX2,Complexin-2,37482,-0.00113994337698058,0.00299386368647784,-0.00700791620247714,0.00472802944851598,0.703387589724537
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMP,Olfactory marker protein,37541,0.00185817037906326,0.00489629439325995,-0.00773856663172623,0.0114549073898528,0.704318718875696
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HCG22,Protein PBMUCL2,37562,-0.00191412344446552,0.00516145013596749,-0.0120305657109618,0.00820231882203076,0.710755298725304
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALLD,Palladin,37598,-0.00148664224242622,0.00401026230149014,-0.00934675635334689,0.00637347186849445,0.710859903581021
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGR,Progesterone receptor,37598,-0.00370696618870163,0.010002016754986,-0.0233109190284742,0.015896986651071,0.710925159365394
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00294713685393064,0.00796995954166431,-0.0185682575555927,0.0126739838477314,0.711551873763771
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.00223248756090468,0.00610145865794332,-0.0141913465304736,0.00972637140866423,0.71444983610512
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPT2,Angiopoietin-2,40489,0.00135506288726859,0.00372145956721521,-0.00593899786447322,0.00864912363901039,0.715772193869669
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNB2,Ephrin-B2,37572,0.00200393747717347,0.00559145991081994,-0.0089553239480336,0.0129631989023805,0.720055345508766
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY2B,Alpha-amylase 2B,39311,-0.00165730973599079,0.00464640148474104,-0.0107642566460832,0.00744963717410164,0.721331408190568
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00125978500999508,0.00355755680416913,-0.00571302632617641,0.00823259634616657,0.723258227013311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,0.0012320878250867,0.00355988121270255,-0.00574527935181031,0.0082094550019837,0.729270223041525
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.00261019195510142,0.00757271919345316,-0.0122323376640668,0.0174527215742696,0.730337789278018
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAC1,Cartilage acidic protein 1,40536,-0.000957717140775624,0.00281331184898114,-0.00647180836477867,0.00455637408322742,0.733542156903223
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYBB2,Beta-crystallin B2,37942,-0.00225025263024048,0.0066286109957763,-0.015242330181962,0.0107418249214811,0.734256653681022
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00266438693286103,0.00796388212366667,-0.0182735958952477,0.0129448220295256,0.737963210858174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IKZF2,Zinc finger protein Helios,39980,0.00300935146280122,0.00901490810619702,-0.0146598684253449,0.0206785713509474,0.738520330281583
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA10,Ephrin type-A receptor 10,39961,0.00206107043999299,0.0062854400898415,-0.0102583921360963,0.0143805330160823,0.742982721834272
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.00108847311082938,0.00333244603115961,-0.00544312111024346,0.00762006733190221,0.743953837356447
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00190801043259632,0.00585724070839368,-0.0133882022210479,0.0095721813558553,0.744616898397544
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR3,Folate receptor gamma,40355,-0.00573876276586386,0.0177100934335634,-0.0404505458956482,0.0289730203639205,0.745912692598759
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00154869071388813,0.00478122472503557,-0.00782250974718158,0.0109198911749578,0.746010681118322
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP4,Caspase-4,37714,0.00533881691858837,0.0164996267674411,-0.0270004515455962,0.0376780853827729,0.746267205666952
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,0.00177976054862303,0.00550835331286846,-0.00901661194459915,0.0125761330418452,0.746623065553404
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMOD2,Leiomodin-2,37541,0.00202014609485761,0.00628472524606956,-0.0102979153874387,0.014338207577154,0.747884034621779
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHD,SH2 domain-containing adapter protein D,37531,0.00264830864000728,0.0084842415274665,-0.013980804753827,0.0192774220338416,0.754935746444196
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.0013960756540926,0.00455723141120853,-0.00753609791187612,0.0103282492200613,0.759347532107672
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL4,Interleukin-4,40044,0.00262665700166507,0.00864352353821939,-0.0143146491332449,0.0195679631365751,0.761217811238731
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPK3A,Uroplakin-3a,37541,0.00146988055245461,0.00483980906421478,-0.00801614521340637,0.0109559063183156,0.761356477566873
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.00137661224511972,0.0045571174648,-0.00755533798588827,0.0103085624761277,0.762596030252451
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMA1,Proteasome subunit alpha type-1,39980,-0.00133170043933338,0.00448035036187794,-0.0101131871486141,0.00744978626994738,0.766293889973474
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EXOSC10,Exosome component 10,37562,0.00179546566571407,0.00607064639374215,-0.0101030012660205,0.0136939325974487,0.767416636479549
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN3,Neuronal-specific septin-3,37959,-0.00208290714976027,0.00710981839929001,-0.0160181512123687,0.0118523369128481,0.769555640776088
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,-0.000795885958551548,0.00272133070798907,-0.00612969414621013,0.00453792222910703,0.769937987023594
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,37541,-0.00217746655430497,0.00759561306786067,-0.0170648681673119,0.0127099350587019,0.774366305996413
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NLGN1,Neuroligin-1,37572,-0.00189474429697555,0.00673069846889094,-0.0150869132960018,0.0112974247020507,0.778325365617588
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,40042,-0.000888216263985945,0.00317784277819481,-0.00711678810924776,0.00534035558127587,0.779862622622454
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBZ,Hemoglobin subunit zeta,37990,0.0028000340047663,0.0101190392183585,-0.0170332828632164,0.022633350872749,0.782007422100588
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,40341,0.000893480916498591,0.0032712180753271,-0.00551810651114253,0.00730506834413971,0.78475375249953
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.00106089275154113,0.00388421849628237,-0.00867396100425457,0.00655217550117231,0.784758356740189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSP90B1,Endoplasmin,39878,-0.00184345580389822,0.00675125567695891,-0.0150759169307377,0.0113890053229412,0.784815539377787
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,-0.0013330873562099,0.00488599139325706,-0.0109096304869937,0.00824345577457394,0.784981495079231
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,37541,-0.00205565943893701,0.00782123179760264,-0.0173852737622382,0.0132739548843642,0.792685247072216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.00138000532673645,0.00525376340044655,-0.0116773815916117,0.00891737093813878,0.792809125187452
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANPEP,Aminopeptidase N,40370,0.000713135178937911,0.00271782048700773,-0.00461379297559723,0.00604006333347305,0.793022401059232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.00137611493890466,0.00530404197951021,-0.0117720372187447,0.00901980734093534,0.795294845815487
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00149987079739741,0.00583239863186437,-0.00993163052105676,0.0129313721158516,0.797057825720064
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,-0.00101845407840135,0.00398989698098793,-0.00883865216113769,0.00680174400433499,0.798527653119474
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL9,Interleukin-9,37714,0.00140688401397795,0.00555301271668343,-0.00947702091072157,0.0122907889386775,0.799997758966564
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KHDC3L,KH domain-containing protein 3,37482,-0.00163977005027373,0.00659055541581037,-0.0145572586652621,0.0112777185647146,0.803514733550578
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.000684063053061021,0.00284499574859312,-0.00626025472030354,0.0048921286141815,0.809989468220085
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELL,L-selectin,38013,0.000536215472498979,0.00223194339747682,-0.00383839358655559,0.00491082453155355,0.810143186622582
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,37541,-0.00138693302179733,0.00586290691616655,-0.0128782305774838,0.0101043645338891,0.813001358762728
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD4,Sushi domain-containing protein 4,37900,0.000994772154041573,0.0043026959343549,-0.00743851187729404,0.00942805618537719,0.817164959683016
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.00123004390660016,0.00538283988499561,-0.00932032226799123,0.0117804100811916,0.819251699748907
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP350,Centrosome-associated protein 350,37482,0.000806934763530899,0.00362092500382456,-0.00629007824396524,0.00790394777102704,0.823653246026953
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,0.000757314667323809,0.0034085960362128,-0.00592353356365328,0.0074381628983009,0.824178236197792
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYTH3,Cytohesin-3,37482,0.00157320079491153,0.00712707736120365,-0.0123958708330476,0.0155422724228707,0.825301648884851
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF3,Fibroblast growth factor 3,37598,0.000646788384822196,0.00294336604560007,-0.00512220906455394,0.00641578583419833,0.826073587984304
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC39A14,Zinc transporter ZIP14,39961,0.000698302364172314,0.00321202245308573,-0.00559726164387573,0.00699386637222035,0.827897384595178
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.00101860930188945,0.004687541619768,-0.00816897227285584,0.0102061908766347,0.827976847525472
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPEP,Glutamyl aminopeptidase,37562,-0.000967293281611689,0.00448163784050954,-0.00975130344901039,0.00781671688578701,0.829119900696045
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROK1,Prokineticin-1,40341,0.00142665991377996,0.00661723225981986,-0.011543115315467,0.0143964351430269,0.829304132820135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.0013984206959764,0.00649169432869555,-0.0141221415802197,0.0113253001882669,0.829445604243707
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.0053598879630344,0.0253479284550401,-0.0550418277349129,0.0443220518088441,0.832537306354978
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS2,"Nitric oxide synthase, inducible",37562,0.000793120505930891,0.00379615203830935,-0.00664733748915543,0.00823357850101721,0.834508092036384
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.00154239053199052,0.00738537884880209,-0.0160177330756426,0.0129329520116616,0.83457292250668
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL3,Insulin-like 3,37942,-0.00118822844820719,0.00575443152380964,-0.0124669142348741,0.0100904573384597,0.83641185038006
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD177,CD177 antigen,40316,0.00253035664547114,0.0122872648343762,-0.0215526824299063,0.0266133957208486,0.83684567802791
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,37572,-0.000836983154249586,0.00414460949672742,-0.00896041776783534,0.00728645145933616,0.839962854792176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF7,Fibroblast growth factor 7,37482,0.00158000472528566,0.00782917616098331,-0.0137651805502416,0.0169251900008129,0.840068545326923
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH4,Cadherin-4,37541,0.000949645625617977,0.00478759644013113,-0.00843404339703905,0.010333334648275,0.842770087228305
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMCN2,Hemicentin-2,37648,-0.00107326037434899,0.00551312054017457,-0.0118789766330912,0.00973245588439317,0.845651285552578
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A3,Protein S100-A3,37900,0.000861928575662989,0.00443070043085993,-0.00782224426882247,0.00954610142014845,0.845759531006289
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00119164749168612,0.00615310238983109,-0.0108684331923828,0.0132517281757551,0.846440337349787
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,37598,0.000906681348802956,0.00472612179790049,-0.008356517375082,0.0101698800726879,0.847866830278541
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,40465,0.00116880279731406,0.00613793872413823,-0.0108615571019969,0.013199162696625,0.848980333513659
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB5,Serpin B5,40042,-0.000893863673510923,0.00469464859683998,-0.0100953749233173,0.00830764757629544,0.848997746038083
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PODXL2,Podocalyxin-like protein 2,40411,-0.000494788139035197,0.00262204784493636,-0.00563400191511047,0.00464442563704007,0.850328046098514
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00101063886739669,0.00542416564014771,-0.0116420035220862,0.00962072578729283,0.852195521301885
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP73,Tumor protein p73,37572,0.000619685663904815,0.00337659644441223,-0.00599844336714316,0.00723781469495279,0.854389916275654
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC1A4,Neutral amino acid transporter A,37572,0.000924158424939736,0.00507290144970567,-0.00901872841648338,0.0108670452663628,0.855447803592101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,37562,-0.000566730765246172,0.00316955219337205,-0.00677905306425539,0.00564559153376304,0.858093833482209
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00114293933837887,0.00649299458254835,-0.0115833300434159,0.0138692087201736,0.860275814771533
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,40341,0.000791051638868814,0.00453074896967654,-0.0080892163416972,0.00967131961943483,0.861399144355648
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.000825631257448552,0.00475376572894013,-0.0101430120861712,0.00849174957127411,0.862119624169868
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPBGL,Trophoblast glycoprotein-like,37572,0.000692886459952248,0.00403258260159279,-0.00721097543916961,0.00859674835907411,0.863580109069397
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.000796719117027254,0.00469961093718996,-0.00841451831986507,0.0100079565539196,0.865383384538117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,40044,0.000607051743029811,0.00373540298767908,-0.00671433811282118,0.0079284415988808,0.870903956202513
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKIV2L,Helicase SKI2W,37562,-0.000637039907573809,0.00392181155685449,-0.0083237905590086,0.00704971074386098,0.870965724400836
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTNL10,Butyrophilin-like protein 10,37482,0.000652735555154718,0.00404366971116758,-0.00727285707873374,0.00857832818904318,0.871763873584753
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCLN,Nicalin,40044,-0.00080000415811833,0.00513867476507013,-0.0108718066976558,0.00927179838141912,0.876284935462078
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN7,Tetraspanin-7,37541,-0.00134857004587507,0.00885593859639001,-0.0187062096947995,0.0160090696030493,0.878969539661168
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL4,Myosin light chain 4,37628,-0.000766769942130603,0.00507547271704761,-0.0107146964675439,0.00918115658328271,0.879919969236615
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,0.000950537153544529,0.00637484362929286,-0.0115441563598695,0.0134452306669585,0.881471081942528
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRC1,Protein regulator of cytokinesis 1,37900,-0.000658667478512571,0.00450116252189242,-0.00948094602142172,0.00816361106439658,0.883660908743435
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,37541,-0.000895659343628687,0.00615326170317897,-0.0129560522818595,0.0111647335946021,0.884272198186927
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,-0.000587354357853495,0.00406369370217497,-0.00855219401411643,0.00737748529840944,0.885078606317837
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,-0.000690731054630629,0.00488113399500861,-0.0102577536848475,0.00887629157558624,0.887468949941745
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESR1,Estrogen receptor,37598,0.000734845452942002,0.00562327166529432,-0.0102867670110349,0.0117564579169189,0.896030972779997
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGLON5,IgLON family member 5,37482,-0.00117261465893821,0.00910088470239451,-0.0190103486756315,0.016665119357755,0.89748131487958
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FH,"Fumarate hydratase, mitochondrial",37541,0.00100974803781798,0.00827185719050254,-0.015203092055567,0.017222588131203,0.902845221978934
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,40341,-0.000469798971447046,0.00385684171967853,-0.00802920874201697,0.00708961079912288,0.903051633767682
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL3,Interleukin-3,37482,-0.000698283572488748,0.00581645757793272,-0.0120985404252369,0.0107019732802594,0.904442961283256
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPGN,Epigen,37900,-0.000569395231119908,0.00477347441996975,-0.00992540509426061,0.00878661463202079,0.90505278674481
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB2,Integrin beta-2,40221,0.000327831907640591,0.00275680121873709,-0.0050754984810841,0.00573116229636529,0.905342232285516
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSD1,Tryptase delta,37959,0.000426016522414077,0.00368490306891511,-0.00679639349265953,0.00764842653748769,0.907962306505721
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLINT1,Clathrin interactor 1,37482,-0.000489494088817082,0.00443702144532384,-0.00918605612165181,0.00820706794401765,0.912156958837683
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAGEA3,Melanoma-associated antigen 3,37714,0.000873823243733293,0.0081660728095527,-0.01513167946299,0.0168793259504566,0.914785405397741
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2,Interleukin-2,40044,-0.000319111406278407,0.0030141855971758,-0.00622691517674298,0.00558869236418617,0.915686970043174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.000510929515417222,0.004876295802438,-0.00904661025736126,0.0100684692881957,0.91655340416933
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,39980,-0.000494769134146849,0.00479276327507139,-0.00988858515328678,0.00889904688499308,0.917779746530584
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.000461099010219348,0.00488360068511604,-0.0091107583326081,0.0100329563530468,0.924778674144716
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNIP4,Kv channel-interacting protein 4,39961,0.000465140183441408,0.00493703093706785,-0.00921144045321158,0.0101417208200944,0.924939938351986
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP2BP,LRP2-binding protein,37572,0.000751780955893485,0.0083887441935614,-0.0156901576634869,0.0171937195752738,0.92859229208151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHC1,SHC-transforming protein 1,37482,0.000987313786687152,0.0112833016330944,-0.0211279574141779,0.0231025849875522,0.93027367644796
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,37541,0.000506256002581122,0.00596786302784058,-0.0111907555319864,0.0122032675371487,0.932397549670648
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,37628,0.00039850343145371,0.00471394324716313,-0.00884082533298603,0.00963783219589345,0.932630633901755
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN6,Prefoldin subunit 6,37572,0.000495032596350434,0.00638615839916322,-0.0120218378660095,0.0130119030587103,0.9382138540857
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,37541,-0.000543882073655288,0.00730494783232372,-0.0148615798250098,0.0137738156776992,0.94065033577281
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00030184631630162,0.00412195569944617,-0.00777718685461288,0.00838087948721612,0.941625076665931
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.000229610606593033,0.00313887329984884,-0.00592258106111069,0.00638180227429676,0.941687356613343
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL6B,Myosin light chain 6B,37572,0.000609209666576099,0.00893429161443928,-0.0169020018977249,0.0181204212308771,0.945637179712873
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.000210824052657497,0.00316543732323423,-0.0059934331008816,0.00641508120619659,0.946899509142114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,40403,0.000171837319259294,0.00264426471739746,-0.00501092152683973,0.00535459616535831,0.948186824897619
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.000210664146339745,0.0034302753454508,-0.00651267553074382,0.00693400382342331,0.951030939680022
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRX,Cone-rod homeobox protein,40042,-0.000633467552521712,0.0103382122183022,-0.0208963635003941,0.0196294283953506,0.951141479049353
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,0.000385369058765803,0.00630959127156694,-0.0119814298335054,0.012752167951037,0.951298906458768
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPB41L5,Band 4.1-like protein 5,37572,0.000367043084836574,0.00615053911172272,-0.01168801357414,0.0124220997438131,0.95241414089506
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.000232377487414601,0.00397870096001207,-0.00803063136903826,0.00756587639420906,0.953426630444522
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY2A,Pancreatic alpha-amylase,39695,-0.000247982894785154,0.00453622616104606,-0.00913898617043543,0.00864302038086512,0.956404297649251
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,-0.000202373038381154,0.00397797106767004,-0.00799919633101443,0.00759445025425212,0.959427142884907
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,0.000138314279572273,0.00290422627843618,-0.00555396922616265,0.00583059778530719,0.962015676617268
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.000165850735154007,0.00396357356422568,-0.00793445492103635,0.00760275345072833,0.966623902832224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK3,Prostate-specific antigen,37998,-0.000221760812554246,0.00551625669833492,-0.0110336239412907,0.0105901023161822,0.96793321602141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,9.17078610275535e-05,0.00235913197756079,-0.00453219081499159,0.0047156065370467,0.968991684893749
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL5,Interleukin-5,40044,0.000497819937992258,0.0140340919421726,-0.0270090002686661,0.0280046401446506,0.97170367781403
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-0.000143299194824114,0.00476504370194789,-0.00948278485064198,0.00919618646099375,0.976009288492448
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAD2,Glutamate decarboxylase 2,37598,-0.000125518229678352,0.00457619839619522,-0.00909486708622098,0.00884383062686428,0.978118388308146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFL4,Insulin growth factor-like family member 4,37598,0.000164421379749786,0.00760330592930809,-0.0147380582416941,0.0150669010011936,0.982747430919968
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,40128,-0.000362955550403509,0.0168122895969863,-0.0333150431604966,0.0325891320596896,0.98277631878581
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REN,Renin,40359,0.00013737541271741,0.00685249941752031,-0.0132935234456224,0.0135682742710572,0.984005740161343
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAG,Myelin-associated glycoprotein,37572,6.72753693924878e-05,0.00450120340283166,-0.00875508330015756,0.00888963403894253,0.988075420634856
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORN4,MORN repeat-containing protein 4,37482,0.000104474491035979,0.00762224658831153,-0.0148351288220546,0.0150440778041266,0.989064329928104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,37482,-3.00440909867913e-05,0.00613433211193275,-0.012053335030375,0.0119932468484014,0.996092294950161
